glucagon has been researched along with Obesity in 849 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 405 (47.70) | 18.7374 |
1990's | 110 (12.96) | 18.2507 |
2000's | 124 (14.61) | 29.6817 |
2010's | 146 (17.20) | 24.3611 |
2020's | 64 (7.54) | 2.80 |
Authors | Studies |
---|---|
Ellingsgaard, H; Karstoft, K; Klarlund Pedersen, B; Peletier, M; Plomgaard, P; Simonsen, C; Trinh, B; van Hall, G | 1 |
Chen, X; Tripathy, D | 1 |
Kamalanathan, S; Roy, A; Sahoo, J | 1 |
Del Prato, S; Gallwitz, B; Holst, JJ; Meier, JJ | 1 |
Mandarim-de-Lacerda, CA; Spezani, R | 1 |
Bojsen-Møller, KN; Dirksen, C; Holst, JJ; Jensen, CZ; Jensen, NJ; Kjeldsen, SAS; Madsbad, S; Martinussen, C; Rungby, J; Veedfald, S; Wewer Albrechtsen, NJ | 1 |
Akheruzzaman, M; Dhurandhar, NV; Feizy, Z; Hegde, V; Shin, AC; Siddik, MAB | 1 |
Dornonville de la Cour, C; Guo, T; Jeppesen, JF; Kruse, T; Lau, J; McGuire, J; Niss, K; Raun, K; Sauerberg, P; Simonsen, L | 1 |
Feigh, M; Harris, MS; Nestor, JJ; Parkes, D; Suschak, JJ | 1 |
Conceição-Furber, E; Coskun, T; Samms, RJ; Sloop, KW | 1 |
Barron, M; Fernando, DG; Geurts, AM; Hayes, H; Kindel, TL | 1 |
Angelidi, AM; Gavrieli, A; Kokkinos, A; Mantzoros, CS; Perakakis, N; Tentolouris, N; Tsilingiris, D; Yannakoulia, M | 1 |
Erfanian, Z; Hassanzadeh-Taheri, M; Hosseini, M; Mohammadifard, M | 1 |
Ahlström, H; Bergsten, P; Forslund, A; Kullberg, J; Manell, H; Mangge, H; Maruszczak, K; Mörwald, K; Pixner, T; Radzikowski, K; Schütz, S; Weghuber, D | 1 |
Abdelaal, M; Docherty, NG; Elliott, JA; Flatt, PR; Khan, D; Le Roux, CW; Moffett, CR; Naughton, V; Sridhar, A | 1 |
Kashtanova, EV; Khudiakova, AD; Polonskaya, YV; Ragino, YI; Shcherbakova, LV; Shramko, VS; Striukova, EV | 1 |
Andreassen, KV; Henriksen, K; Karsdal, MA; Kayed, A; Khan, S; Melander, SA | 1 |
Bhawal, R; Chen, W; Jing, H; Lidan, S; Qiang, Z; Qianqian, Z; Wenxi, W; Zhihong, Y | 1 |
Hope, DCD; Tan, TM | 1 |
Bojsen-Møller, KN; Holst, JJ; Kristiansen, VB; Madsbad, S; Richter, MM; Svane, MS | 1 |
Csanalosi, M; Kabisch, S; Kemper, M; Keyhani-Nejad, F; Markova, M; Meyer, NMT; Pfeiffer, AFH; Pivovarova-Ramich, O; Rohn, S; Schäfer, SM; Schuppelius, B; Zhang, J | 1 |
Arora, S; Kalra, S; Kapoor, N | 1 |
Müller, TD; Novikoff, A | 1 |
Doggrell, SA | 1 |
Chaves, IZ; Hansen, KE; Murali, S; Ney, DM; Suen, G | 1 |
Chen, P; Feng, C; Hou, P; Liu, J; Zhang, X; Zheng, W; Zhou, X | 1 |
Bloom, S; Carling, D; Davies, I; Dore, M; Goldin, R; Hope, DCD; Khoo, B; Le Gall, M; McGlone, ER; Owen, B; Siebert, M; Tan, TM | 1 |
Ahrén, B; Nogueiras, R; Tschöp, M | 1 |
Argyrakopoulou, G; Bontozoglou, N; Kalra, B; Kokkinos, A; Konstantinidou, SK; Kouvari, M; Kumar, A; Kumar, M; Kyriakopoulou, K; Mantzoros, CS; Simati, S; Stefanakis, K | 1 |
Nauck, MA; Nogueiras, R; Tschöp, MH | 1 |
Baek, S; Byeon, J; Choi, J; Hompesch, M; Kang, S; Shin, W | 1 |
Chen, L; Chen, W; Cui, W; Hu, X; Li, X; Shang, H; Sun, X; Wang, J; Wu, J; Xiao, RP; Yuan, Y; Zeng, F; Zhang, J; Zhang, X; Zheng, W | 1 |
Argyrakopoulou, G; Kalra, B; Kokkinos, A; Konstantinidou, SK; Kouvari, M; Kumar, A; Mantzoros, CS; Simati, S; Stefanakis, K | 1 |
Bhattacharya, S; Okoh, GI; Thompson, D; Vishnoi, S; Walsh, EM | 1 |
Cortes, D; de Knegt, VE; Gluud, LL; Halkjær, SI; Jensen, JB; Kallemose, T; Petersen, AM; Wewer Albrechtsen, NJ | 1 |
Endahl, L; Friedrichsen, MH; Goldwater, R; Kankam, M; Kreiner, FF; Nygård, SB; Toubro, S | 1 |
Christensen, B; Dollerup, OL; Gillum, MP; Hartmann, B; Holst, JJ; Jessen, N; Møller, N; Trammell, SAJ; Treebak, JT | 1 |
Al-Massadi, O; Diéguez, C; Fernø, J; Nogueiras, R; Quiñones, M | 1 |
Chen, S; Klein, S; Scherer, PE; Smith, GI; Stern, JH; Unger, RH | 1 |
Chen, Y; Hu, C; Hu, M; Hu, Y; Li, D; Li, X; Liao, S; Liu, B; Liu, J; Lu, Y; Lv, X; Qian, Q; Tan, M; Wang, Y; Wu, D; Xiong, X; Zhang, D; Zhang, Z | 1 |
Ainslie, PN; Caldwell, HG; Clarke, K; Little, JP; Myette-Côté, É | 1 |
Ambery, PD; Cooper, AT; Heise, T; Hirshberg, B; Hornigold, DC; Klaus, B; Meier, JJ; Parker, VER; Petrone, M; Plum-Moerschel, L; Posch, MG; Robertson, D; Schlichthaar, H; Wang, T | 1 |
Kareenhalli, V; Somvanshi, PR; Tomar, M | 1 |
DiMarchi, RD; Finan, B; Knerr, PJ; Mowery, SA; Perez-Tilve, D; Tschöp, MH | 1 |
Avraham, Y; Bi, X; Cai, X; Dai, Y; He, L; Huang, W; Li, C; Liu, C; Qian, H; Sun, L; Tong, J; Wang, Y; Zhou, J | 1 |
Bagger, JI; Demant, M; Holst, JJ; Knop, FK; Kønig, MJ; Langhoff, JL; Lund, A; Rigbolt, K; Strandberg, C; Suppli, MP; van Hall, G; Vilsbøll, T; Wewer Albrechtsen, NJ | 1 |
Azhar, S; Bittner, A; Bittner, S; Chan, J; Cortez, Y; Dong, D; Han, L; Kraemer, FB; Peterson, RG; Shen, WJ; Umar, M | 1 |
Annicotte, JS; Barrachina, C; Cavelier, P; Chavey, C; de Toledo, M; Gromada, X; Lopez-Mejia, IC; Pratlong, M; Tazi, J | 1 |
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
Pei, Z; Wang, S; Yan, J; Yang, X; Zhou, D | 1 |
Abdel-Wahab, YH; Conlon, JM; Flatt, PR; Graham, GV | 1 |
Khoo, B; Tan, TM | 1 |
Bandyopadhyay, GK; Brenner, D; Kisseleva, T; Lam, K; Lee, YS; Liu, X; Moon, JS; Riopel, M; You, S | 1 |
Bahekar, R; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, M; Patel, V; Savsani, H | 1 |
Iizuka, K; Kubota, S; Kuwata, H; Liu, Y; Seino, Y; Yabe, D | 1 |
Chen, W; Cui, J; Shang, A; Wang, W | 1 |
Fappi, A; Mittendorfer, B | 1 |
Anderson, JN; Bao, Y; Bartlett, JR; Bissonnette, S; Briant, AR; Carcel, C; Chan, K; Chen, H; Chen, L; Cheng, C; Chrétien, M; Conway Fitzgerald, A; Cyr, Y; Du, Y; El-Sayed, YY; Endo, T; Faraj, M; Fujimoto, K; Girsen, A; Goto, H; Hashimoto, D; Hayasaka, K; Hayase, E; Herrmann, N; Hidaka, D; Holst, JJ; Igbinosa, I; Iijima, H; Jeandidier, N; Jeong, DY; Jeong, GT; Joubert, M; Kagawa, I; Kahata, K; Kaushik, LK; Kim, SK; Kim, SR; Kuang, Y; Laird, M; Lamantia, V; Li, P; Li, Y; Li, Z; Lindsay, SE; Liu, X; Loizon, E; Lu, Z; Lyell, DJ; Ma, J; Magnani, CJ; Mahalingam, AK; Mandal, N; Mayer, G; Michimata, R; Ngo Sock, ET; Okada, K; Onozawa, M; Opigez, V; Palanisamy, M; Parienti, JJ; Park, YR; Pavlikova, B; Peyro Saint Paul, L; Ramsahye, N; Reyes, GA; Reznik, Y; Richardson, MT; Samo, IA; Sarkar, R; Shendge, AK; Shimizu, C; Shiratori, S; Steinberg, JR; Sugita, J; Sukwong, P; Sun, X; Sunagoya, K; Sunwoo, IY; Svendsen, B; Tang, L; Tang, Z; Teshima, T; Totée, C; Turner, BE; Unno, M; Vidal, H; Wang, C; Wang, M; Wang, S; Wang, X; Wang, Z; Wassef, H; Weeks, BT; Wong Chi Man, M; Xu, C; Xu, W; Yamamoto, S; Yu, H; Zhang, WY; Zhang, X; Zhong, Y | 1 |
Burling, K; Gribble, F; Lewis, HB; Meek, CL; Reimann, F | 1 |
Flatt, PR; Irwin, N; McCloskey, AG; McKillop, AM; Moffett, RC; Mohan, S | 1 |
Antipenko, J; Cunningham, SE; DiMarchi, R; Finan, B; Gamble, KL; Habegger, KM; Holleman, C; Hunter, CS; Kharitonenkov, A; Kim, T; Nason, SR; Paul, JR; Pierre, TH; Presedo, N; Young, ME | 1 |
Elovaris, RA; Feinle-Bisset, C; Hajishafiee, M; Heilbronn, LK; Horowitz, M; Jones, KL; Poppitt, SD | 1 |
Gu, X; Huang, F; Huang, M; Huang, P; Ma, R; Meng, L; Tan, J; Wang, J | 1 |
Chen, X; DeFronzo, RA; Maldonado, E; Tripathy, D | 1 |
Aguilera-Aguilera, R; Gonzalez-Cara, C; Mendoza, FJ; Perez-Ecija, A; Toribio, RE | 1 |
Cao, X; Han, X; Huang, WY; Jia, W; Li, J; Peng, S; Peng, Y; Wang, L; Xu, Y; Ye, J; Ye, X; Zhang, S; Zhang, X; Zhou, Y | 1 |
Bock, C; Carnero, EA; Chivukula, K; Meyer, C; Smith, SR; Sparks, LM; Tillner, J; Vega, RB; Whytock, KL; Yi, F | 1 |
Brown, GS; Diaz, M; Lackey, AI; Sato, PY; Snyder, J; Yuzhen, T | 1 |
Ardévol, A; Beltrán-Debón, R; Blay, M; Grau-Bové, C; Miguéns-Gómez, A; Pinent, M; Rodríguez-Gallego, E; Sierra-Cruz, M; Terra, X | 1 |
Ameneiro, C; Beiroa, D; Bernardo, G; Bilbao, J; Bravo, SB; Carneiro, C; Cho, JW; Coppari, R; Cuñarro, J; Da Silva Lima, N; Dieguez, C; Dp Chantada-Vazquez, M; Fernandez, U; Fernández-Ramos, D; Ferno, J; Fidalgo, M; Fondevila, MF; Fruhbeck, G; Garcia-Vence, M; Gonzalez-Rellan, MJ; Guallar, D; Herzig, S; Iglesias, C; López, M; Lopitz-Otsoa, F; Martinez-Chantar, ML; Mato, JM; Millet, O; Müller, TD; Nogueiras, R; Novoa, E; Perez-Fernandez, R; Porteiro, B; Rodríguez, A; Sabio, G; Senra, A; Seoane, S; Tovar, S; Varela-Rey, M; Veyrat-Durebex, C; Vidal, A; Woodhoo, A; Yang, WH | 1 |
Biggs, E; Foreman, R; Galvin, SG; Gribble, FM; Jermutus, L; Kay, RG; Larraufie, P; Meek, CL; Ravn, P; Reimann, F | 1 |
Böni-Schnetzler, M; Dalmas, E; Donath, MY; Dror, E; Goetz, N; Herrera, PL; Koch, N; Makshana, V; Meier, DT; Nordmann, TM; Schulze, F; Stawiski, M; Thorel, F; Traub, S | 1 |
Geisler, CE; Renquist, BJ | 1 |
Bossart, M; Dudda, A; Elvert, R; Evers, A; Glien, M; Haack, T; Henkel, B; Kadereit, D; Kurz, M; Lorenz, K; Lorenz, M; Stengelin, S; Wagner, M | 1 |
Clemmensen, C; DiMarchi, RD; Finan, B; Hofmann, SM; Jall, S; Müller, TD; Neff, F; Sachs, S; Tschöp, MH | 1 |
Li, J; Li, W; Liang, J; Luan, B; Lv, S; Qiu, X; Zhang, C; Zhang, ZN | 1 |
Bergman, RN; Dunaif, A; Sam, S; Vellanki, P; Yalamanchi, SK | 1 |
DiMarchi, R; Tschöp, M | 1 |
Barkai, HS; Flatt, SW; Heath, DD; Pakiz, B; Rock, CL | 1 |
Díaz-Villaseñor, A; Palacios-González, B; Torres, N; Tovar, AR; Tovar-Palacio, C; Velázquez-Villegas, LA | 1 |
Eaton, P; Rudyk, O | 1 |
Ahmed, AR; Behary, P; Bloom, SR; Chahal, H; Holst, JJ; Kenkre, J; Miras, AD; Tan, T; Tharakan, G; Wewer Albrechtsen, NJ | 1 |
Auwerx, J; Dongiovanni, P; Kim, K; Nayak, S; Ozcan, L; Pajvani, UB; Ryu, D; Ueberheide, B; Valenti, L | 1 |
Henquin, JC; Ibrahim, MM; Rahier, J | 1 |
Adamidou, A; Arafat, AM; Assefa, B; Bähr, V; Birkenfeld, AL; Bumke-Vogt, C; Frystyk, J; Lieske, S; Mahmoud, AM; Möhlig, M; Pfeiffer, AFH; Sarem, Z; Spranger, J; Weickert, MO | 1 |
Albrechtsen, NJW | 1 |
Clark, M; Hoenig, M; Reiche, D; Schaeffer, DJ | 1 |
Goode, JP; McMahon, C; Poppitt, SD; Silvestre, MP; Tay, A; Vlaskovsky, P | 1 |
DiMarchi, RD; Finan, B; Gelfanov, V; Knerr, PJ; Perez-Tilve, D; Tschöp, MH | 1 |
Aithal, GP; Douglas, JA; King, JA; Misu, H; Nimmo, MA; Sargeant, JA; Stensel, DJ; Takamura, T; Takayama, H; Turner, MC; Webb, DR; Yates, T | 1 |
Bahekar, R; Jain, M; Joharapurkar, A; Kshirsagar, S; Pandey, D; Patel, D; Patel, H; Patel, M; Patel, V; Sutariya, B | 1 |
Haluzík, M; Holubová, M; Hrubá, L; Kuneš, J; Maletínská, L; Mikulášková, B; Pražienková, V; Železná, B; Zemenová, J | 1 |
Flatt, PR; Irwin, N; Pathak, V | 2 |
Wewer Albrechtsen, NJ | 1 |
Albrechtsen, NJW; Gabe, MBN; Holst, JJ; Rosenkilde, MM | 1 |
Bloom, SR; Scott, RV | 1 |
Adams-Huet, B; Burgess, S; Li, X; Lingvay, I; Mari, A; Mitchell, L; Pop, LM; Zhao, TJ | 1 |
Feinle-Bisset, C; Fitzgerald, PCE; Giesbertz, P; Horowitz, M; Steinert, RE; Ullrich, SS | 1 |
Horowitz, M; Rayner, CK | 1 |
Cabrera, A; Del Castillo, D; Molina, A; París, M; Raga, E; Sabench, F; Sánchez, A; Vives, M | 1 |
Bonikowska, K; Magnusson, P; Sjöholm, Å | 1 |
Brandt, SJ; DiMarchi, RD; Müller, TD; Stemmer, K; Tschöp, MH | 1 |
Bjørn Andersen, U; Goetze, JP; Holst, JJ; Jeppesen, JL; Linneberg, A; Lundegaard Asferg, C | 1 |
Araujo, TR; Bonfleur, ML; Boschero, AC; Carneiro, EM; da Silva, JA; Freitas, IN; Lubaczeuski, C; Magalhães, EA; Ribeiro, ES; Ribeiro, RA; Silva, JN; Vettorazzi, JF | 1 |
Bracht, A; Carreño, FO; Constantin, J; Constantin, RP; de Moraes, SMF; Gasparin, FRS; Ghizoni, CVC; Gilglioni, EH; Ishii-Iwamoto, EL; Maeda Júnior, AS; Natali, MRM; Rocha, M; Utsunomiya, KS | 1 |
Chen, L; Cui, W; Hou, N; Hu, X; Liu, Y; Ma, D; Shang, H; Sun, X; Wang, C; Wang, J; Xiao, RP; Xiao, Y; Yuan, Y; Zeng, F; Zhang, X; Zhang, Y; Zheng, W | 1 |
Andersen, MM; Bergmann, NC; Bergmann, S; Christensen, MB; Gasbjerg, LS; Hartmann, B; Holst, JJ; Jessen, L; Knop, FK; Lund, A; Meessen, ECE; Vilsbøll, T | 1 |
Dash, S; Floh, A; Lee, SJ; Stahel, P; Sud, SK | 1 |
Andersson, T; Chorell, E; Holst, JJ; Larsson, C; Lindahl, B; Mellberg, C; Olsson, T; Otten, J; Ryberg, M | 1 |
Contreras, C; Diéguez, C; González-García, I; López, M; Milbank, E | 1 |
Calanna, S; Di Pino, A; Maria Rabuazzo, A; Maria Zagami, R; Piro, S; Purrello, F; Urbano, F | 1 |
Abdul-Ghani, MA | 1 |
Imagawa, A; Iwahashi, H; Kozawa, J; Okita, K; Shimomura, I; Yamagata, K | 1 |
Drucker, DJ; Sadry, SA | 1 |
Bano, G | 1 |
Bloom, SR; Bouvy, ND; Buurman, WA; de Jonge, C; Greve, JW; le Roux, CW; Rensen, SS; Schaper, NC; Verdam, FJ; Vincent, RP | 1 |
Franklin, ZJ; Irwin, N; O'Harte, FP | 1 |
Blaak, EE; Holst, JJ; Knop, FK; Konings, E; Schrauwen, P; Timmers, S | 1 |
Anselmino, M; Astiarraga, B; Baldi, S; Camastra, S; Ciociaro, D; Ferrannini, E; Gastaldelli, A; Holst, JJ; Mari, A; Muscelli, E; Nannipieri, M | 1 |
Adamidou, A; Arafat, AM; Möhlig, M; Otto, B; Perschel, FH; Pfeiffer, AF; Spranger, J; Weickert, MO | 1 |
Bhat, VK; Flatt, PR; Gault, VA; Irwin, N | 1 |
Berglund, ED; Elmquist, JK; Kim, MH; Lee, CE; Liu, C; Liu, T; Sohn, JW; Vianna, CR; Williams, KW; Xu, Y | 1 |
Chabenne, J; Clemmensen, C; Dimarchi, R; Finan, B; Fischer, K; Hofmann, SM; Küchler, D; Müller, TD; Ograjsek, T; Pfluger, PT; Pinkstaff, J; Schriever, SC; Sehrer, L; Sullivan, L; Tschöp, MH | 1 |
Björnholm, M; Chibalin, AV; Deshmukh, AS; Garcia-Roves, PM; Holmström, MH; Jiang, LQ; Sjögren, RJ; Vieira, E; Zachariah Tom, R; Zierath, JR | 1 |
Andreani, T; Belani, J; Bradley, P; Cao, Y; Chen, P; Cox, K; Dai, P; Dai, X; DeMong, D; Feng, KI; Gauuan, J; Greenlee, W; Grotz, D; Hwa, J; Kang, L; Kozlowski, J; Lachowicz, J; Lavey, B; Liang, M; Lin, P; Lin, SI; McNamara, P; Meng, T; Miller, M; Morrison, R; Patel, B; Sondey, C; Soriano, A; Stamford, A; Wong, J; Wong, M; Yang, DY; Yu, W; Zhai, Y; Zhang, H; Zhao, H; Zhou, G | 1 |
Bar Yamin, H; Barnea, M; Chapnik, N; Froy, O; Genzer, Y | 1 |
Rui, L | 1 |
Condren, AB; Donahue, EP; Farmer, TD; Healey, EC; Kim, K; McCoy, GA; O'Brien, TP; Printz, RL; Shiota, M; Ueta, K | 1 |
Alonso-Magdalena, P; Fuentes, E; Marroquí, L; Merino, B; Nadal, A; Quesada, I | 1 |
Gao, Z; Ke, B; Wei, X; Ye, J; Ye, X; Zhao, Z | 1 |
Charron, MJ; Du, XQ; Foda, ZH; Kleiner, RE; Leissring, MA; Liu, DR; Maianti, JP; McFedries, A; Saghatelian, A; Seeliger, MA; Tang, WJ | 1 |
Flatt, PR; Gault, VA; Irwin, N; Lynch, AM; O'Harte, FP; Pathak, N; Pathak, V | 1 |
Calle, RA; Fryburg, DA; Ghosh, A; Lee, DS; Raymond, RH; Robertson, RP; Savage, PJ; Shankar, SS; Vassileva, MT; Weir, GC | 1 |
Pellitero, S; Puig-Domingo, M | 1 |
Biller, BM; Bredella, MA; Dichtel, LE; Gerweck, AV; Gurel, MH; Miller, KK; Riccio, AD; Russell, BM; Sluss, PM; Yuen, KC | 1 |
Bahekar, R; Jain, MR; Joharapurkar, AA; Kshirsagar, SG; Patel, KN; Patel, V; Srivastava, BK | 1 |
Baretić, M; Troskot, R | 1 |
Escalada, FJ | 1 |
Bassil, M; Burgos, SA; Chevalier, S; Gougeon, R; Lamarche, M; Marliss, EB; Morais, JA | 1 |
Ader, M; Bergman, RN; Woolcott, OO | 1 |
Bhonde, RR; Chalasani, M; Ganneru, S; Malakapalli, V; Nappanveettil, G; Singh, H; Venkatesan, V | 1 |
Ahmed, L; Bantle, JP; Bessler, M; Billington, CJ; Connett, JE; Ikramuddin, S; Inabnet, WB; Korner, J; Nguyen, KT; Thomas, A; Vella, A; Wang, Q | 1 |
Cho, WK; Jung, MH; Park, MS; Park, SH; Suh, BK | 1 |
Borck, PC; Boschero, AC; Carneiro, EM; Irles, E; Nadal, A; Porciuncula, PM; Quesada, I; Ribeiro, RA; Rickli, S; Santos-Silva, JC; Vettorazzi, JF | 1 |
Caldwell, D; Chen, Q; Coughlan, MC; Florian, M; Fu, A; Jin, X; Lalande, M; Laziyan, M; Mailloux, R; Patry, D; Petrov, I; Wang, GS; Willmore, W; Yan, J | 1 |
Bindels, LB; Burkart, V; Hartmann, B; Henrich, B; Holst, JJ; Hwang, JH; Kolb, H; MacKenzie, C; Martinez, I; Nowotny, B; Nowotny, P; Pacini, G; Roden, M; Schloot, NC; Simon, MC; Stehle, P; Strassburger, K; Walter, J; Zivehe, F | 1 |
Alonso-Magdalena, P; García-Arévalo, M; Gonzalez, A; Lluesma, M; Marroquí, L; Merino, B; Nadal, A; Ñeco, P; Quesada, I | 1 |
Abdel-Wahab, YH; Conlon, JM; Flatt, PR; Ojo, OO; Owolabi, BO; Srinivasan, DK | 1 |
Ahrén, B; Andersen, B; Omar, BA; Rakipovski, G; Raun, K | 1 |
Carlson, OD; Egan, JM; Elahi, D; Habener, JF; Meneilly, GS; Ruff, DA | 1 |
Heden, TD; Kanaley, JA; Leidy, HJ; Nyhoff, LM; Park, YM; Thyfault, JP; Winn, NC | 1 |
Adams-Huet, B; Bouza, B; Dart, L; Franklin, B; Mitchell, J; Phillips, M; Shah, M | 1 |
Bendtsen, F; Bojsen-Møller, KN; Dirksen, C; Hartmann, B; Holst, JJ; Jørgensen, NB; Kristiansen, VB; Madsbad, S; Nielsen, S; Svane, MS | 1 |
Beglinger, C; Cajacob, L; Drewe, J; Herzog, R; Meyer-Gerspach, AC; Riva, D; Wölnerhanssen, BK | 1 |
Fredriksson, R; Gohel, PA; Hilmarsson, TG; Maestri, G; Mickael, M; Schiöth, HB; Wiemerslage, L; Williams, MJ | 1 |
Franklin, ZJ; Hewage, CM; Irwin, N; McShane, LM; O'Flynn, D; O'Harte, FP | 1 |
Billert, M; Kaczmarek, P; Kolodziejski, PA; Mackowiak, P; Nowak, KW; Pruszynska-Oszmalek, E; Sassek, M; Strowski, MZ; Szczepankiewicz, D | 1 |
Bjornvad, CR; Cronin, AM; Hoelmkjaer, KM; Holst, JJ; Mandrup-Poulsen, T; Nielsen, DH; Wewer Albrechtsen, NJ | 1 |
Britton, HM; Clee, SM; Denroche, HC; Glavas, MM; Karunakaran, S; Kieffer, TJ; Philippe, M; Quong, WL; Tudurí, E | 1 |
Batra, M; Bellini, N; Chaudhuri, A; Dandona, P; Dhindsa, S; Ghanim, H; Green, K; Hejna, J; Kuhadiya, ND; Makdissi, A; Mehta, A; Sandhu, S; Yang, M | 1 |
Conlon, JM; Flatt, PR; Lynch, AM; Ng, MT; O'Harte, FP | 1 |
Clemmensen, C; DiMarchi, RD; Finan, B; Gelfanov, V; Müller, TD; Perez-Tilve, D; Tschöp, MH | 1 |
Dusaulcy, R; Gosmain, Y; Gribble, F; Handgraaf, S; Heddad-Masson, M; Philippe, J; Reimann, F; Skarupelova, S; Vesin, C; Visentin, F | 1 |
Biebermann, H; Brandt, S; Clemmensen, C; De Angelis, M; DiMarchi, R; Döring, Y; Finan, B; Fischer, K; Flamant, F; Fuchs, H; Gailus-Durner, V; Gauthier, K; Gelfanov, V; Habegger, KM; Healy, ME; Heikenwalder, M; Hofmann, SM; Hrabě de Angelis, M; Jall, S; Jastroch, M; Keuper, M; Kleinert, M; Köhrle, J; Liu, F; Liu, P; Lutter, D; Malehmir, M; Moreth, K; Müller, L; Müller, TD; Neff, F; Perez-Tilve, D; Rozman, J; Sánchez-Garrido, MA; Schramm, KW; Stemmer, K; Tschöp, MH; Tuckermann, J; Weber, A; Weber, C; Yang, B; Zhu, Z | 1 |
Grunewald, ZI; Heden, TD; Kanaley, JA; Liu, Y; Nyhoff, LM; Winn, NC | 1 |
Fourmy, D | 1 |
Ekelund, M; Groop, L; Hedenbro, J; Lindqvist, A; Pierzynowski, S; Wierup, N | 1 |
Liu, H; Wang, L; Wang, X; Wei, C; Xue, N; Zhang, L | 1 |
Boesch, C; Brandejsky, V; Campos, V; Despland, C; Kreis, R; Schneiter, P; Tappy, L | 1 |
Baskin, DG; Cummings, BP; Digitale, EK; Graham, JL; Griffen, SC; Havel, PJ; Reed, BJ; Stanhope, KL; Sweet, IR | 1 |
Bodenner, DL; Coker, RH; Evans, WJ; Kern, PA; Kortebein, PM; Williams, RH; Yeo, SE | 2 |
Blackwood, A; Farooqi, IS; Greenfield, JR; Gribble, FM; Habib, AM; Henning, E; Holst, JJ; Keogh, JM; Reimann, F | 1 |
Thorens, B | 1 |
Astrup, A; Due, A; Heding, A; Holst, JJ; Larsen, TM; Sloth, B | 1 |
Addabbo, F; Chander, PN; Chen, J; Gobe, G; Goligorsky, MS; Kuo, MC; Li, H; Nasjletti, A; Ni, J; Park, HC; Patschan, D; Pelger, E; Zhang, F | 1 |
Hazama, M; Moritoh, Y; Takeuchi, K | 1 |
Barati, MT; Epstein, PN; Moore, JP; Portillo, J; Song, Y; Villafuerte, BC | 1 |
Basu, A; Basu, R; Chandramouli, V; Landau, BR; Rizza, RA; Schumann, W | 1 |
Ackermans, MT; Duran, M; Faas, L; Fliers, E; Houten, SM; Ruiter, AF; Sauerwein, HP; Serlie, MJ; Smeenge, M; Soeters, MR; Wanders, RJ | 1 |
Fukuda, S; Ishii, Y; Matsui, K; Matsushita, M; Miyajima, K; Nishizawa, E; Oda, T; Ohta, T; Sano, R; Sasase, T; Ueda, N; Yamamoto, H | 1 |
Cognard, E; Shepherd, PR; Smith, GC; Vickers, MH | 1 |
Atangan, L; Bi, V; Boone, T; Gu, W; Hill, D; Hu, S; Komorowski, R; Lindberg, RA; Shen, Y; Sivits, G; Véniant, MM; Vonderfecht, S; Winters, KA; Yan, H; Yang, J | 1 |
Fisler, JS; Slavin, BG; Warden, CH; Zarow, C | 1 |
Kliewer, SA; Mangelsdorf, DJ | 1 |
Haltia, LT; Kaasinen, V; Rinne, JO; Savontaus, E; Vahlberg, T | 1 |
Choi, MS; Jeon, SM; Kim, HJ; Lee, MK; Park, YB; Shin, SK; Shin, YC; Woo, MN | 1 |
Baggio, LL; Bahrami, J; Drucker, DJ; Li, K; Longuet, C | 1 |
Caprio, S; D'Adamo, E; Hershkop, K; Santoro, N; Weiss, R | 1 |
Bloom, SR; Field, BC; Wynne, K | 1 |
Bartness, TJ; DiMarchi, R; Geary, N; Habegger, KM; Heppner, KM; Tschöp, MH | 1 |
Genis, A; Huisamen, B; Lochner, A; Marais, E | 1 |
Bailey, A; Kernan, K; Lernmark, A; Moralejo, D; Osborne, W; Yanay, O | 1 |
Gaidhu, MP; Gao, X; Gonzalez, R; Reingold, BK; Tsushima, RG; Unniappan, S | 1 |
Andreelli, F; Batterham, RL; Chandarana, K; Choudhury, AI; Drew, ME; Fauveau, V; Gelegen, C; Karra, E; Viollet, B; Withers, DJ | 1 |
Choe, YH; Jin, DK; Kim, SJ; Kim, SW; Lee, HJ; Lee, JH; Park, SW; Sohn, YB; Son, JS | 1 |
Fleeman, LM; Morton, JM; Rand, JS; Verkest, KR | 1 |
Flatt, PR; Franklin, ZJ; Irwin, N; McDonnell, B; Montgomery, IA | 1 |
Blachier, F; Hao, F; He, Q; Kong, X; Li, P; Ren, P; Tang, H; Wu, G; Wu, Y; Yin, Y | 1 |
Arasaki, CH; Carneiro, G; Geloneze, B; Silva, EA; Umeda, LM; Zanella, MT | 1 |
Shepherd, PR; Smith, GC; Vickers, MH | 1 |
Chen, S; Erickson, MR; Parkes, DG; Roth, JD | 1 |
Brady, E; Candelore, ML; Dallas-Yang, Q; Jiang, G; Li, Z; Liu, F; Lu, K; Mu, J; Parmee, ER; Qureshi, SA; Shen, DM; Shen, X; Sinharoy, R; Woods, J; Wright, M; Zhang, BB; Zhang, F; Zhu, L; Zycband, E | 1 |
Damm, P; Nolan, CJ; Prentki, M | 1 |
Eyster, KM | 1 |
Berger, MM; Chioléro, RL; Delodder, F; Feihl, F; Pittet, YK; Rohrer, M; Tappy, L | 1 |
Fernández-Real, JM; Frühbeck, G; Moreno-Navarrete, JM; Ortega, FJ; Ricart, W; Sabater, M | 1 |
Grarup, N; Hainerová, IA; Hansen, T; Hartmann, B; Holst, JJ; Jørgensen, T; Kielgast, U; Kissow, H; Lauritzen, T; Lebl, J; Linneberg, A; Ma, L; Madsbad, S; Madsen, OD; Pedersen, O; Rosenkilde, M; Sandbaek, A; Torekov, SS; Wang, J; Witte, DR | 1 |
Cao, P; Gao, X; Han, JD; Huang, J; Jiang, L; Li, J; Li, W; Liu, Y; Mao, T; Qi, L; Qiu, Y; Rui, L; Shao, M; Song, B; Wang, Q; Zhang, Y | 1 |
Aaboe, K; Holst, JJ; Knop, FK; Krarup, T; Madsbad, S; Vilsbøll, T; Vølund, A | 1 |
Comencini, E; Corradi, M; Cortese, S; Fasan, I; Fornari, E; Maffeis, C; Surano, MG; Tommasi, M | 1 |
Bloom, SR; Jones, BJ; Tan, T | 1 |
Bianchi, E; Cao, J; Carrington, PE; Chicchi, GG; Hubert, J; Kosinski, JR; Marsh, DJ; Miller, C; Mu, J; Pessi, A; Pocai, A; Sinharoy, R | 1 |
Accili, D; Backs, J; Chen, BX; Fukamizu, A; Li, G; Marks, AR; Ozcan, L; Pajvani, U; Park, SK; Singer, HA; Tabas, I; Wong, CC; Wronska, A; Xu, T; Yates, JR | 1 |
Bojsen-Møller, KN; Clausen, TR; Dirksen, C; Holst, JJ; Hvolris, L; Jacobsen, SH; Jørgensen, NB; Lindqvist Hansen, D; Madsbad, S; Naver, L; Worm, D; Wulff, BS | 1 |
Chen, Z; Cho, KW; Jiang, L; Ren, D; Rui, L; Sasaki, Y; Shen, H; Sheng, L; Zhou, Y | 1 |
Cree-Green, M; Mizokami-Stout, K; Nadeau, KJ | 1 |
Bahekar, R; Detroja, J; Dhanesha, N; Dhote, V; Gandhi, T; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, K; Patel, V | 1 |
Flatt, PR; Irwin, N; Moffett, RC; Montgomery, IA | 1 |
Fukunari, A; Iwasaki, S; Kakimoto, T; Kimata, H; Utsumi, H | 1 |
Adeli, K; Baker, C; Bradshaw, CD; Brant, AF; Cramer, CT; Filippov, S; Hanselman, JC; Houghton, JL; Hurley, TR; Naples, M; Newton, RS; Pinkosky, SL; Spahr, MA; Srivastava, RA | 1 |
Aksu, M; Baydemir, R; Bayram, F; Cakir, I; Ismailogullari, S; Karaca, Z; Korkmaz, S; Tanriverdi, F | 1 |
Arafat, AM; Belli, S; Cheng, C; D'Alessio, D; DiMarchi, RD; Gelfanov, V; Habegger, KM; Hembree, JL; Heppner, KM; Hofmann, SM; Holland, J; Itoh, N; Kapps, M; Kharitonenkov, A; Konishi, M; Konkar, A; Krishna, R; Müller, TD; Ottaway, N; Perez-Tilve, D; Pfluger, PT; Seeley, RJ; Smiley, D; Spranger, J; Stemmer, K; Tschöp, MH; Woods, SC | 1 |
Gauna, C; Ghigo, E; Giordano, R; Grottoli, S; Maccagno, B; Maccario, M; Rossetto, R; Tassone, F | 1 |
Egan, JM; Elahi, D; Habener, JF; Meneilly, GS | 1 |
Chapman, IM; Feinle, C; Horowitz, M; Wishart, J | 1 |
Holst, JJ; Krarup, T; Madsbad, S; Vilsbøll, T | 1 |
Horowitz, M; Lee, A; Morley, JE; Patrick, P; Wishart, J | 1 |
Bergman, RN; Brubaker, PL; Dea, MK; Kabir, M; Kim, SP; Mittelman, SD; van Citters, GW | 1 |
Bjerve, KS; Grill, VE; Mostad, IL; Qvigstad, E | 1 |
Astrup, A; Feldt-Rasmussen, U; Holst, JJ; Mersebach, H; Svendsen, OL | 1 |
Agersø, H; Holst, JJ; Krarup, T; Vilsbøll, T | 1 |
Azuma, T; Furukawa, M; Hattori, T; Inokuchi, H; Kawai, K; Magami, Y; Mizuguchi, J; Moriyasu, F; Nakayama, D; Ohyashiki, J; Yoshimoto, T | 1 |
Bloomgarden, ZT | 2 |
Hermansen, K; Holst, JJ; Storm, H; Thomsen, C | 1 |
Flatt, PR; Gault, VA; Green, BD; Harriott, P; Mooney, MH; O'Harte, FP | 1 |
Larsen, PJ; Tang-Christensen, M; Vrang, N | 1 |
Holst, JJ; Juul, AG; Krarup, T; Madsbad, S; Sonne, J; Vilsbøll, T; Vølund, A | 1 |
MAYER, J; SHULL, KH | 1 |
CLARKE, DW; MAYER, J; WRENSHALL, GA | 1 |
CLAYTON, GW; LIBRIK, L | 1 |
AVERY, ME; FINKELSTEIN, JW | 1 |
SNEYD, JG | 1 |
FRATINO, P; MAGGI, G; RODARI, T | 1 |
PAV, J; SONKA, J | 1 |
BAYLON, H; GRUENFELD, JP; KREIS, H | 1 |
FORD, JD; GOURLEY, B; HAWORTH, JC; ISRAELS, S | 1 |
BUTTERFIELD, WJ; DETTWYLER, W | 1 |
SCHULTRICH, S | 1 |
MAYER, J | 3 |
GORDON, ES | 2 |
BLUM, SF; FALOON, WW; HARO, EN | 1 |
MAGGI, G; RODARI, T; VALAGUSSA, F | 1 |
Beck-Nielsen, H; Hojlund, K; Holst, JJ; Hother-Nielsen, O; Staehr, P | 1 |
Burghen, GA; Cashion, AK; Cowan, PA; Lustig, RH; Umpierrez, GE; Velasquez-Mieyer, PA | 1 |
Hooft, R | 1 |
Burghen, GA; Cashion, AK; Christensen, M; Cowan, PA; Lustig, RH; Spencer, KA; Umpierrez, GE; Velasquez-Mieyer, PA | 1 |
Adner, N; Gutniak, M; Hellström, PM; Holst, JJ; King, N; Mansten, S; Näslund, E | 1 |
Ernsberger, P; Koletsky, RJ; Velliquette, RA | 2 |
Balci, H; Damci, T; Ilkova, H; Korugan, U; Osar, Z; Ozyazar, M; Yalin, S | 1 |
Coschigano, KT; Guo, Y; Kopchick, JJ; Kumar, U; Lipsett, M; Liu, JL; Liu, YL; Robertson, K | 1 |
Donahue, EP; Fujimoto, Y; Shiota, M | 1 |
Beglinger, C; Bock, A; Drewe, J; Goeke, B; Gutmann, H; Gutzwiller, JP; Henzen, C; Huber, AR; Kreyenbuehl, M; Tschopp, S; Zehnder, CE | 1 |
Bogacka, I; Li, B; Martin, RJ; Roane, DS; Ryan, DH; Xi, X; Zhou, J | 1 |
Bloom, SR; Small, CJ | 2 |
Feinle-Bisset, C; Horowitz, M; Jones, K; Nauck, M | 1 |
Aguirre, CA; Atwater, IJ; Burrows, R; Díaz, EO; Galgani, JE | 1 |
Canals, I; Chavanieu, A; Claret, M; Corominola, H; Delagrange, P; Gomis, R; Gorostiaga, C; Grassy, G; Nadal, B; Pfeiffer, B; Renard, P | 1 |
Hamann, A; Morcos, M; Nawroth, P | 1 |
Ballaux, D; Mertens, I; Van Gaal, L; Verkade, HJ | 1 |
Adam, TC; Westerterp-Plantenga, MS | 2 |
Baron, AD; Gedulin, BR; Gedulin, G; Nielsen, LL; Nikoulina, SE; Parkes, DG; Smith, PA; Young, AA | 1 |
Starzyk, J; Sztefko, K; Tomasik, PJ | 1 |
Sato, F; Tamura, Y | 1 |
Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Irwin, N; O'Harte, FP | 1 |
Ino, M; Ito, M; Miyamoto, N; Nagasu, T; Takahashi, E; Tanaka, I | 1 |
Purnell, JQ; Weyer, C | 1 |
Bardini, G; Brogi, M; Ciani, S; Cremasco, F; Dicembrini, I; Mannucci, E; Messeri, G; Ognibene, A; Petracca, MG; Pezzatini, A; Rotella, CM; Tesi, F | 1 |
Cani, PD; Delzenne, NM; Maton, N; Neyrinck, AM | 1 |
Daimon, M; Ikezawa, Y; Manaka, H; Ohnuma, H; Sasaki, H; Yamatani, K | 1 |
Cummings, DE | 1 |
Bojanowska, E | 1 |
Ali, AA; Bhathena, SJ; Hansen, CT; Mohamed, AI; Velasquez, MT | 1 |
Hahm, S; Mizuno, TM; Mobbs, CV; Montgomery, C; Salton, SR; Scherer, PE; Watson, E; Windsor, J | 1 |
Bloom, SR; Dakin, CL; Druce, MR; Ellis, SM; Filipsson, K; Frost, GS; Ghatei, MA; Kent, AS; Neary, NM; Park, AJ; Semjonous, NM; Small, CJ; Wang, F | 1 |
Ke, L; Li, HL; Li, XJ; Wang, Y; Wu, YH; Zhang, XE; Zhang, XX | 1 |
Torre-Villalvazo, I; Torres, N; Tovar, AR | 1 |
Cassidy, RS; Flatt, PR; Gault, VA; Green, BD; Irwin, N | 1 |
Arafat, AM; Möhlig, M; Otto, B; Perschel, FH; Pfeiffer, AF; Rochlitz, H; Schöfl, C; Spranger, J; Weickert, MO | 1 |
Marks, V | 1 |
Gedulin, BR; Herrmann, K; Jodka, CM; Young, AA | 1 |
Dedova, I; Duffy, L; Herzog, H; Karl, T; Lee, NJ; Lin, EJ; Matsumoto, I; O'brien, E; Sainsbury, A; Slack, K | 1 |
Aguirre, C; Díaz, E; Galgani, J | 1 |
Inoue, T; Itakura, Y; Nakagawa, T; Noguchi, H; Taiji, M; Tsuchida, A; Yamanaka, M | 1 |
Barucci, N; Burns, M; Buxton, JM; Clairmont, KB; Claus, TH; Livingston, JN; Ortiz, AA; Pan, CQ; Reynolds, JC; Roczniak, S; Whelan, JP; Yang, L | 1 |
Escalante, B; Gonzalez-Granillo, M; Hernández-Pando, R; Noriega-López, L; Santillán-Doherty, P; Torres, N; Tovar, AR | 1 |
Ciechanowicz, A; Frankow, M; Majkowska, L; Parczewski, M; Pilarska, K; Safranow, K; Stefanski, A | 1 |
Eichhorn, I; Göncz, E; Grötzinger, C; Hamprecht, B; Nowak, KW; Pfeiffer-Guglielmi, B; Pless, G; Plöckinger, U; Sauer, IM; Singh, V; Strowski, MZ; Wiedenmann, B; Zacharias, S | 1 |
Cassidy, RS; Flatt, PR; Gault, VA; Irwin, N; McClean, PL | 1 |
DiMarchi, RD; Li, P; Rogers, T; Smiley, D; Zhang, F | 1 |
Kocić, G; Kocić, R; Pavlović, D; Pesić, M | 1 |
Cassidy, RS; Flatt, PR; Gault, VA; Holst, JJ; Irwin, N; McClean, PL | 1 |
Flatt, PR; Hunter, K; Irwin, N | 1 |
Baz-Hecht, M; Bernier, R; Devine, E; Goldfine, AB; Holst, JJ; Jones, DB; Mun, EC; Patti, ME; Schneider, BE | 1 |
Bartlett, JB; Berg, S; Carey, F; Charles, AD; Convey, G; De Schoolmeester, J; Freeman, S; Loxham, SJ; Poucher, SM; Teague, J; Turnbull, AV; Walker, M | 1 |
Artmann, A; Jensen, PB; Larsen, LK; Larsen, PJ; Lykkegaard, K; Tang-Christensen, M; Vrang, N | 1 |
Caffrey, JL; Carroll, JF; Deere, C; Franks, SF; Kaiser, KA | 1 |
Brismar, K; Efendic, S; Lehtihet, M | 1 |
Banks, MR; Klein, S; Patterson, BW; Polonsky, KS; Villareal, DT | 1 |
Chen, S; Grayburn, P; Orci, L; Ravazzola, M; Unger, RH; Wang, MY | 1 |
Bawa, B; Colarusso, A; Egger, JR; Koshy, N; Kovack, B; Laferrère, B; Lee, H; McGinty, J; Olivan, B; Teixeira, J; Tran, H; Yapp, K | 1 |
Benedetti, A; Forsham, PH; Grodsky, GM; Simpson, RG | 1 |
Hudson, A; Pimstone, BL; Shapiro, B; Sheppard, MC | 1 |
Creutzfeldt, W; Ebert, R | 2 |
Genuth, SM; Hoppel, CL | 1 |
Kolanowski, J | 3 |
Imura, H; Ishikawa, K; Kuzuya, H; Seino, S; Seino, Y; Shimazu, T; Takemura, J; Tsuda, K | 1 |
Baile, CA; Boden, G; Matschinsky, FM; McLaughlin, CL | 1 |
Freinkel, N; Metzger, BE; Ravnikar, V; Vileisis, RA | 1 |
Lunetta, M; Maugeri, D; Papalia, D; Tribulato, A; Trovato, G | 1 |
Germaniuk, IaL | 1 |
Ikeda, M; Imura, H; Ishida, H; Nishi, S; Seino, S; Seino, Y; Seno, M; Takemura, J; Tsuda, K; Usami, M | 1 |
Imura, H; Ishida, H; Nishi, S; Seino, S; Seino, Y; Takemura, J; Tsuda, K; Usami, M | 1 |
Gibbs, J; Smith, GP | 2 |
Exton, JH | 1 |
Camus, JC; Chatelain, P; Christophe, J; De Neef, P; Poloczek, P; Robberecht, P | 1 |
Kardos, M; Molnár, D; Soltész, G | 1 |
Durant, PJ; Harris, RA; McCune, SA | 1 |
Andersen, B; Holst, JJ; Lauritsen, KB; Stadil, F; Sørensen, TI | 1 |
Ardill, J; Darragh, A; Lafferty, H; Tomkin, GH | 1 |
Rudolf, MC; Sherwin, RS | 1 |
Nagulesparan, M; Unger, RH; Vasquez, B | 1 |
Beno, I; Chorváthová, V; Ovecka, M; Ozdin, L | 1 |
Akerblom, HK; Knip, M; Kouvalainen, K; Lautala, P; Martin, JM | 1 |
Alford, FP; Chisholm, DJ; Whitehouse, S; Zimmet, P | 1 |
Beck-Nielsen, H; Holst, JJ; Lovgreen, NA; Pedersen, O; Schwartz, TW | 1 |
Berger, M; Erhardt, G; Starke, AA; Zimmermann, H | 1 |
Iwasa, S; Kobayashi, T; Kondo, K; Nihei, J; Ohneda, A | 1 |
Hidaka, H; Klimes, I; Nagulesparan, M; Unger, RH; Vasquez, B | 1 |
Geffner, ME; Gillard, BK; Itami, RM; Kaplan, SA; Levin, SR; Lippe, BM; Taylor, IL | 1 |
Cahn, PJ; Dubuc, PU; Willis, P | 1 |
Alberti, KG; Cook, D; Francis, AJ; Hanning, I; Heine, RJ; Orskov, H; Pernet, A; Ponchner, M | 1 |
Bolgiano, DC; Halter, JB; McKnight, B; Porte, D; Ward, WK | 1 |
Leclercq, B | 1 |
Baker, SG; Joffe, BI; Lamprey, JM; Seftel, HC; Shires, R; Viljoen, M | 1 |
Borghi, VC; Cesar, FP; Wajchenberg, BL | 1 |
Nilsson-Ehle, P; Olsson, SA; Petersson, BG; Sörbris, R | 1 |
Hansen, BC | 1 |
Heber, D; Henson, LC | 1 |
Bevilacqua, M; Dagani, R; Frigeni, G; Meroni, R; Norbiato, G; Raggi, U; Scorza, D; Vago, T | 1 |
Mahler, RJ | 2 |
Jeanrenaud, B; Rohner-Jeanrenaud, F | 4 |
Bier, DM; Gelfand, RA; Matthews, DE; Sherwin, RS | 1 |
Baile, CA; Gingerich, RL; McLaughlin, CL | 2 |
Beyer, J; Oppermann, D | 1 |
Beno, I; Chorváthová, V; Jurcovicová, M | 1 |
Agosti, C; Morenghi, R; Saponati, G; Uccella, R | 1 |
Albuquerque, RH; Borghi, VC; Wajchenberg, BL | 1 |
Allen, CE; Buchwald, H; Chan, EK; Mackey, MA; Rucker, RD; Schneider, PD; Snover, DC | 1 |
Hendler, RG; Sherwin, RS | 1 |
Marliss, E; Steiner, G; Vranic, M; Zinman, B | 1 |
Capelli, M; Ciavarella, A; Cocchi, V; Flammini, M; Forlani, G; Vannini, P | 1 |
Baranyai, Z; Kardos, M; Molnár, D; Soltész, G | 1 |
Sullivan, L | 1 |
Hayek, A | 1 |
Cahn, PJ; Dubuc, PU; Ristimaki, S; Willis, PL | 1 |
Becker, D; Drash, A; Hopwood, N; Pang, SJ; Villalpando-Hernández, S | 1 |
de Biasi, F; Garotti, MC; Nosadini, R; Tessari, P; Tiengo, A; Ursini, F | 1 |
Greenwood, MR; Sullivan, AC; Triscari, J | 2 |
Nilsson-Ehle, P; Petersson, BG; Sörbris, R | 1 |
Azain, MJ; Martin, RJ | 1 |
Griglio, S; Kalopissis, AD; Le Liepvre, X; Malewiak, MI | 1 |
Matschinsky, FM; Norfleet, WT; Pagliara, A; Rujanavech, C | 1 |
Hayek, A; Woodside, WF | 1 |
Felig, P; Koivisto, VA; Soman, VR | 1 |
Bailey, CJ; Buchanan, KD; Flatt, PR | 1 |
Chikamori, K; Mori, H; Nishimura, N; Saito, S; Sato, K; Suehiro, F | 1 |
Brodows, RG; Lilavivathana, U | 1 |
Bryce, GF; Sullivan, AC; Triscari, J | 1 |
Feinglos, MN; Lebovitz, HE | 1 |
Morita, S; Steiner, G; Vranic, M | 1 |
Heinke, P; Ratzmann, KP; Schulz, B; Witt, S; Ziegler, M | 1 |
Danforth, E; Hanson, JS; Horton, ES; LaGrange, BM; Phinney, SD; Sims, EA | 1 |
Ensinck, JW; Gold, EM; Michas, CA; Walter, RM | 1 |
Alberti, KG; Barnes, AJ; Bloom, SR; Johnston, DG; Joplin, GF; Nattrass, M | 1 |
Czyzyk, A; Heding, LG; Jayyab, AK; Krókewski, AS; Malczewski, B | 1 |
Beylot, M; Bienvenu, F; Mornex, R; Riou, JP | 1 |
Chikamori, K; Suehiro, F | 1 |
Bistrian, BR; Blackburn, GL; George, DT; Wannemacher, RW | 2 |
Ratzmann, KP; Schulz, B; Witt, S; Ziegler, M | 1 |
Albisser, AM; Hanna, AK; Marliss, EB; Minuk, HL; Vranic, M; Zinman, B | 1 |
Atkinson, RL; Bray, GA; Dahms, WT; Sperling, MA | 1 |
Baiardi, M; Giusti, M; Grimaldi, GP; Marugo, M; Mortara, R; Motta, A | 1 |
Dubuc, PU | 1 |
Alberti, KG; Andrews, WJ; Buchanan, KD; Henry, RW | 1 |
Aoki, TT | 1 |
Abraira, C; Lawrence, AM | 2 |
Belbez Pek, S; Hansen, BC; Jen, KC; Wolfe, RA | 1 |
Czyzyk, A; Heding, LG; Jayyab, AK; Królewski, AS; Malczewski, B | 1 |
Andres, R; Blix, PM; Elahi, D; Hershcopf, RJ; Muller, DC; Nagulesparan, M; Rubenstein, AH; Tobin, JD; Unger, RH | 1 |
Barbara, L; Benfenati, F; Capelli, M; Cornia, G; Giacomoni, P; Marini, A; Miglioli, M; Pironi, L; Salera, M | 1 |
Andres, R; Elahi, D; Muller, DC; Tobin, JD; Tzankoff, SP | 1 |
Beno, I; Jurcovicová, J; Ozdín, L | 1 |
Cession-Fossion, A; Luyckx, A; Scheen, A; Scheen-Lavigne, M | 2 |
Clark, CM; Clark, JB | 1 |
Epshteĭn, EV | 2 |
Berger, M; Jörgens, V; Starke, A; Starke, G; Zimmermann, H | 1 |
Ratzmann, KP | 2 |
Ikeda, H; Matsuo, T; Nishikawa, K | 1 |
Kather, H; Simon, B | 1 |
Hustvedt, BE; Jeanrenaud, B; Karakash, C; Rohner-Jeanrenaud, F | 1 |
Burman, KD; Jones, L; O'Brien, JT; Ramos, EA; Smallridge, RC; Wartofsky, L; Wright, FD | 1 |
Adèr, HJ; Drent, ML; van der Veen, EA; Wever, LD | 1 |
Ballard, FJ; Berry, MN; Brinkman, M; Butler, RN; Clark, DG; Nestel, PJ; Oliver, JR; Owens, PC; Tomas, FM; Withers, RT | 1 |
Agostini, G; Brambilla, P; Caumo, A; Cobelli, C; Galli-Kienle, M; Magni, F; Monti, LD; Poma, R; Stefani, I; Tomasini, L | 1 |
Gottschlich, MM; Khoury, JC; Mayes, T; Warden, GD | 1 |
Elliott, R; Jia, X; Kwok, YN; McIntosh, CH; Pederson, RA | 1 |
Casals, MM; Clark, WS; Gebhart, SP; Mixon, PS; Phillips, LS; Umpierrez, GE | 1 |
Castillo, MJ; Lefebvre, PJ; Scheen, AJ | 2 |
Fau, D; Griffaton, G; Kalopissis, AD | 1 |
Beck-Nielsen, H; Henriksen, JE; Holm, N; Madsbad, S; Vaag, A | 1 |
Bogardus, C; Esposito-Del Puente, A; Feinglos, MN; Kuhn, CM; Lillioja, S; McCubbin, JA; Surwit, RS | 1 |
Gabbe, SG; Landon, MB; O'Dorisio, T; Osei, K; Platt, M; Samuels, P | 1 |
Cuneo, RC; Salomon, F; Sönksen, PH; Umpleby, AM | 1 |
Balasse, EO; Féry, F | 1 |
Anderson, BL; Barbieri, TF; Keim, NL; Wu, MM | 1 |
Colzi, G; Cresci, B; Galli, G; Giannini, S; Mannucci, E; Messeri, G; Piani, F; Rizzello, SM; Rotella, CM; Vannini, R | 1 |
Bruno, A; Cassader, M; Cavallo-Perin, P; Gruden, G; Pagano, G; Scaglione, L | 1 |
De Sio, G; Ippoliti, M; Monteburini, T; Recchioni, A; Refe, A; Testa, I; Testa, R | 1 |
Hirose, H; Ito, K; Kido, K; Koyama, K; Maruyama, H; Saruta, T; Tashiro, Y | 1 |
Bucci, T; Gill, AM; Warbritton, A; Wolff, GL; Yen, TT | 1 |
Blackard, WG; Clore, JN | 1 |
Ditzler, TM; Gumbiner, B; Henry, RR; Joyce, M; Murata, C; Song, YM; Suh, KI | 1 |
Inoue, S; Numata, K; Saito, M; Shishido, T; Tanaka, K | 1 |
Durlach, V; Gross, A; Grulet, H; Hecart, AC; Leutenegger, M | 1 |
Ceriello, A; Consoli, G; D'Onofrio, F; De Rosa, N; Giugliano, D; Minei, A; Quatraro, A | 1 |
Birkenhäger, JC; Docter, R; Fauser, BC; Jacobs, ML; Loriaux, DL; Pache, TD; Weber, RF | 1 |
Haymond, MW; Jensen, MD; Kanaley, JA | 1 |
Feldman, EC; Kirk, CA; Nelson, RW | 1 |
Brown, DW | 1 |
Grossman, EB; Gumbiner, B; Low, CC | 1 |
Cozzolino, D; Giugliano, D; Lefebvre, PJ; Salvatore, T; Sasso, FC; Sessa, G; Torella, R | 1 |
Alzaid, A; Basu, A; Caumo, A; Cobelli, C; Dinneen, S; Rizza, RA | 1 |
Cheli, V; Ciuchi, E; Giusti, R; Melga, P; Odetti, P; Prando, R | 1 |
Camisasca, R; Pacchioni, M; Pontiroli, AE; Pozza, G | 1 |
Morgan, LM | 1 |
Gaillard, R; Jéquier, E; Lefèbvre, PJ; Paquot, N; Scheen, A; Schneiter, P; Tappy, L | 1 |
Carroll, R; Chan, SJ; Gong, Q; Martin, S; Rouillé, Y; Steiner, DF | 1 |
Bouchard, C; Després, JP; Klein Kranenbarg, WM; Lamarche, B; Mauriège, P; Nadeau, A; Prud'homme, D; Tremblay, A | 1 |
Fletcher, JM; Knapper, JM; Morgan, LM | 1 |
Besedovsky, HO; del Rey, A; Klusman, I; Monge-Arditi, G | 1 |
Mineo, I; Nakagawa, C; Tarui, S | 1 |
Beety, JM; Howland, R; Marks, V; Morgan, LM; Ranganath, LR; Wright, JW | 1 |
Assimacopoulos-Jeannet, F; Felber, JP; Jeanrenaud, B; Jéquier, E; Mosimann, F; Müller, C; Pachiaudi, C; Riou, JP; Schneiter, P; Tappy, L | 1 |
Coleman, TG; Hall, JE; Montani, JP; Summers, RL; Woodward, LH | 1 |
Beitz, DC; Hippen, AR; Smith, TR; Young, JW | 1 |
Aalseth, DL; Abribat, T; Loo, SC; McCann, JP | 1 |
Ihm, SH; Lee, KU; Park, JY; Park, SW; Yoo, HJ | 1 |
Bloom, SR; Gunn, I; O'Shea, D | 1 |
Donahey, JC; Seeley, RJ; van Dijk, G; Woods, SC | 1 |
Arai, K; Hayashi, T; Hukuda, G; Kanazawa, M; Kanazawa, Y; Komeda, K; Nomoto, S; Notoya, Y; Shirabe, S; Tanaka, A | 1 |
Katsuura, G; Takeyama, C | 1 |
Compton, DS; Davis, HR; France, CF; Graziano, MP; Hoos, LM; Mullins, DE; Pines, JM; Strader, CD; Sybertz, EJ; Van Heek, M | 1 |
Belfiore, F; Campione, R; Iannello, S | 1 |
Apa, R; Caruso, A; Ciampelli, M; Cucinelli, F; Fulghesu, AM; Guido, M; Lanzone, A; Murgia, F | 1 |
Ghibaudi, L; Hwa, JJ; Strader, CD; Tedesco, R; Williams, P; Witten, MB | 1 |
Cseh, K; Salamon, D; Salamon, F; Simon, K; Speer, G; Winkler, G | 1 |
Bodkin, NL; Ortmeyer, HK | 1 |
Elahi, D; Meneilly, GS | 1 |
Gutniak, M; Hellström, PM; Näslund, E; Rössner, S; Skogar, S | 1 |
Peterson, RG; Roth, MD; Shen, HQ | 1 |
Fukuda, H; Ikeda, H; Iritani, N; Komiya, M; Sugimoto, T | 1 |
Cseh, K; Hajós, P; Harmos, G; Kovács, M; Salamon, D; Salamon, F; Simon, K; Speer, G; Szekeres, O; Winkler, G | 1 |
Girard, J | 1 |
Christophe, J | 1 |
Habener, JF; Holz, GG; Kieffer, TJ; Leech, CA; Moritz, W; Ricordi, C; Seufert, J | 1 |
Marks, V; Morgan, L; Norris, F; Ranganath, L; Wright, J | 2 |
Binder, C; Dinesen, B; Hartling, SG; Houssa, P; Røder, ME; Sodoyez-Goffaux, F; Vestergaard, H | 1 |
Barkeling, B; Blundell, JE; Gutniak, M; Hellström, PM; Holst, JJ; King, N; Näslund, E; Rössner, S | 1 |
Boerwinkle, E; Bray, MS; Hanis, CL | 1 |
Bloom, SR; Cohen, MA; Edwards, CM | 1 |
Beglinger, C; Drewe, J; Göke, B; Gutzwiller, JP; Lareida, J; Rohrer, B; Schmidt, H | 1 |
Bhavsar, S; Bodkin, N; Denaro, M; Gedulin, BR; Hansen, B; Jodka, C; Young, AA | 1 |
Burcelin, R; Charron, MJ; Friedman, JM; Kamohara, S; Li, J; Tannenbaum, GS | 1 |
Ahrén, B; Havel, PJ | 1 |
Endo, T; Funo, S; Iizuka, S; Kawamura, H; Kimura, M; Sato, T; Suzuki, W; Tabuchi, M; Yanagisawa, T | 1 |
Cravello, L; Ferrari, E; Fioravanti, M; Giacchero, R; Lovati, E; Pontiggia, B; Rondanelli, M; Solerte, SB; Stabile, M; Vignati, G | 1 |
Balkan, B; Holst, JJ; Kwasnik, L; Li, X; Miserendino, R | 1 |
de Pablos-Velasco, P; Santana-Rodríguez, A; Sosa-Henríquez, M | 1 |
McCarty, MF | 2 |
Bosch, F; Casellas, A; Devedjian, JC; George, M; Gros, L; Pelegrín, M; Pujol, A; Visa, J | 1 |
Hellerstein, MK; Hirsch, J; Hudgins, LC; Neese, RA; Seidman, CE; Tremaroli, JD | 1 |
Alvarez, E; Blázquez, E; Chowen, JA; Eng, J; Gómez, R; Maestre, O; Muñoz, RM; Navarro, M; Rodriquez de Fonseca, F; Roncero, I | 1 |
Hales, CN; Ozanne, SE; Petry, CJ; Wang, CL | 1 |
Baldi, S; Camastra, S; Ferrannini, E; Gastaldelli, A; Landau, BR; Natali, A; Pettiti, M; Toschi, E | 1 |
Bashmakov, Y; Brown, MS; Goldstein, JL; Hammer, RE; Matsuda, M; Shimomura, I | 1 |
Ferrari, E; Fioravanti, M; Precerutti, S; Rondanelli, M; Severgnini, S; Solerte, SB; Vignati, G | 1 |
Bardini, G; Ciani, S; Cremasco, F; Fanelli, A; Mannucci, E; Mencucci, A; Messeri, G; Ognibene, A; Pierazzuoli, E; Rotella, CM | 1 |
Daimon, M; Igarashi, M; Kato, T; Manaka, H; Ohnuma, H; Sasaki, H; Yamatani, K | 1 |
Dralyuk, F; Mittal, AA; Polonsky, KS; Pugh, WL; Roe, MW; Sreenan, SK | 1 |
Cherrington, AD; Dixon, K; Fujimoto, Y; Grimsby, J; Grippo, JF; Jetton, TL; Magnuson, MA; Pan, D; Postic, C; Shiota, M | 1 |
Beety, JM; Morgan, LM; Ranganath, LR; Wright, J | 1 |
Bardini, G; Ciani, S; Cremasco, F; Mannucci, E; Mencucci, A; Messeri, G; Ognibene, A; Pierazzuoli, E; Rotella, CM | 1 |
Adage, T; Adan, RA; Baskin, DG; de Boer, SF; de Vries, K; Konsman, JP; Kuipers, F; Scheurink, AJ; Schwartz, MW; van Dijk, G | 1 |
Basu, A; Basu, R; Jensen, MD; Rizza, RA; Shah, P; Vella, A | 1 |
Benelli, C; Desbuquois, B; Fouque, F; Geoffroy, V; Lugnier, C | 1 |
Friis-Hansen, L; Holst, JJ; Lacourse, KA; Samuelson, LC | 1 |
Beck-Nielsen, H; Holst, JJ; Hother-Nielsen, O; Levin, K; Staehr, P | 1 |
Astrup, A; Ersbøll, AK; Flint, A; Holst, JJ; Raben, A | 1 |
Astrup, A; Buemann, B; Juul Holst, J; Lysgård Madsen, J; Toubro, S; Verdich, C | 1 |
Huang, HW; Larpadisorn, K; Lesser, II; Volpe, SL | 1 |
Hermus, AR; Janssen, SW; Knijnenburg, Q; Lange, WP; Martens, GJ; Sweep, CG; van der Laak, JA; Verhofstad, AA | 1 |
Astrup, A; Beglinger, C; Flint, A; Gutzwiller, JP; Hellström, PM; Holst, JJ; Long, SJ; Morgan, LM; Näslund, E; Verdich, C | 1 |
Ahmed, M; Grapengiesser, E | 1 |
Dansk, H; Grapengiesser, E; Gylfe, E; Hellman, B | 1 |
Fledelius, C; Knudsen, LB; Larsen, PJ; Tang-Christensen, M | 1 |
Burcelin, R; Crivelli, V; Dacosta, A; Roy-Tirelli, A; Thorens, B | 1 |
Dirlewanger, M; Lefèbvre, PJ; Paquot, N; Scheen, AJ; Tappy, L | 1 |
Born, J; Fehm, HL; Fruehwald-Schultes, B; Kern, W; Oltmanns, KM; Peters, A; Sopke, S; Toschek, B | 1 |
Cooper, BP; Fucetola, R; Haupt, DW; Melson, AK; Newcomer, JW; Schweiger, JA; Selke, G | 1 |
Malek, A; Sztefko, K; Tomasik, PJ | 1 |
Ashworth, D; Aubert, ML; Broqua, P; Evans, DM; Haigh, R; Junien, JL; Sudre, B; White, RB | 1 |
Gallwitz, B; Meier, JJ; Nauck, MA; Schmidt, WE | 1 |
Ammann, R; Hedinger, C; Säuberli, H; Woodtli, W; Zimmermann, K | 1 |
Bemelmans, S; Bodson, A; Crabbe, J; Desmecht, P; Kolanowski, J; Stein, F | 1 |
Balagura, S; de Castro, JM; Harrell, LE | 1 |
Arky, RA; Boulter, PR; O'Brian, JT; Saudek, CD; Spark, RF | 1 |
Kowalik-Borówka, E; Tatoń, J | 1 |
Hagler, L; Herman, RH; Lufkin, EG; Rosensweig, NS; Stifel, FB; Taunton, OD; Teplick, RS | 1 |
Lavine, RL; Perrino, PV; Recant, L; Voyles, N | 1 |
Goldrick, B; Nestel, P | 1 |
Orci, L; Unger, RH | 1 |
Broer, Y; Freychet, P; Rosselin, G | 1 |
Gahagan, J; Martin, RJ | 1 |
Austin, MW; Solomon, SS; Turpin, BP | 1 |
Mahmood, HA; Marks, V; Wood, PJ | 1 |
Jolly, SR; Lech, JJ; Menahan, LA | 1 |
Smirnova, GI | 2 |
Hamilton, CL; Livingston, JN; Lockwood, DH | 1 |
Donald, RA; Dunn, PJ; Espiner, EA; Hinton, D; Redekopp, C | 1 |
Bray, GA | 1 |
Beloff-Chain, A; Mansford, KR; Newman, ME | 1 |
Felber, JP | 1 |
de Ruiter, L; Hervey, GR; Parameswaran, SV; Steffens, AB | 1 |
Banasiak, MF; Driscoll, T; Hatfield, HH; Kalkhoff, RK; Kim, HJ | 1 |
Páv, J; Srámková, J | 1 |
Bray, GA; Campfield, LA; Inoue, S | 1 |
Andĕl, M; Brodan, V; Kuhn, E | 1 |
Bryce, GF; Johnson, PR; Stern, JS; Sullivan, AC | 1 |
Baetens, D; Coleman, DL; Malaisse-Lagae, F; Orci, L; Ravazzola, M; Stefan, Y | 1 |
Bruns, W | 1 |
Hayek, A; Woodside, W | 1 |
Bianchi, L; Gyr, K; Häuptli, W; Stähelin, HB | 1 |
Brown, JC; Otte, SC | 1 |
Andĕl, M; Brodan, V; Kucerová, L; Slabochová, Z; Vondra, K | 1 |
Belfiore, F; Iannello, S; Rabuazzo, AM | 1 |
Atkinson, RL; Bray, GA; Dahms, WT; Frame, C; Rodin, J; Schwartz, A; Taylor, I | 1 |
Giengo, A; Gregolin, C; Nosadini, R; Tessari, P; Ursini, F | 1 |
Calafato, M; Ferlito, S; Fichera, C | 1 |
Choidini, G; Elicio, N; Pronzato, P; Reggiani, E; Valice, S | 1 |
Crabbé, J; Desmecht, P; Henquin, JC; Kolanowski, J; Salvador, G | 1 |
Herrera Pombo, JL | 1 |
Bennett, PH; Bennion, LJ; Flock, EV; Mott, D; Nagulesparan, M; Roth, J; Savage, PJ; Unger, RH | 1 |
Squadrito, G | 1 |
Cacciari, E; Capelli, M; Cassio, A; Platè, L; Tanas, R; Tassinari, D; Turchi, S; Villa, MP; Zappulla, F | 1 |
McKenzie, AK; Schteingart, DE; Tsao, HS; Victoria, RS | 1 |
Chiodini, G; Giaretti, R; Innocenti-Ducci, L; Montefusco, S; Pronzato, P; Reggiani, E; Valice, S | 1 |
Astengo, F; Balestreri, R; Bertolini, S; Castello, C; Fattorini, A; Fuliano, P; Risso, M | 1 |
Bolognesi, F; Cocco, R; Giusti, M; Marugo, M; Reitano, A | 1 |
Lacroix, M; Lefebvre, P; Luyckx, A; Mosora, F; Pirnay, F | 1 |
Eaton, RP; Simonelli, C | 1 |
Hülsmann, WC | 1 |
Christensen, SE; Hansen, AP; Lundbaek, K | 1 |
Drost, H; Gries, FA; Grüneklee, D; Voegtle-Boehringer, M | 1 |
Cucinotta, D; Di Cesare, E; Longo, G; Quartarone, M; Squadrito, G | 1 |
Cucinotta, D; Quartarone, M; Saitta, A; Sardo, A; Squadrito, G | 1 |
Apfelbaum, M | 1 |
Arky, RA; Brandt, K; Knopp, RH | 1 |
Balasse, EO | 1 |
Barisch, J; Barry, RE; Benfield, J; Bray, GA; Morin, RJ; Sperling, MA | 1 |
Gerich, JE; Kane, JP; Lewis, SB; Wallin, JD | 1 |
Chiumello, G; Del Guercio, MJ; Di Natale, B; Gargantini, L; Garlaschi, C; Meschi, F | 1 |
Frame, CM | 1 |
Gorden, P; Kahn, R; Megyesi, K | 1 |
Hems, DA | 1 |
Dubuc, PU; Ensinck, JW; Mahler, RJ; Mobley, PW | 1 |
Marliss, EB; Steiner, G; Streja, DA; Vranic, M | 1 |
Clarke, WL; Haymond, MW; Pagliara, AS; Santiago, JV | 1 |
Eaton, RP; Lueker, R; Schade, DS | 1 |
Girard, J; Göschke, H; Stahl, M | 1 |
Baratono, S; Carta, Q; Cerutti, F; Miglio, C | 1 |
Rochman, H; Rubenstein, A; Scarlett, JA; Zeidler, A | 1 |
Chaussain, JL; Georges, P; Job, JC; Olive, G | 1 |
Sekso, M; Solter, M; Vizner, B | 1 |
Andler, W; Bernasconi, S; Giovannelli, G | 1 |
Felig, P; Fisher, M; Hendler, R; Sherwin, RS | 2 |
Czyzyk, A | 1 |
Felig, P | 1 |
Cameron, DP; Cuendet, GS; Loten, EG; Marliss, EB; Renold, AE | 1 |
Burman, KD | 1 |
Aoki, TT; Cahill, GF; Müller, WA | 1 |
Baratono, S; Carta, Q; Cerutti, F; Ciancimino, F | 1 |
Eaton, RP; Schade, DS | 3 |
Felig, P; Hendler, RG; Sherwin, RS | 1 |
Cabezas-Cerrato, J; Casanueva, F; Fernández-Cruz, A; Marco Mur, AL; Vila, T; Villanueva Arangúren, L | 1 |
Caccamo, A; Chiumello, G; del Guercio, MJ; di Natale, B; Gargantini, L; Garlaschi, C | 1 |
Hahn, P; Novak, M | 1 |
Göschke, H; Stahl, M; Thölen, H | 1 |
Freychet, P; Laburthe, M; Rançon, F; Rosselin, G | 1 |
Carmina, E; Janni, A; Lanzara, P; Marozzi, P | 1 |
Di Mario, U; Fallucca, F; Mirabella, C; Tinelli, F | 1 |
Conway, M; Eaton, RP; Schade, DS | 2 |
Lecomte, MJ; Lefebvre, PJ; Luyckx, AS | 1 |
Ahrén, B; Efendic, S; Gutniak, M; Holst, JJ; Orskov, C | 1 |
Houslay, MD; Palmer, TM; Taberner, PV | 1 |
Imamura, K; Inokuchi, T; Isogai, S; Orita, M; Takao, T | 1 |
Richter, WO; Ritter, MM; Schwandt, P | 1 |
Aburaya, J; Enoki, S; Matsukara, S; Mitsukawa, T; Nakazato, M; Takemura, J; Toshimori, H | 1 |
Bouchard, C; Després, JP; Lupien, PJ; Moorjani, S; Nadeau, A; Pouliot, MC; Prud'Homme, D; Tremblay, A | 1 |
Jablenska, R; Lardinois, CK; Petkov, P; Starich, GH; Zafirova, M | 1 |
Bazin, R; Krief, S | 1 |
Ceriello, A; Cozzolino, D; D'Onofrio, F; Franchimont, P; Giugliano, D; Lefebvre, PJ; Salvatore, T; Torella, R | 1 |
Bailey, DJ; Blackard, WG; Clore, JN; Nestler, JE; Post, EP | 1 |
Fukushima, H; Hamaguchi, T; Ichinose, K; Kishikawa, H; Shichiri, M; Shirotani, T; Uehara, M; Wada, S; Yamaguchi, K | 1 |
Maffeis, C; Micciolo, R; Pinelli, L; Zaffanello, M; Zoccante, L | 1 |
De Leeuw, I; Van Acker, K; Van Gaal, L; Vansant, G | 1 |
Houslay, MD; Milligan, G; Palmer, T; Strassheim, D | 1 |
Demigne, C; Mazur, A; Remesy, C | 1 |
Jensen, MD | 1 |
Cozzolino, D; D'Onofrio, F; Franchimont, P; Giugliano, D; Lefebvre, PJ; Torella, R | 1 |
Bompiani, GD; Bucalo, ML; Donatelli, M; Iraci, T; Miceli, G; Puglisi, S; Russo, V; Scarpinato, A; Terrizzi, C; Verga, S | 1 |
Howard, CF; Wolff, J; Yasuda, M | 1 |
Elstein, M; Golland, IM; Laing, I; Shalet, SM; Vaughan Williams, CA | 1 |
Andersen, T; Astrup, A; Breum, L; Bülow, J; Christensen, NJ; Madsen, J; Quaade, F | 1 |
Rodin, J | 1 |
Gage, D; Geliebter, A; Hashim, SA; McCray, RS; Melton, PM | 1 |
Farrell, PA; Gustafson, AB; Kalkhoff, RK | 1 |
Bottoms, GD; Feldman, EC; Himsel, CA; Nelson, RW | 1 |
Flynn, T; Gumbiner, B; Henry, RR; Thorburn, AW | 1 |
Möhrle, W; Richter, WO; Ritter, MM; Schwandt, P | 1 |
al-Attas, OS; al-Dress, AZ; Khan, MS; Laajam, MA | 1 |
Kanter, Y; Piell, E; Santo, M | 1 |
Marsh, HM; McMahon, M; Rizza, RA | 1 |
Bhathena, SJ; Carswell, N; Hansen, CT; Jones, J; Kennedy, BW; Michaelis, OE; Recant, L; Smith, PM; Voyles, NR | 1 |
Gawler, DJ; Houslay, MD; Milligan, G; Wilson, A | 1 |
Bonora, E; Cacciatori, V; Cigolini, M; Corgnati, A; Moghetti, P; Muggeo, M; Querena, M; Zancanaro, C | 1 |
Garlick, PJ; McNurlan, MA | 1 |
D'Onofrio, F; Paolisso, G; Passariello, N; Pizza, G; Sgambato, S; Varricchio, M | 1 |
Classen, M; Maier, V; Schmid, R; Schulte-Frohlinde, E; Schusdziarra, V | 1 |
Gawler, DJ; Houslay, MD; Wilson, A | 1 |
Himms-Hagen, J | 2 |
Emara, MK; Hassan, M; Hourani, H; Moussa, M; Saadah, A | 1 |
Asano, T; Kan, K; Ninomiya, H; Okumura, M; Yamamoto, T | 1 |
de Waard, F; Garbaczewski, L; Hill, P; Koppeschaar, H; Thijssen, JH; Wynder, EL | 1 |
Howe, B; McFee, AS; O'Dorisio, TM; Sirinek, KR | 1 |
Ditschuneit, HH; Lawecki, J; Lukas, B; Maier, V; Pfeiffer, EF; Schusdziarra, V | 1 |
Griglio, S; Le Liepvre, X; Malewiak, MI | 1 |
Bonner-Weir, S; Weir, GC | 1 |
Bartness, TJ; Gosnell, BA; Levine, AS; Morley, JE | 1 |
Cavalie, G; Lachkar, H; Mirouze, J; Monnier, L; Orsetti, A; Richard, JL; Rodier, M | 1 |
Balabolkin, MI; Kaiusheva, IV | 1 |
Lasichak, A; Lo, GS; Tsai, AC; Vinik, AI | 1 |
Bhathena, SJ; Ellwood, KC; Michaelis, OE | 1 |
de Teresa, A; di Chiara, G; Martino, C; Verrillo, A; Verrillo, L | 1 |
Ching, KN; Ho, LT; Lam, HC; Tang, KT; Wang, JT; Wang, LM | 1 |
Ceriello, A; Cozzolino, D; D'Onofrio, F; Giugliano, D; Salvatore, T; Torella, R | 2 |
de Waard, F; Garbaczewski, L; Hill, P; Koppeschaar, H; Thijssen, JH | 1 |
Cozzolino, D; D'Onofrio, F; Franchimont, P; Giugliano, D; Lefebvre, PJ; Salvatore, T; Torella, R | 1 |
Arner, P; Backman, L; Einarsson, K; Ewerth, S; Livingston, JN | 1 |
Schwandt, P | 1 |
Cabrerizzo Garcia, L; Lassmann, V; Vague, P; Vialettes, B | 1 |
Bhathena, SJ; Ellwood, KC; Michaelis, OE; Recant, L; Revett, K; Voyles, NR | 1 |
Bégin-Heick, N; Black, M; Heick, HM | 1 |
Aparicio, P; Bhathena, SJ; Recant, L; Revett, K; Voyles, N | 1 |
Hashimoto, N; Iwaoka, H; Kanatsuka, A; Makino, H; Sakurada, M; Taira, M; Yamaguchi, T; Yoshida, A; Yoshida, S | 1 |
Chiodera, P; Coiro, V; d'Amato, L; Davoli, C; Gelmini, G; Muzzetto, P; Orlandi, N; Passeri, M; Sabadini, G; Volpi, R | 1 |
D'Onofrio, F; Paolisso, G; Sgambato, S; Tesauro, P; Varricchio, M | 1 |
Jaworska, W; Rybakowa, M; Sołtysik-Wilk, E; Sucharski, P; Szafran, Z; Sztefko, K | 1 |
Lockwood, D; Nair, KS; Welle, S | 1 |
Bierwolf, B; Brunner, E; Danneberg, G; Pohl, A; Verlohren, HJ | 1 |
Polásková, J; Sonka, J; Sonka, K | 1 |
Bégin-Heick, N; Welsh, J | 1 |
Brechtel, G; Griver, K; Henry, RR | 1 |
Efendic, S; Karlander, S; Vranic, M | 1 |
Baraldi, G; Capelli, M; Melchionda, N; Pasquali, R; Patrono, D | 1 |
Bahendeka, SK; Buchanan, KD; Moore, RE; Tomkin, GH | 1 |
Laakso, M; Penttilä, I; Pyörälä, K; Sarlund, H | 1 |
Daniel, K; Grzeszczak, W; Kokot, F; Szurkowski, M | 2 |
Ford, GC; Garrow, JS; Halliday, D; Heels, S; Nair, KS | 1 |
Ahuja, SK; Amy, RM; Manickavel, V; Russell, JC | 1 |
Leclercq-Meyer, V; Malaisse, WJ; Marchand, J | 1 |
Kissebah, AH; Schectman, G | 1 |
Gelfand, RA; Sherwin, RS | 1 |
Harris, RB; Martin, RJ | 1 |
Linscheer, WG; Patel, DG; Raheja, KL | 1 |
Monti, M; Nilsson-Ehle, P; Olsson, SA; Sörbris, R | 1 |
Chen, YD; Golay, A; Jaspan, JB; Reaven, GM; Swislocki, AL | 2 |
Olefsky, JM; Prager, R; Wallace, P | 2 |
Akerblom, HK; Kouvalainen, K; Lautala, P; Martin, JM | 1 |
Meryn, S; Stein, D; Straus, EW | 2 |
Balázsi, I; Nagy, K; Varsányi-Nagy, M | 1 |
Adamafio, NA; Cameron, CM; Dunbar, JC; Kostyo, JL | 1 |
Doeden, B; Rizza, R | 1 |
Biso, P; Buratti, P; Capelli, M; Melchionda, N; Pasquali, R; Pasqui, F; Patrono, D | 1 |
Brodows, RG | 1 |
Joffe, BI; Seftel, HC; Shires, R | 1 |
Levin, BE; Nauss-Karol, C; Sullivan, AC; Triscari, J | 1 |
Hansen, BC; Jen, KL; Pek, SB; Wolfe, RA | 1 |
Dahmani, Y; Donev, S; Duhault, J; Marquié, G; Petkov, P | 1 |
Ikeda, M; Imura, H; Matsukura, S; Nakahara, H; Nishi, S; Seino, Y; Usami, M | 1 |
Beard, JC; Benedetti, TJ; Halter, JB; Johnston, CL; Porte, D; Ward, WK | 1 |
Campisi, R; Carducci Artenisio, A; Consolo, F; Forte, F; Lettina, G; Perrone, G; Ragonese, F; Saitta, G | 1 |
Jeanrenaud, B | 1 |
Costin, G; Kogut, MD | 1 |
AvRuskin, TW; Juan, C; Kasi, K; Kleinberg, DL; Pillai, S | 1 |
Campion, DR; Hausman, GJ; Martin, RJ; Ramsay, TG | 1 |
Gerich, JE; Langlois, M; Noacco, C | 1 |
Klitgaard, HM; Meade, RC; Ward, WF | 1 |
Berger, M; Gries, FA; Herberg, L | 1 |
Chen, R; Chiumello, G | 1 |
Ansanelli, V; Cutillo, S; D'Onofrio, F; Pacelli, V; Stoppoloni, G | 1 |
Voskresenskiĭ, ON | 1 |
Beloff-Chain, A; Findlay, JA; Lever, JD; Rookledge, KA | 1 |
Amigues, N; Chimenes, H; Darnis, F; Delorme, ML; Mossé, A | 1 |
Frohman, LA | 2 |
Hellman, B; Idahl, LA | 3 |
Clarke, BF | 1 |
Parmentier, J; Rubay, J | 1 |
Drash, A | 2 |
Gorden, P; Roth, J; Sherman, B | 1 |
Hales, CN | 1 |
Kahn, CR; Neville, DM; Roth, J | 1 |
Frasier, SD | 1 |
Lernmark, A | 1 |
Foppiani, E; Giordano, G; Marugo, M; Minuto, F | 1 |
Fussgänger, RD; Laube, H; Pfeiffer, EF | 1 |
Aoki, TT; Brennan, MF; Cahill, GF; Muller, WA | 2 |
Aubert, R; Lemonnier, D; Rosselin, G; Suquet, JP | 1 |
Crabbé, J; Desmecht, P; Kolanowski, J | 1 |
Chikamori, K; Fujinaka, S; Hirano, M; Masuda, K; Tetsuka, U | 1 |
Pichler, E | 1 |
Caccamo, A; Chiumello, G; Del Guercio, MJ; Devetta, M; Di Natale, B | 1 |
Felig, P; Hendler, R; Wise, JK | 3 |
Gossain, VV; Kalkhoff, RK; Matute, ML | 2 |
Tuchinda, C | 1 |
Porte, D; Woods, SC | 1 |
Laube, H; Pfeiffer, EF | 1 |
Gerich, J; Grodsky, GM; Karam, J; Levin, S; Sando, H | 1 |
Gleason, RE; Johansen, K; Soeldner, JS | 1 |
Danforth, E; Sims, EA | 1 |
Cameron, DP; Insch, S; Opat, F | 1 |
Frenkel, G; Kraicer, PF; Shani, J | 1 |
Barta, L; Molnár, M; Szabó, M; Tichy, MV | 1 |
Crabbé, J; De Gasparo, M; Desmecht, P; Kolanowski, J | 1 |
Trimble, GX | 1 |
Arky, RA; Boulter, PR; Saudek, CD | 1 |
Genuth, SM | 1 |
Apfelbaum, M; Assan, R; Reinberg, A | 1 |
Engel, K; Gentzsch, R; Gläser, A; Lohmann, D; Schönfelder, M | 1 |
Jablońska, A | 1 |
Vandeweghe, M; Vermeulen, A | 1 |
Spahn, U; Voss, E | 1 |
Dost, FH; Gladtke, E; von Hattingberg, HM | 1 |
Marks, V; Salmols, E | 1 |
Melani, F | 1 |
Genes, SG | 1 |
Westman, S | 1 |
Duprey, J; Lubetzki, J | 1 |
Arky, RA; Knopp, RH | 1 |
Horton, ES; Salans, LB; Sims, EA | 1 |
Greenwood, FC; Landon, J | 1 |
Levine, R | 1 |
Adezati, L; Cristofolini, MP; Pagliaini, R; Prando, R | 1 |
Assan, R; Tchobroutsky, G; Tiengo, A | 1 |
Kiphis, DM | 1 |
Gerhold, WM | 1 |
Parra-Covarrubias, A | 1 |
Du, EL; Rodger, NW; Squires, BP | 1 |
Crabbé, J; Kolanowski, J | 1 |
Quabbe, HJ; Römhild, U; Sardemann, C | 1 |
Corredor, DG; Danowski, TS; Mendelsohn, LV; Sabeh, G; Sunder, JH; Wasserman, RE | 1 |
Junod, A; Lambert, AE; Letarte, J; Stauffacher, W | 1 |
Arky, RA; Braun, AP; Finger, M; Veverbrants, E | 1 |
Aoki, TT; Cahill, GF; Felig, P; Marliss, E; Pozefsky, T | 1 |
Kowalski, H; Lawecki, J; Rogala, H | 1 |
Helge, H; Quabbe, HJ; Weber, B | 1 |
Bartelt, KM; Lawecki, J; Melani, F; Pfeiffer, EF | 1 |
Berger, S; Mako, M; Metz, R; Nice, M | 1 |
Crockford, PM; Hazzard, WR; Williams, RH | 2 |
Bittnerová, H; Kujalová, V; Rath, R | 1 |
Benedetti, A; Forsham, PH; Grodsky, GM; Karam, JH; Simpson, RG | 1 |
Larsen, OA; Lassen, NA; Lbitsch, V; Nielsen, SL; Quaade, F | 1 |
Abramson, EA; Arky, RA; Freinkel, N | 1 |
Beringer von, A; Geyer, G; Mösslacher, H; Tragl, KH; Waldhäusl, W | 1 |
Bunge, HC | 1 |
Benedetti, A | 1 |
Kujalová, V; Rath, R | 1 |
Jablońska-Ulbrych, A; Spahn, U | 1 |
Bailey, CJ; Flatt, PR; Swanston-Flatt, SK | 1 |
Moody, AJ | 1 |
129 review(s) available for glucagon and Obesity
Article | Year |
---|---|
The incretin/glucagon system as a target for pharmacotherapy of obesity.
Topics: Animals; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Obesity | 2022 |
The current significance and prospects for the use of dual receptor agonism GLP-1/Glucagon.
Topics: Animals; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incretins; Obesity | 2022 |
Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
Topics: Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Obesity; Receptors, Glucagon; Weight Loss | 2022 |
Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity.
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Obesity; Oxyntomodulin | 2023 |
Glucagon and energy expenditure; Revisiting amino acid metabolism and implications for weight loss therapy.
Topics: Amino Acids; Energy Metabolism; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Obesity; Receptors, Glucagon; Weight Loss | 2023 |
The molecular pharmacology of glucagon agonists in diabetes and obesity.
Topics: Animals; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Mice; Obesity; Receptors, Glucagon | 2023 |
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy.
Topics: Body Weight; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Obesity | 2023 |
Gut hormone co-agonists for the treatment of obesity: from bench to bedside.
Topics: Diabetes Mellitus, Type 2; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; United States | 2023 |
Glucagon Control on Food Intake and Energy Balance.
Topics: Animals; Anti-Obesity Agents; Appetite Regulation; Body Weight; Diabetes Mellitus; Energy Metabolism; Glucagon; Glucose; Humans; Hypoglycemic Agents; Lipid Metabolism; Molecular Targeted Therapy; Obesity; Peptides; Receptors, Glucagon; Thermogenesis | 2019 |
Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Design; Gastric Inhibitory Polypeptide; Glucagon; Humans; Obesity; Peptide Fragments; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Structure-Activity Relationship | 2020 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Combination gut hormones: prospects and questions for the future of obesity and diabetes therapy.
Topics: Animals; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Gastrointestinal Microbiome; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; Peptide YY | 2020 |
A Review of Recent Findings on Meal Sequence: An Attractive Dietary Approach to Prevention and Management of Type 2 Diabetes.
Topics: Diabetes Mellitus, Type 2; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Dietary Fiber; Dietary Proteins; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Intestinal Mucosa; Meals; Nutritional Physiological Phenomena; Obesity | 2020 |
Dietary protein intake and obesity-associated cardiometabolic function.
Topics: Animals; Blood Glucose; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Diet, High-Protein; Diet, High-Protein Low-Carbohydrate; Dietary Proteins; Glucagon; Humans; Insulin; Non-alcoholic Fatty Liver Disease; Obesity; Triglycerides | 2020 |
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Topics: Adipose Tissue; Animals; Diet; Endocrine System Diseases; Fatty Liver; Glucagon; Gluconeogenesis; Glucose; Homeostasis; Hormones; Humans; Hydrocortisone; Hyperinsulinism; Lipid Metabolism; Lipids; Lipogenesis; Lipolysis; Liver; Non-alcoholic Fatty Liver Disease; Obesity; Overnutrition; Oxidation-Reduction; Signal Transduction; Virus Diseases | 2017 |
The role of glucagon in weight loss-mediated metabolic improvement: a systematic review and meta-analysis.
Topics: Bariatric Surgery; Blood Glucose; Diet, Reducing; Fasting; Glucagon; Humans; Insulin Resistance; Obesity; Observational Studies as Topic; Weight Loss | 2018 |
Optimization of peptide-based polyagonists for treatment of diabetes and obesity.
Topics: Amino Acid Sequence; Animals; Diabetes Mellitus, Type 2; Drug Discovery; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; Peptides | 2018 |
Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes.
Topics: Cholecystokinin; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Obesity; Peptides; Receptor, Cholecystokinin B | 2018 |
Glucagon receptor signaling in metabolic diseases.
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemia; Hypoglycemic Agents; Obesity; Receptors, Glucagon; Signal Transduction | 2018 |
Oxyntomodulin: Actions and role in diabetes.
Topics: Amino Acids; Diabetes Mellitus; Glucagon; Humans; Obesity; Oxyntomodulin; Proglucagon; Proprotein Convertases | 2018 |
Problem or solution: The strange story of glucagon.
Topics: Diabetes Mellitus, Type 2; Energy Metabolism; Glucagon; Humans; Hyperglycemia; Incretins; Insulin; Obesity; Receptors, Glucagon | 2018 |
Peptide-based multi-agonists: a new paradigm in metabolic pharmacology.
Topics: Animals; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; Peptides | 2018 |
Glucagon, GLP-1 and Thermogenesis.
Topics: Adipose Tissue, Brown; Animals; Energy Metabolism; Glucagon; Glucagon-Like Peptide 1; Humans; Molecular Targeted Therapy; Obesity; Thermogenesis | 2019 |
Type 2 diabetes and the evolving paradigm in glucose regulation.
Topics: Adipocytes; Appetite; Brain; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose; Humans; Insulin Resistance; Insulin-Secreting Cells; Kidney; Liver; Muscle, Skeletal; Obesity; Sodium-Glucose Transport Proteins | 2013 |
Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.
Topics: Animals; Blood Glucose; Body Weight; Central Nervous System; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Leptin; Obesity | 2013 |
Energy metabolism in the liver.
Topics: Circadian Rhythm; Cytokines; Diabetes Mellitus, Type 2; Endoplasmic Reticulum; Energy Metabolism; Fatty Acids; Glucagon; Gluconeogenesis; Glucose; Human Growth Hormone; Humans; Insulin; Lipogenesis; Liver; Non-alcoholic Fatty Liver Disease; Obesity | 2014 |
Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes.
Topics: Blood Glucose; Diabetes Mellitus; Diet; Energy Metabolism; Glucagon; Glucagon-Secreting Cells; Homeostasis; Humans; Hyperglycemia; Lipid Metabolism; Obesity; Receptors, Glucagon | 2014 |
[New therapies for type 2 diabetes mellitus].
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Diacylglycerol O-Acyltransferase; Dipeptidyl Peptidase 4; Drug Therapy, Combination; Drugs, Investigational; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucokinase; Gluconeogenesis; Glucose; Humans; Hypoglycemic Agents; Incretins; Insulin Resistance; Insulin, Long-Acting; Molecular Targeted Therapy; Obesity; Phosphofructokinase-2; Sodium-Glucose Transport Proteins; Weight Loss | 2015 |
How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Topics: Anti-Obesity Agents; Bariatric Surgery; Biological Transport; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycosuria; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Kidney Tubules, Proximal; Microvilli; Multicenter Studies as Topic; Obesity; Peptides; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Venoms; Weight Loss | 2015 |
Glucose homeostasis during short-term and prolonged exposure to high altitudes.
Topics: Adipose Tissue; Altitude; Diabetes Mellitus; Glucagon; Glucose; Glycogen; Homeostasis; Humans; Hyperinsulinism; Hypoglycemia; Hypoxia; Liver; Muscle, Skeletal; Obesity; Time Factors | 2015 |
Unimolecular Polypharmacy for Treatment of Diabetes and Obesity.
Topics: Amino Acid Sequence; Bariatric Surgery; Diabetes Mellitus, Type 2; Glucagon; Humans; Obesity; Peptides; Polypharmacy | 2016 |
Glucose sensing and the pathogenesis of obesity and type 2 diabetes.
Topics: Animals; Appetite Regulation; Blood Glucose; Brain; Diabetes Mellitus, Type 2; Fatty Acids; Glucagon; Insulin; Mice; Obesity; Pancreas; Portal System; Rats | 2008 |
Fibroblast growth factor 21: from pharmacology to physiology.
Topics: Adipose Tissue; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Fibroblast Growth Factors; Glucagon; Growth Substances; Humans; Insulin; Liver; Mice; Obesity; Pancreas; Primates; Rodentia; Starvation; Triglycerides; Weight Loss | 2010 |
The mechanism of action for oxyntomodulin in the regulation of obesity.
Topics: Animals; Appetite Depressants; Appetite Regulation; Clinical Trials as Topic; Drug Evaluation, Preclinical; Eating; Energy Metabolism; Enteroendocrine Cells; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptides; Humans; Obesity; Oxyntomodulin | 2010 |
The metabolic actions of glucagon revisited.
Topics: Adipose Tissue; Animals; Energy Metabolism; Glucagon; Humans; Lipid Metabolism; Metabolism; Models, Biological; Obesity | 2010 |
GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities.
Topics: Animals; Diabetes Mellitus; Eating; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Islet Amyloid Polypeptide; Metabolic Diseases; Obesity; Receptors, Glucagon | 2012 |
Type 2 diabetes across generations: from pathophysiology to prevention and management.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diabetic Retinopathy; Epigenesis, Genetic; Female; Fetal Development; Genetic Predisposition to Disease; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Incretins; Insulin Resistance; Insulin-Secreting Cells; Life Style; Liver; Muscle, Skeletal; Myocardium; Obesity; Prediabetic State; Pregnancy | 2011 |
Dysfunctional hormonal regulation of metabolism in obesity.
Topics: Adipose Tissue; Glucagon; Hormones; Humans; Insulin; Obesity | 2011 |
Minireview: Glucagon in stress and energy homeostasis.
Topics: Animals; Energy Metabolism; Feeding Behavior; Glucagon; Glucose; Homeostasis; Hormones; Humans; Hypoglycemia; Metabolism; Models, Biological; Obesity; Receptors, Glucagon; Stress, Physiological; Stress, Psychological | 2012 |
Insulin resistance in type 2 diabetic youth.
Topics: Adolescent; Body Mass Index; C-Peptide; Child; Diabetes Mellitus, Type 2; Exercise Tolerance; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Metformin; Obesity; Phenotype; Young Adult | 2012 |
Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
Topics: Animals; Behavior, Animal; Central Nervous System; Eating; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Humans; Obesity; Oxyntomodulin; Peptide Fragments; Peptides; Proglucagon; Protein Precursors; Receptors, Glucagon | 2003 |
[NEW CONCEPTS ON THE PATHOGENESIS OF DIABETES MELLITUS].
Topics: Adrenal Cortex Hormones; Diabetes Mellitus; Endopeptidases; Glucagon; Growth Hormone; Humans; Insulin Antibodies; Lipoproteins; Nervous System; Obesity; Oxidoreductases | 1964 |
[MORPHOLOGICAL PROBLEMS IN DIABETES RESEARCH].
Topics: Adolescent; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucagon; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Islands; Islets of Langerhans; Obesity; Pathology; Research | 1964 |
APPETITE AND THE MANY OBESITIES.
Topics: Appetite; Blood Glucose; Body Temperature Regulation; Carbohydrate Metabolism; Child; Classification; Dietary Fats; Endocrine System Diseases; Gastrointestinal Tract; Glucagon; Glucose; Gold; Humans; Hunger; Hypothalamus; Intestinal Absorption; Obesity; Physiology; Psychology | 1964 |
LIPID METABOLISM, DIABETES MELLITUS, AND OBESITY.
Topics: Carbohydrate Metabolism; Diabetes Mellitus; Fatty Acids; Glucagon; Glucose; Glycerides; Glycolysis; Growth Hormone; Humans; Hyperlipidemias; Insulin; Lipid Metabolism; Obesity | 1964 |
Gut hormones and the control of appetite.
Topics: Animals; Appetite Regulation; Cholecystokinin; Gastrointestinal Hormones; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Leptin; Obesity; Oxyntomodulin; Pancreatic Polypeptide; Peptide Fragments; Peptide Hormones; Peptide YY; Protein Precursors | 2004 |
[Oral diabetes treatment. Which substance is indicated at which time?].
Topics: Administration, Oral; Diabetes Mellitus, Type 2; Germany; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Metformin; Obesity; Peptide Fragments; Peptides; Practice Guidelines as Topic; Practice Patterns, Physicians'; Treatment Outcome | 2004 |
Gut hormones as peripheral anti obesity targets.
Topics: Animals; Anti-Obesity Agents; Appetite Regulation; Drug Design; Gastrointestinal Hormones; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Mice; Obesity; Oxyntomodulin; Pancreatic Polypeptide; Peptide Fragments; Peptide Hormones; Peptide YY; Protein Precursors; Rats; Receptors, G-Protein-Coupled | 2004 |
Modern, new pharmacotherapy for obesity. A gastrointestinal approach.
Topics: Amylases; Androgens; Anti-Obesity Agents; Citrates; Cyclobutanes; Dietary Fats; Fat Substitutes; Fatty Acids; Glucagon; Glucagon-Like Peptide 1; Glucosidases; Human Growth Hormone; Humans; Intestinal Absorption; Lactones; Lipase; Obesity; Orlistat; Peptide Fragments; Protein Precursors; Sucrose | 2004 |
[Impaired hepatic glucose metabolism].
Topics: Glucagon; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Obesity; Postprandial Period | 2005 |
Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Obesity; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain | 2003 |
Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): the role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress.
Topics: Animals; Diabetes Mellitus; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; Pancreas; Peptide Fragments; Protein Precursors; Stress, Physiological | 2005 |
Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders.
Topics: Adipocytes; Bile Acids and Salts; Cholesterol; Cholesterol, LDL; Diabetes Mellitus; Glucagon; Homeostasis; Homocysteine; Humans; Hyperlipidemias; Insulin; Intestinal Absorption; Kidney Diseases; Lipid Metabolism; Liver; Liver Diseases; Obesity; Soybean Proteins; Sterol Regulatory Element Binding Protein 1 | 2006 |
Human obesity: its hormonal basis and the role of gastric inhibitory polypeptide.
Topics: Adipose Tissue; Animals; Energy Metabolism; Gastric Inhibitory Polypeptide; Glucagon; Humans; Insulin; Obesity; Phenotype | 2006 |
Some aspects of the problem of regulation of food intake and obesity.
Topics: Animals; Child; Eating; Female; Glucagon; Glucose; Humans; Hypothalamus; Male; Obesity | 1966 |
Gastric inhibitory polypeptide.
Topics: Adolescent; Adult; Diabetes Mellitus; Gastric Inhibitory Polypeptide; Gastric Juice; Gastrointestinal Hormones; Glucagon; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Secretion; Islets of Langerhans; Malabsorption Syndromes; Obesity; Somatostatin | 1980 |
Influence of insulin and glucagon on sodium balance in obese subjects during fasting and refeeding.
Topics: 3-Hydroxybutyric Acid; Blood Glucose; Body Weight; Fasting; Food; Glucagon; Hormones; Humans; Hydroxybutyrates; Insulin; Obesity; Sodium; Somatostatin | 1981 |
[Peptide hormones of the digestive organs (review of the literature)].
Topics: Cholecystokinin; Diabetes Mellitus, Type 2; Digestive System Physiological Phenomena; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Insulin; Motilin; Neurotensin; Obesity; Pancreatic Polypeptide; Pentagastrin; Secretin; Somatostatin; Vasoactive Intestinal Peptide | 1983 |
Gut peptides and postprandial satiety.
Topics: Animals; Appetite Regulation; Bombesin; Cholecystokinin; Eating; Glucagon; Humans; Neurons, Afferent; Obesity; Peptides; Somatostatin; Vagus Nerve | 1984 |
Maternal ketosis and its effects on the fetus.
Topics: Acidosis; Birth Weight; Blood Glucose; Brain; Fasting; Fatty Acids, Nonesterified; Female; Fetus; Glucagon; Gluconeogenesis; Homeostasis; Humans; Insulin; Ketone Bodies; Ketosis; Maternal-Fetal Exchange; Models, Biological; Obesity; Placenta; Pregnancy; Pregnancy Complications; Pregnancy in Diabetics | 1983 |
Adipose tissue metabolism and its control in birds.
Topics: Adipose Tissue; Animal Feed; Animals; Birds; Chickens; Disease Models, Animal; Female; Glucagon; Gonadal Steroid Hormones; Insulin; Lipids; Lipolysis; Liver; Male; Obesity; Poultry; Poultry Diseases; Sex Factors; Triglycerides | 1984 |
Hormonal changes: are they useful in the classification of obesities?
Topics: Animals; Basal Metabolism; Body Weight; Glucagon; Hormones; Humans; Insulin; Macaca mulatta; Obesity; Pancreatic Polypeptide | 1984 |
The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity.
Topics: Adipose Tissue; Alloxan; Animals; Glucagon; Glucose; Humans; Hyperplasia; Insulin; Insulin Resistance; Islets of Langerhans; Liver; Mice; Mice, Obese; Microscopy, Electron; Muscles; Obesity; Receptor, Insulin; Streptozocin | 1981 |
The metabolic role of GIP: physiology and pathology.
Topics: Adipocytes; Animals; Diabetes Mellitus, Type 2; Diet; Digestive System Physiological Phenomena; Energy Metabolism; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Insulin; Mice; Mice, Inbred NOD; Models, Biological; Obesity; Organ Specificity; Peptide Fragments; Protein Precursors; Rats; Rats, Zucker; Receptors, Gastrointestinal Hormone; Receptors, Glucagon | 1996 |
The role of prohormone convertases in insulin biosynthesis: evidence for inherited defects in their action in man and experimental animals.
Topics: Animals; Aspartic Acid Endopeptidases; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Islets of Langerhans; Obesity; Organ Specificity; Proinsulin; Proprotein Convertase 2; Proprotein Convertases; Subtilisins | 1996 |
Nutrient-induced secretion and metabolic effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
Topics: Adaptation, Physiological; Adipose Tissue; Animals; Coronary Disease; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Obesity; Peptide Fragments | 1996 |
[The pathogenesis of NIDDM: genetic defects and environmental factors].
Topics: Diabetes Mellitus, Type 2; Diet; DNA, Mitochondrial; Exercise; Glucagon; Glucokinase; Glycogen Synthase; Humans; Insulin; Mutation; Obesity; Receptor, Insulin; Receptors, Adrenergic, beta; Stress, Physiological | 1996 |
Control of appetite--the role of glucagon-like peptide-1 (7-36) amide.
Topics: Adipocytes; Animals; Appetite Regulation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Neurotransmitter Agents; Obesity; Peptide Fragments | 1997 |
[ob/ob mouse].
Topics: Animals; Body Temperature Regulation; Disease Models, Animal; Glucagon; Insulin; Leptin; Mice; Mice, Obese; Obesity; Proteins | 1998 |
[Physiopathological fundamentals of type 2 diabetes].
Topics: Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Gluconeogenesis; Humans; Insulin; Insulin Resistance; Obesity | 1999 |
Is there appetite after GLP-1 and PACAP?
Topics: Animals; Appetite; Appetite Depressants; Digestive System Physiological Phenomena; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Homeostasis; Humans; Hypothalamus; Islets of Langerhans; Models, Biological; Neuropeptides; Obesity; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Precursors; Receptors, Glucagon | 1998 |
[New prospects in genetics of obesity].
Topics: Adult; Animals; Aspartic Acid Endopeptidases; Carrier Proteins; Child; Female; Glucagon; Humans; Leptin; Male; Mice; Mice, Obese; Obesity; Obesity, Morbid; Proprotein Convertases; Rats; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Receptors, Cell Surface; Receptors, Cytokine; Receptors, Leptin; Tumor Necrosis Factor-alpha | 1999 |
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
Topics: Adult; Appetite; Cross-Over Studies; Dose-Response Relationship, Drug; Eating; Energy Metabolism; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hunger; Infusions, Intravenous; Injections, Intravenous; Male; Obesity; Peptide Fragments; Randomized Controlled Trials as Topic; Satiety Response | 2001 |
Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Brief Psychiatric Rating Scale; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Hydrocortisone; Insulin; Male; Obesity; Schizophrenia | 2002 |
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
Topics: Animals; Body Weight; Eating; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; Peptide Fragments; Protein Precursors | 2002 |
Renin, aldosterone and glucagon in the natriuresis of fasting.
Topics: Adrenocorticotropic Hormone; Aldosterone; Dietary Carbohydrates; Dietary Proteins; Fasting; Fludrocortisone; Glucagon; Humans; Kidney Tubules, Distal; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Natriuresis; Obesity; Potassium; Renin; Secretory Rate; Sodium; Spironolactone | 1975 |
[The use of methods applied in the study of cellular hormone receptors in clinical physiopathology].
Topics: Adenylyl Cyclases; Adrenal Glands; Adrenocorticotropic Hormone; Catecholamines; Cell Physiological Phenomena; Chorionic Gonadotropin; Female; Glucagon; Graves Disease; Growth Hormone; Humans; Insulin; Kidney; Liver; Metabolic Diseases; Obesity; Ovary; Prostaglandins; Receptors, Cell Surface | 1975 |
Obesity: changes in lipid metabolism and the role of insulin.
Topics: Adipose Tissue; Bile; Body Weight; Cholesterol; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Hyperlipidemias; Insulin; Lipid Metabolism; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Male; Obesity; Triglycerides | 1976 |
Physiology and pathophysiology of glucagon.
Topics: Animals; Cattle; Cerebrovascular Circulation; Diabetes Mellitus; Diet; Dogs; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Humans; Insulin; Intercellular Junctions; Islets of Langerhans; Ketones; Liver; Male; Obesity; Physical Exertion; Rabbits; Rats; Receptors, Cell Surface; Regional Blood Flow; Starvation; Stomach; Swine | 1976 |
[Metabolic effects of glucagon in obesity in children (a review of the literature)].
Topics: Adipose Tissue; Blood Glucose; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Humans; Insulin; Insulin Secretion; Lipid Metabolism; Obesity; Receptors, Drug | 1978 |
The Zucker-fatty rat: a review.
Topics: Adipose Tissue; Age Factors; Animals; Blood Glucose; Eating; Feeding Behavior; Genes, Recessive; Glucagon; Gluconeogenesis; Glycolysis; Hypothalamus; Hypothyroidism; Insulin; Kidney; Lipid Metabolism; Models, Biological; Obesity; Pituitary Gland; Rats; Reproduction | 1977 |
Regulatory mechanisms of energy needs. Coordinating role of the endocrine glands.
Topics: Appetite Regulation; Catecholamines; Diet; Digestion; Endocrine Glands; Energy Metabolism; Estrogens; Fasting; Fatty Acids; Female; Glucagon; Glucocorticoids; Glucose; Humans; Hydrocortisone; Insulin; Obesity; Physical Exertion; Placental Hormones; Pregnancy; Stress, Physiological; Thyroid Hormones | 1977 |
On the mechanisms of fasting natriuresis and of carbohydrate-induced sodium retention.
Topics: Aldosterone; Blood Glucose; Dietary Carbohydrates; Electrolytes; Fasting; Glucagon; Humans; Hydroxybutyrates; Insulin; Ketone Bodies; Kidney; Natriuresis; Obesity; Sodium; Starvation | 1977 |
[Physiologic and pathophysiologic function of glucagon].
Topics: Animals; Diabetes Mellitus; Diet; Dogs; Glucagon; Glycogen Storage Disease; Humans; Hyperlipidemias; Infant, Newborn; Obesity | 1977 |
[Diet therapy of diabetes mellitus].
Topics: Circadian Rhythm; Diabetes Mellitus; Dietary Carbohydrates; Energy Intake; Glucagon; Hyperglycemia; Insulin; Lipoproteins; Obesity | 1978 |
[Benign symmetric lipomatosis: a symptom of alcoholic liver disease?].
Topics: Adult; Aged; Blood Glucose; Epinephrine; Glucagon; Glucose Tolerance Test; Hepatic Encephalopathy; Hepatitis, Alcoholic; Humans; Lipomatosis; Liver; Liver Diseases, Alcoholic; Male; Middle Aged; Obesity; Transaminases | 1979 |
GIP and the entero-insular axis.
Topics: Animals; Blood Glucose; Fasting; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Obesity; Pancreas; Radioimmunoassay; Rats | 1979 |
[Role of glucagon in pathophysiology (author's transl)].
Topics: Diabetes Mellitus; Endocrine System Diseases; Glucagon; Humans; Infant, Newborn; Myocardial Infarction; Obesity | 1979 |
Insulin resistance in obesity: a critical analysis at enzyme level. A review.
Topics: Adipose Tissue; Animals; Diabetes Mellitus; Glucagon; Gluconeogenesis; Humans; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Lipolysis; Liver; Mice; Muscles; Obesity; Proteins; Rats | 1979 |
[Glucagon-induced lipolysis and obesity].
Topics: Adult; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Insulin; Lipid Metabolism; Middle Aged; Obesity | 1978 |
[Etiology of diabetes (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Autoimmune Diseases; Child; Child, Preschool; Diabetes Mellitus; Endocrine System Diseases; Female; Glucagon; Growth Hormone; Humans; Hyperglycemia; Islets of Langerhans; Male; Menopause; Middle Aged; Obesity; Pancreatic Diseases; Pregnancy; Sex Factors; Somatostatin; Virus Diseases | 1977 |
The effects of very restrictive high protein diets.
Topics: Adipose Tissue; Adult; Body Weight; Diet, Reducing; Dietary Proteins; Fasting; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Liver; Nitrogen; Obesity; Oxygen Consumption; Potassium; Vitamins | 1976 |
Amino acid metabolism in man.
Topics: Alanine; Amino Acids; Brain; Diabetes Mellitus; Erythrocytes; Glucagon; Glucocorticoids; Gluconeogenesis; Glucose; Hormones; Humans; Hypoglycemia; Insulin; Kidney; Liver; Models, Biological; Muscles; Obesity; Physical Exertion; Proteins; Starvation | 1975 |
Genetic obesity: is the defect in the sympathetic nervous system? A review through developmental studies in the preobese Zucker rat.
Topics: Adipose Tissue; Adrenal Glands; Animals; Body Temperature Regulation; Complement Factor D; Eating; Glucagon; Hyperphagia; Insulin; Liver; Muscles; Neurotransmitter Agents; Obesity; Pituitary Gland; Rats; Rats, Zucker; Serine Endopeptidases; Sympathetic Nervous System | 1991 |
Are gut peptides a new class of anorectic agents?
Topics: Animals; Appetite Depressants; Bombesin; Cholecystokinin; Glucagon; Humans; Obesity; Satiation | 1992 |
Influence of nutrient intake on protein turnover.
Topics: Amino Acids; Diabetes Mellitus; Diet; Glucagon; Glucocorticoids; Growth; Humans; Insulin; Neoplasms; Nutritional Physiological Phenomena; Nutritional Status; Obesity; Proteins; Wounds and Injuries | 1989 |
Brown adipose tissue thermogenesis and obesity.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Carbohydrate Metabolism; Diet; Glucagon; Humans; Insulin; Lipid Metabolism; Nitrogen; Obesity; Receptors, Adrenergic; Triiodothyronine | 1989 |
Pancreatic somatostatin.
Topics: Animals; Diabetes Mellitus; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Somatostatin | 1985 |
Peptidergic regulation of feeding.
Topics: Afferent Pathways; Animals; Bombesin; Brain Mapping; Calcitonin; Calcitonin Gene-Related Peptide; Cholecystokinin; Corticotropin-Releasing Hormone; Disease Models, Animal; Endorphins; Feeding Behavior; Glucagon; Humans; Insulin; Motilin; Nerve Tissue Proteins; Neuropeptide Y; Neurotensin; Obesity; Pancreatic Polypeptide; Satiety Response; Somatostatin; Species Specificity; Stress, Psychological; Taste; Thyrotropin-Releasing Hormone | 1985 |
Brown adipose tissue metabolism and thermogenesis.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Central Nervous System; Cold Temperature; Diet; Fatty Acids; Food Deprivation; Glucagon; Glucocorticoids; Gonadal Steroid Hormones; Guanosine Diphosphate; Humans; Insulin; Light; Melatonin; Norepinephrine; Obesity; Oxygen Consumption; Periodicity; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sodium-Potassium-Exchanging ATPase; Sympathetic Nervous System; Thyroid Hormones; Triglycerides | 1985 |
Hormones and lipoprotein metabolism.
Topics: Catecholamines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucocorticoids; Gonadal Steroid Hormones; Growth Hormone; Hormones; Humans; Hyperinsulinism; Insulin; Lipoproteins; Menopause; Obesity; Thyroxine | 1987 |
An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause.
Topics: Adipose Tissue; Animals; Central Nervous System Diseases; Glucagon; Glucose; Insulin; Insulin Secretion; Lipids; Liver; Mice; Obesity; Rats; Triglycerides | 1985 |
[Pancreatic hormones and arteriosclerosis].
Topics: Aging; Animals; Arteriosclerosis; Blood Proteins; Cholesterol; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dogs; Fatty Acids; Fatty Liver; Glucagon; Guinea Pigs; Hypercholesterolemia; Insulin; Insulin Secretion; Lipotropic Agents; NADP; Obesity; Pancreatectomy; Phosphatidylcholines; Rabbits; Rats; Sterols; Tissue Extracts | 1967 |
Metabolic aspects of obesity.
Topics: Acidosis; Adenosine Triphosphate; Adipose Tissue; Adrenal Cortex Hormones; Alcoholism; Animals; Body Temperature; Body Temperature Regulation; Carbohydrate Metabolism; Cushing Syndrome; Dehydroepiandrosterone; Eating; Edema; Fatty Acids; Fatty Acids, Nonesterified; Feeding Behavior; Glucagon; Glucose; Glycerolphosphate Dehydrogenase; Glycerophosphates; Growth Hormone; Humans; Hyperinsulinism; Hypoglycemia; Insulin; Insulin Secretion; Lipid Metabolism; Lipid Mobilization; Lipids; Lipotropic Agents; Metabolic Diseases; Muscle Proteins; Nitrogen; Obesity; Oxidation-Reduction; Oxidative Phosphorylation; Physical Exertion; Shivering; Triglycerides; Water; Water-Electrolyte Balance | 1970 |
The endocrine function of the pancreas.
Topics: Animals; Carbohydrate Metabolism; Cyclic AMP; Diabetes Mellitus; Dogs; Glucagon; Humans; Insulin; Obesity; Pancreas; Rats | 1969 |
The pathogenesis of diabetes mellitus.
Topics: Albumins; Amino Acids; Catecholamines; Cyclic AMP; Diabetes Mellitus; Endocrine System Diseases; Female; Glucagon; Glucose; Hormones; Humans; Insulin; Insulin Antagonists; Insulin Secretion; Obesity; Pregnancy; Pregnancy in Diabetics; Sympatholytics; Sympathomimetics | 1970 |
Diabetes mellitus in childhood: a review.
Topics: Adrenocorticotropic Hormone; Affective Symptoms; Age Factors; Blood Glucose; Catecholamines; Child; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Coma; Diabetic Ketoacidosis; Diet Therapy; Glucagon; Gluconeogenesis; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hypoglycemic Agents; Infusions, Parenteral; Insulin; Lipid Metabolism; Obesity; Prediabetic State; United States | 1971 |
The role of insulin in the regulation of glucose metabolism.
Topics: Adipose Tissue; Animals; Autonomic Nervous System; Cyclic AMP; Glucagon; Glucose; Insulin; Insulin Secretion; Intestinal Mucosa; Islets of Langerhans; Microsomes; Obesity; Receptors, Drug; Secretory Rate; Stimulation, Chemical | 1971 |
Current concepts of diabetes mellitus in childhood: a review.
Topics: Abnormalities, Multiple; Child; Diabetes Mellitus, Type 1; Diet, Diabetic; Female; Glucagon; Glucose Tolerance Test; Glycosuria; Humans; Hypoglycemia; Hypogonadism; Infant, Newborn; Infant, Newborn, Diseases; Insulin; Intellectual Disability; Male; Obesity; Prediabetic State; Respiratory Distress Syndrome, Newborn | 1974 |
Natriuresis of starvation and glucagon.
Topics: Diet, Reducing; Dietary Carbohydrates; Glucagon; Humans; Kidney; Natriuresis; Obesity; Potassium; Sodium; Starvation; Water-Electrolyte Balance | 1974 |
Neural control of the endocrine pancreas.
Topics: Autonomic Nervous System; Brain; Catecholamines; Denervation; Diabetes Mellitus; Electric Stimulation; Glucagon; Humans; Hypoglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Microscopy, Electron; Nervous System Physiological Phenomena; Obesity; Parasympathetic Nervous System; Parasympathomimetics; Peripheral Nerves; Reflex; Stress, Physiological; Sympathetic Nervous System | 1974 |
Metabolic effects of glucocorticoids in man.
Topics: Adolescent; Adult; Alanine; Amino Acids; Blood Glucose; Cortisone; Cushing Syndrome; Dexamethasone; Dietary Proteins; Glucagon; Glucocorticoids; Glucose; Humans; Insulin; Obesity; Starvation | 1974 |
Obesity and diabetes mellitus.
Topics: Adipose Tissue; Age Factors; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Complications; Diabetes Mellitus; Diet Therapy; Dietary Carbohydrates; Glucagon; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Pancreas; Perfusion; Proinsulin; Rats; Time Factors; Tolbutamide; Triglycerides | 1974 |
Synthesis and secretion of insulin in dynamic perfusion systems.
Topics: Animals; Antimetabolites; Arginine; Carbon Radioisotopes; Computers; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Isotope Labeling; Leucine; Models, Biological; Obesity; Oligomycins; Pancreas; Perfusion; Rats; Time Factors; Tolbutamide | 1974 |
The pathogenesis of pancreatic islet cell hyperplasia and insulin insensitivity in obesity.
Topics: Adrenal Cortex; Amino Acids; Biological Transport, Active; Epinephrine; Fatty Acids, Nonesterified; Genes; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Hyperplasia; Hypothalamus; Insulin; Islets of Langerhans; Obesity | 1974 |
Insulin, growth hormone, and glucagon in prediabetes mellitus--a review.
Topics: Adolescent; Adult; Aged; Blood Glucose; Child; Diabetes Mellitus; Diseases in Twins; Genotype; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged; Obesity; Prediabetic State | 1974 |
Role of insulin in obesity.
Topics: Adipose Tissue; Animals; Dietary Carbohydrates; Dietary Fats; Eating; Fatty Acids; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypothalamus; Insulin; Insulin Resistance; Insulin Secretion; Obesity | 1974 |
[Free fatty acids in the serum--regulatory mechanism and clinical significance].
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Dietary Fats; Fatty Acids, Nonesterified; Female; Glucagon; Hepatitis A; Humans; Hyperthyroidism; Insulin; Lipid Metabolism; Lipid Metabolism, Inborn Errors; Male; Norepinephrine; Obesity; Physical Exertion; Prednisone; Pregnancy; Rats; Triglycerides | 1969 |
[The differential diagnosis of pathological carbohydrate tolerance].
Topics: Adolescent; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus; Diagnosis, Differential; Fasting; Glucagon; Glucose; Glucose Tolerance Test; Humans; Indicators and Reagents; Infant; Infant, Newborn; Injections, Intravenous; Kinetics; Obesity; Seizures; Tolbutamide | 1970 |
[Glucagon mediated insulin release in man].
Topics: Blood Glucose; Diabetes Mellitus; Ethanol; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose; Humans; Hyperglycemia; Injections, Intravenous; Insulin; Insulin Secretion; Liver Cirrhosis; Methandrostenolone; Obesity; Pancreas | 1968 |
[Critical considerations regarding the obesity-hyperinsulinism concept].
Topics: Animals; Blood Glucose; Glucagon; Glucocorticoids; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hyperinsulinism; Injections, Intravenous; Insulin; Obesity; Rats; Tolbutamide | 1968 |
[Evolution of concepts on the pathogenesis of diabetes mellitus].
Topics: Acromegaly; Adenoma; Adipose Tissue; Adrenal Gland Neoplasms; Biological Transport; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; History, 19th Century; History, 20th Century; Humans; Hyperthyroidism; Insulin; Insulin Antagonists; Liver; Muscles; Obesity; Pituitary Neoplasms; Stress, Psychological | 1969 |
[Blood insulin and diabetes. I. Method of study--normal subjects--diabetic disease].
Topics: Cortisone; Diabetes Mellitus; Dietary Proteins; Gastrointestinal Hormones; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Methods; Obesity; Pancreas; Radioimmunoassay; Stimulation, Chemical; Tolbutamide | 1971 |
Evaluation of islet-cell function in man.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Child; Diabetes Mellitus; Fasting; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Prediabetic State; Radioimmunoassay; Tolbutamide | 1971 |
Inducible metabolic abnormalities during development of obesity.
Topics: Adipose Tissue; Endocrine System Diseases; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Insulin; Lipids; Metabolic Diseases; Muscles; Obesity | 1971 |
Hormone studies in health and disease using radioimmunological assay.
Topics: Acromegaly; Calcitonin; Chorionic Gonadotropin; Diabetes Mellitus; Feedback; Follicle Stimulating Hormone; Gigantism; Glucagon; Growth Hormone; Hormones; Humans; Hypoglycemia; Insulin; Iodine Radioisotopes; Isotope Labeling; Luteinizing Hormone; Obesity; Parathyroid Hormone; Peptides; Radioimmunoassay; Radioisotope Dilution Technique; Stress, Physiological; Thyrotropin | 1968 |
New horizons in our knowledge of diabetes mellitus.
Topics: Animals; Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Sulfonylurea Compounds | 1971 |
The hypothalamus and metabolic control.
Topics: Adipose Tissue; Adrenal Glands; Animals; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Dogs; Electroencephalography; Fatty Acids; Glucagon; Growth Hormone; Humans; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypothalamus; Insulin; Insulin Secretion; Lipid Metabolism; Metabolism; Obesity; Rats; Triglycerides; Vagus Nerve | 1971 |
Gut glucagon-like immunoreactants.
Topics: Antigens; Chemical Phenomena; Chemistry; Diabetes Mellitus; Dumping Syndrome; Gastrectomy; Gastrointestinal Hormones; Glucagon-Like Peptides; Humans; Intestine, Small; Obesity; Pancreatitis; Peptides; Radioimmunoassay; Vagotomy | 1980 |
81 trial(s) available for glucagon and Obesity
Article | Year |
---|---|
Blocking endogenous IL-6 impairs mobilization of free fatty acids during rest and exercise in lean and obese men.
Topics: Adult; Antibodies, Monoclonal, Humanized; Carbohydrates; Exercise; Fatty Acids; Glucagon; Glucose; Humans; Hydrocortisone; Interleukin-6; Kinetics; Lipolysis; Obesity; Oxidation-Reduction; Receptors, Interleukin-6; Rest; Thinness | 2021 |
Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity.
Topics: Glicentin; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Lipids; Obesity; Overweight; Oxyntomodulin; Peptides; Proglucagon | 2022 |
Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Glucagon; Humans; Hypertension; Hypoglycemic Agents; Morbidity; Obesity; Overweight; Weight Loss | 2023 |
No effect of multi-strain probiotic supplementation on metabolic and inflammatory markers and newborn body composition in pregnant women with obesity: Results from a randomized, double-blind placebo-controlled study.
Topics: Biomarkers; Body Composition; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Infant, Newborn; Obesity; Pregnancy; Pregnant Women; Probiotics | 2023 |
Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity.
Topics: Adult; Blood Glucose; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Obesity; Overweight; Weight Loss | 2023 |
Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity.
Topics: Blood Glucose; C-Peptide; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Niacinamide; Obesity; Pyridinium Compounds | 2019 |
A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Dietary Supplements; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycemic Index; Humans; Ketones; Male; Middle Aged; Obesity | 2019 |
Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Male; Middle Aged; Obesity; Overweight; Peptides; Prognosis; Receptors, Glucagon | 2020 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Topics: Adipose Tissue, White; Adult; Aged; Air Pollutants; Animals; Anti-Inflammatory Agents; Arginine; bcl-2-Associated X Protein; Biofuels; Biological Products; Blood Glucose; Breast Neoplasms; Caspases; CD36 Antigens; Cell Communication; Cell Proliferation; Cell Survival; Cooking; Cross-Sectional Studies; Databases, Factual; Diabetes Mellitus, Type 2; Diphtheria Toxin; Double-Blind Method; Exenatide; Extracellular Polymeric Substance Matrix; Feasibility Studies; Female; Filgrastim; Fruit; Galactose; Gene Deletion; Gene Knockdown Techniques; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Glucose; Glycated Hemoglobin; Hematopoietic Stem Cell Mobilization; Household Articles; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Lung; Lymphoma; Male; Metals, Heavy; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nanoparticles; Neoplasms; Obesity; Obstetrics; Odds Ratio; Oxygen; Peripheral Blood Stem Cell Transplantation; Photochemotherapy; Plant Extracts; Polyethylene Glycols; Polyglutamic Acid; Porosity; Postprandial Period; Prospective Studies; Quality of Life; Receptors, Glucagon; Receptors, LDL; Receptors, Somatostatin; Registries; Rhodophyta; Rhodotorula; Risk Factors; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Signal Transduction; Somatostatin; Stilbenes; Terminalia; Treatment Outcome; United States; Venoms | 2021 |
Effects of intragastric administration of L-tryptophan on the glycaemic response to a nutrient drink in men with type 2 diabetes - impacts on gastric emptying, glucoregulatory hormones and glucose absorption.
Topics: 3-O-Methylglucose; Aged; Beverages; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Routes; Gastric Emptying; Glucagon; Glucose; Humans; Insulin; Intestinal Absorption; Male; Middle Aged; Nutrients; Obesity; Postprandial Period; Tryptophan | 2021 |
Prolonged Glucagon Infusion Does Not Affect Energy Expenditure in Individuals with Overweight/Obesity: A Randomized Trial.
Topics: Adult; Calorimetry; Drug Administration Schedule; Energy Metabolism; Female; Glucagon; Humans; Infusions, Intravenous; Male; Middle Aged; Obesity; Overweight; Oxidation-Reduction; Time Factors | 2021 |
A walnut-containing meal had similar effects on early satiety, CCK, and PYY, but attenuated the postprandial GLP-1 and insulin response compared to a nut-free control meal.
Topics: Adult; Aged; Cholecystokinin; Cross-Over Studies; Diet; Energy Intake; Feeding Behavior; Female; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Juglans; Male; Meals; Middle Aged; Nuts; Obesity; Peptide YY; Peptides; Postprandial Period; Satiation | 2017 |
Glucagon Decreases IGF-1 Bioactivity in Humans, Independently of Insulin, by Modulating Its Binding Proteins.
Topics: Adult; Blotting, Western; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Forkhead Box Protein O1; Glucagon; Growth Hormone; Humans; Injections, Intramuscular; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Male; Obesity; Statistics, Nonparametric | 2017 |
Effects of Intragastric Administration of Tryptophan on the Blood Glucose Response to a Nutrient Drink and Energy Intake, in Lean and Obese Men.
Topics: Administration, Oral; Adult; Appetite Depressants; Beverages; Biomarkers; Blood Glucose; C-Peptide; Cholecystokinin; Double-Blind Method; Energy Intake; Food, Formulated; Gastric Emptying; Glucagon; Humans; Male; Obesity; Postprandial Period; South Australia; Time Factors; Treatment Outcome; Tryptophan | 2018 |
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
Topics: Adult; Aged; Appetite; Blood Glucose; Calorimetry; Cross-Over Studies; Double-Blind Method; Energy Intake; Energy Metabolism; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Obesity; Overweight; Weight Loss | 2019 |
Postprandial levels of GLP-1, GIP and glucagon after 2 years of weight loss with a Paleolithic diet: a randomised controlled trial in healthy obese women.
Topics: Aged; Biomarkers; Diet, Paleolithic; Energy Intake; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Middle Aged; Obesity; Postprandial Period; Weight Loss | 2019 |
Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Meals; Middle Aged; Obesity; Postprandial Period; Up-Regulation | 2013 |
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
Topics: Antioxidants; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Postprandial Period; Resveratrol; Stilbenes; Time Factors; Treatment Outcome | 2013 |
The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus.
Topics: Adult; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Ghrelin; Glucagon; Humans; Male; Obesity; Satiation; Satiety Response | 2013 |
Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Topics: Adiponectin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Treatment Outcome; Weight Loss | 2015 |
Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Limosilactobacillus reuteri; Male; Middle Aged; Obesity; Oxidative Stress; Pilot Projects; Probiotics; Prospective Studies; Protein Precursors | 2015 |
Does GLP-1 suppress its own basal secretion?
Topics: Adult; Basal Metabolism; Blood Glucose; Feedback, Physiological; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Obesity; Peptide Fragments; Peptides; Thinness | 2016 |
Prior exercise does not alter the incretin response to a subsequent meal in obese women.
Topics: Adult; Blood Glucose; Eating; Exercise; Female; Glucagon; Humans; Incretins; Obesity | 2015 |
Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects.
Topics: Adolescent; Adult; Aged; Appetite; Blood Glucose; Body Mass Index; C-Peptide; Cross-Over Studies; Exercise; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Male; Meals; Mental Recall; Middle Aged; Obesity; Overweight; Postprandial Period; Young Adult | 2017 |
Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Enzyme-Linked Immunosorbent Assay; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Linear Models; Male; Obesity; Peptide Fragments; Postprandial Period; Single-Blind Method; Sitagliptin Phosphate | 2016 |
Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Body Weight; C-Peptide; Case-Control Studies; Diabetes Mellitus; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Young Adult | 2016 |
Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Female; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Middle Aged; Obesity; Overweight; Postprandial Period; Time Factors; Treatment Outcome | 2016 |
Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Diet; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Humans; Insulin; Lactic Acid; Male; Meals; Nutritive Sweeteners; Obesity; Overweight; Postprandial Period; Sweetening Agents; Treatment Outcome; Triglycerides; Uric Acid; Young Adult | 2017 |
Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
Topics: Administration, Oral; Adult; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glutamine; Humans; Insulin; Insulin Secretion; Male; Obesity; Thinness | 2009 |
The effect of a high-MUFA, low-glycaemic index diet and a low-fat diet on appetite and glucose metabolism during a 6-month weight maintenance period.
Topics: Adult; Analysis of Variance; Appetite Regulation; Area Under Curve; Blood Glucose; Body Mass Index; Body Weight; Diet, Fat-Restricted; Energy Intake; Fatty Acids, Monounsaturated; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glycemic Index; Humans; Insulin; Male; Obesity; Pancreatic Polypeptide; Peptide YY; Time Factors; Triglycerides | 2009 |
The impact of exercise training compared to caloric restriction on hepatic and peripheral insulin resistance in obesity.
Topics: Aged; Aged, 80 and over; Body Weight; Caloric Restriction; Exercise; Gas Chromatography-Mass Spectrometry; Glucagon; Humans; Insulin; Insulin Resistance; Liver; Middle Aged; Obesity; Overweight; Patient Selection; Weight Loss | 2009 |
Delayed response of amylin levels after an oral glucose challenge in children with Prader-Willi syndrome.
Topics: Adolescent; Blood Glucose; Child; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Islet Amyloid Polypeptide; Male; Obesity; Prader-Willi Syndrome | 2011 |
Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies; Treatment Outcome; Weight Loss | 2011 |
Metabolic and physiologic effects of an endotoxin challenge in healthy obese subjects.
Topics: Adult; Analysis of Variance; Biomarkers; Blood Pressure; Body Mass Index; Body Temperature; C-Reactive Protein; Calorimetry, Indirect; Cardiac Output; Cross-Over Studies; Female; Glucagon; Heart Rate; Hemodynamics; Humans; Hydrocortisone; Inflammation Mediators; Injections, Intravenous; Interleukin-6; Lipopolysaccharides; Male; Obesity; Prospective Studies; Single-Blind Method; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Topics: Adult; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hyperglycemia; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Obesity, Morbid; Postprandial Period; Time Factors | 2012 |
Fibroblast growth factor 21 mediates specific glucagon actions.
Topics: Adult; Animals; Anti-Obesity Agents; Cells, Cultured; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibroblast Growth Factors; Glucagon; HEK293 Cells; Hepatocytes; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Knockout; Mice, Mutant Strains; Molecular Targeted Therapy; Obesity; Peptides; Rats; Receptors, Glucagon; Recombinant Proteins | 2013 |
Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Obesity; Peptide Fragments; Protein Precursors | 2002 |
Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.
Topics: Adolescent; Adult; Dietary Fats; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Male; Obesity; Peptide Fragments; Protein Precursors; Thinness | 2002 |
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
Topics: 1-Deoxynojirimycin; Adult; Aged; Appetite; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Middle Aged; Obesity; Peptide Fragments; Postprandial Period; Protein Precursors | 2002 |
Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.
Topics: Area Under Curve; Blood Glucose; Butter; Cholesterol, HDL; Chylomicrons; Coronary Artery Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids; Fatty Acids, Monounsaturated; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Obesity; Olive Oil; Peptide Fragments; Plant Oils; Postprandial Period; Protein Precursors; Triglycerides | 2003 |
Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults.
Topics: Adult; Anthropometry; Black or African American; Female; Gastrointestinal Agents; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Obesity; Octreotide; Peptide Fragments; Prospective Studies; Protein Precursors; White People | 2004 |
Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Eating; Feeding Behavior; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Hunger; Infusions, Parenteral; Injections, Subcutaneous; Male; Middle Aged; Nausea; Obesity; Peptide Fragments; Protein Precursors; Recombinant Proteins; Satiation; Thirst; Weight Loss | 2004 |
Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients.
Topics: Adult; Aged; Anti-Obesity Agents; Cross-Over Studies; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Lactones; Male; Middle Aged; Obesity; Orlistat; Peptide Fragments; Protein Precursors; Single-Blind Method; Weight Loss | 2004 |
Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.
Topics: Adult; Blood Glucose; Cross-Over Studies; Double-Blind Method; Drinking; Glomerular Filtration Rate; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Kidney Tubules, Proximal; Male; Natriuresis; Obesity; Peptide Fragments; Protein Precursors; Protons; Renin; Renin-Angiotensin System; Sodium; Thirst; Urine | 2004 |
Effect of glycemic index on whole-body substrate oxidation in obese women.
Topics: Adult; Area Under Curve; Blood Glucose; Calorimetry, Indirect; Cross-Over Studies; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Glucagon; Glycemic Index; Humans; Insulin; Obesity; Oxidation-Reduction; Postprandial Period | 2005 |
Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects.
Topics: Adult; Appetite Regulation; Blood Glucose; Cross-Over Studies; Dietary Fiber; Eating; Fatty Acids, Nonesterified; Female; Galactans; Galactose; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Mannans; Middle Aged; Obesity; Peptide Fragments; Plant Gums; Protein Precursors; Satiety Response | 2005 |
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Topics: Animals; Behavior, Animal; Diabetes Mellitus; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Synergism; Eating; Energy Intake; Feeding Behavior; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Immunohistochemistry; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Motor Activity; Obesity; Peptide Fragments; Peptide YY; Rats | 2005 |
Weight loss therapy improves pancreatic endocrine function in obese older adults.
Topics: Aged; Aging; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Obesity; Risk Factors; Weight Loss | 2008 |
Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
Topics: Adult; Female; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Ileum; Insulin; Jejunum; Male; Middle Aged; Obesity; Pancreatic Hormones; Pancreatic Polypeptide | 1983 |
Alcohol-potentiated reactive hypoglycaemia depends on the nature of the carbohydrate ingested at the same time.
Topics: Adult; Alcohol Drinking; Alcoholic Beverages; Blood Glucose; Dietary Carbohydrates; Drug Synergism; Ethanol; Glucagon; Humans; Hypoglycemia; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Social Behavior; Starch; Sucrose | 1984 |
Effects of potassium supplementation on insulin binding and insulin action in human obesity: protein-modified fast and refeeding.
Topics: Adult; Blood Glucose; Combined Modality Therapy; Dietary Proteins; Fasting; Female; Glucagon; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Monocytes; Obesity; Potassium; Potassium Chloride; Receptor, Insulin | 1984 |
Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects.
Topics: Adult; Blood Glucose; Carrier Proteins; Diet, Reducing; Double-Blind Method; Energy Intake; Epinephrine; Exercise; Female; Glucagon; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Male; Middle Aged; Norepinephrine; Obesity; Placebos; Thyrotropin; Triiodothyronine | 1995 |
Differences in substrate metabolism between self-perceived 'large-eating' and 'small-eating' women.
Topics: Adult; Appetite; Basal Metabolism; Calorimetry, Indirect; Carbon Dioxide; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Eating; Energy Metabolism; Female; Glucagon; Humans; Insulin; Insulin-Like Growth Factor I; Middle Aged; Obesity; Oxygen Consumption; Rest; Self Concept | 1995 |
Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
Topics: Age of Onset; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Liver; Middle Aged; Obesity; Reference Values; Triglycerides; Tritium; Twins, Monozygotic | 1995 |
Glycemic response to stress is altered in euglycemic Pima Indians.
Topics: Adolescent; Adult; Blood Glucose; Catecholamines; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Indians, North American; Insulin; Insulin Resistance; Male; Mathematics; Obesity; Prevalence; Radioimmunoassay; Risk Factors; Software; Stress, Psychological; White People | 1994 |
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.
Topics: Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glycated Hemoglobin; Homeostasis; Humans; Islets of Langerhans; Lipids; Male; Metformin; Middle Aged; Obesity; Prospective Studies; Risk Factors; Single-Blind Method | 1993 |
Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
Topics: Analysis of Variance; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Monounsaturated; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Obesity; Time Factors; Triglycerides; Weight Loss | 1996 |
Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Cohort Studies; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Injections, Intravenous; Injections, Subcutaneous; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Reference Values | 1997 |
Acute insulin response to intravenous glucagon in polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Female; Glucagon; Glucose; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Obesity; Polycystic Ovary Syndrome | 1998 |
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.
Topics: Adult; Blood Glucose; C-Peptide; Double-Blind Method; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Hunger; Infusions, Intravenous; Insulin; Male; Obesity; Pain Measurement; Peptide Fragments; Postprandial Period; Protein Precursors; Radioimmunoassay; Satiation | 1998 |
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
Topics: Adult; Appetite; Blood Glucose; Body Mass Index; C-Peptide; Cross-Over Studies; Double-Blind Method; Eating; Energy Intake; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Hunger; Infusions, Intravenous; Insulin; Male; Obesity; Peptide Fragments; Peptide YY; Protein Precursors | 1999 |
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.
Topics: Appetite; Blood Glucose; Brain Chemistry; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Infusions, Intravenous; Insulin; Male; Middle Aged; Obesity; Peptide Fragments; Protein Precursors; Satiation | 1999 |
Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Dietary Carbohydrates; Dietary Fats; Eating; Energy Metabolism; Fasting; Fatty Acids; Female; Glucagon; Humans; Hypertriglyceridemia; Insulin; Lipoproteins, VLDL; Male; Middle Aged; Obesity; Thinness; Triglycerides | 2000 |
Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects.
Topics: Adolescent; Adult; Blood Glucose; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Leptin; Male; Metformin; Middle Aged; Obesity; Peptide Fragments; Peptides | 2001 |
Systemic and regional free fatty acid metabolism in type 2 diabetes.
Topics: Abdomen; Adipose Tissue; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Hormones; Human Growth Hormone; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipolysis; Male; Middle Aged; Obesity; Palmitates; Protein Synthesis Inhibitors; Somatostatin; Tritium | 2001 |
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
Topics: Adult; Appetite; Basal Metabolism; Body Mass Index; Energy Metabolism; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Kinetics; Male; Obesity; Oxidation-Reduction; Peptide Fragments; Protein Precursors | 2001 |
Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program.
Topics: Adult; Basal Metabolism; Blood Glucose; Blood Proteins; Body Composition; C-Peptide; Cholesterol; Chromium; Diet; Dietary Supplements; Double-Blind Method; Exercise; Fasting; Female; Glucagon; Humans; Insulin; Iron; Lipids; Middle Aged; Obesity; Patient Compliance; Placebos; Zinc | 2001 |
Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men.
Topics: Adipose Tissue; Adult; Blood Pressure; Body Weight; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Leptin; Male; Metformin; Obesity; Reference Values | 2002 |
On the relationship between ketonuria and natriuresis during fasting and upon refeeding in obese patients.
Topics: Adult; Dietary Proteins; Fasting; Female; Glucagon; Glucose; Humans; Hydroxybutyrates; Ketone Bodies; Male; Natriuresis; Obesity; Quaternary Ammonium Compounds | 1978 |
Influence of glucagon on natriuresis and glucose-induced sodium retention in the fasting obese subject.
Topics: Adult; Diet, Sodium-Restricted; Drug Antagonism; Fasting; Female; Glucagon; Glucose; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney; Male; Middle Aged; Natriuresis; Obesity; Sodium; Water-Electrolyte Balance | 1977 |
Effects of aspartame in young persons during weight reduction.
Topics: Adolescent; Adult; Amino Acids; Aspartame; Blood Coagulation Tests; Blood Glucose; Body Weight; Child; Clinical Trials as Topic; Diet, Reducing; Dipeptides; Female; Glucagon; Humans; Insulin; Male; Methanol; Obesity; Placebos | 1976 |
Effect of diet composition on metabolic adaptations to hypocaloric nutrition: comparison of high carbohydrate and high fat isocaloric diets.
Topics: Adolescent; Adult; Blood Glucose; Body Weight; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Glucagon; Humans; Insulin; Lipid Metabolism; Male; Obesity; Uric Acid | 1977 |
Comparative effects of fructose, aspartame, glucose, and water preloads on calorie and macronutrient intake.
Topics: Adult; Aspartame; Blood Glucose; Dietary Carbohydrates; Dietary Fats; Dipeptides; Drinking; Energy Intake; Energy Metabolism; Fatty Acids, Nonesterified; Female; Fructose; Glucagon; Glucose; Humans; Insulin; Male; Middle Aged; Nutritional Physiological Phenomena; Obesity | 1990 |
Gastric balloon to treat obesity: a double-blind study in nondieting subjects.
Topics: Adult; Double-Blind Method; Eating; Female; Gastric Balloon; Gastric Emptying; Glucagon; Glucose; Humans; Insulin; Male; Obesity; Time Factors; Weight Loss | 1990 |
Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.
Topics: Blood Glucose; C-Peptide; Calorimetry; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Lipid Metabolism; Male; Middle Aged; Obesity; Oxidation-Reduction | 1990 |
Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects.
Topics: Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Interactions; Erythrocytes; Female; Glucagon; Humans; Insulin; Kinetics; Magnesium; Male; Obesity | 1989 |
[Comparison of biosynthetic human insulin and purified pork insulin. Studies in insulin-resistant obese patients using the insulin suppression test].
Topics: Adult; Aged; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Insulin, Regular, Pork; Male; Middle Aged; Obesity; Recombinant Proteins; Somatostatin; Swine | 1986 |
Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dietary Fiber; Female; Glucagon; Glycine max; Humans; Insulin; Male; Middle Aged; Obesity; Pancreatic Hormones; Pancreatic Polypeptide; Polysaccharides; Somatostatin; Triglycerides | 1987 |
[Plasma glucagon and insulin profile in obese non-diabetic and non-insulin-dependent diabetic patients on a daily 800 calorie diet].
Topics: Adult; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Energy Intake; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Obesity | 1986 |
Further evaluation of the role of insulin in sodium retention associated with carbohydrate administration after a fast in the obese.
Topics: Administration, Oral; Blood Glucose; Fasting; Female; Glucagon; Glucose; Humans; Injections, Intravenous; Insulin; Male; Natriuresis; Obesity; Potassium; Sodium; Water-Electrolyte Balance | 1972 |
640 other study(ies) available for glucagon and Obesity
Article | Year |
---|---|
Response to Letter to the Editor from Roy et al: "Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function".
Topics: Glucagon; Glucose Tolerance Test; Humans; Insulin Resistance; Obesity | 2022 |
Letter to the Editor From Roy et al: "Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-cell Function".
Topics: Glucagon; Glucose Tolerance Test; Humans; Insulin Resistance; Obesity | 2022 |
On measurements of glucagon secretion in healthy, obese, and Roux-en-Y gastric bypass operated individuals using sandwich ELISA.
Topics: Blood Glucose; Enzyme-Linked Immunosorbent Assay; Gastric Bypass; Glucagon; Humans; Obesity; Proglucagon | 2022 |
E4orf1-induced reduction in endogenous insulin level is independent of pancreas endocrine function.
Topics: Adenovirus E4 Proteins; Animals; Blood Glucose; Doxycycline; Glucagon; Glucose; Glyburide; Hyperinsulinism; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Mice; Mice, Inbred C57BL; Obesity; Phenylephrine | 2022 |
Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls.
Topics: Animals; Blood Glucose; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Mice; Mice, Obese; Obesity; Rats; Receptors, Glucagon; Weight Loss | 2022 |
Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis.
Topics: Animals; Cholesterol; Collagen; Disease Models, Animal; Galectin 3; Glucagon; Glucagon-Like Peptide 1; Inflammation; Interleukin-2; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Receptors, Antigen, T-Cell; Receptors, Glucagon; Recombinant Fusion Proteins; Transaminases; Triglycerides | 2022 |
Sleeve Gastrectomy Improves High-Fat Diet-Associated Hepatic Steatosis Independent of the Glucagon-like-Petpide-1 Receptor in Rats.
Topics: Animals; Diet, High-Fat; Fatty Liver; Female; Gastrectomy; Glucagon; Glucagon-Like Peptide Receptors; Glucagon-Like Peptide-1 Receptor; Glucose; Male; Mice; Obesity; Rats; Rats, Inbred Lew | 2022 |
The maternal reduced uteroplacental perfusion model of preeclampsia induces sexually dimorphic metabolic responses in rat offspring.
Topics: Animals; Female; Ghrelin; Glucagon; Insulin; Male; Obesity; Perfusion; Pre-Eclampsia; Pregnancy; Rats; Rats, Wistar | 2022 |
Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
Topics: Adolescent; Child; Glucagon; Glucose; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity; Triglycerides; Uric Acid | 2022 |
Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Fenofibrate; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Insulin; Liraglutide; Male; Metformin; Obesity; Ramipril; Rats; Rats, Sprague-Dawley; Rats, Zucker; Rosuvastatin Calcium; Somatostatin | 2022 |
Blood Adipokines/Cytokines in Young People with Chronic Bronchitis and Abdominal Obesity.
Topics: Adipokines; Adiponectin; Adolescent; Bronchitis, Chronic; C-Peptide; Complement Factor D; Cytokines; Ghrelin; Glucagon; Humans; Interleukin-6; Islet Amyloid Polypeptide; Lipocalin-2; Obesity; Obesity, Abdominal; Resistin | 2022 |
The Effects of Dual GLP-1/Glucagon Receptor Agonists with Different Receptor Selectivity in Mouse Models of Obesity and Nonalcoholic Steatohepatitis.
Topics: Animals; Body Weight; Complement C4; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Lipids; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Receptors, Glucagon | 2023 |
Postprandial secretion of follistatin after gastric bypass surgery and sleeve gastrectomy.
Topics: Amino Acids; Blood Glucose; Follistatin; Gastrectomy; Gastric Bypass; Glucagon; Humans; Insulin; Obesity | 2023 |
Implication of sugar, protein and incretins in excessive glucagon secretion in type 2 diabetes after mixed meals.
Topics: Blood Glucose; Caseins; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Meals; Obesity; Sucrose; Sugars | 2023 |
The Insulin: Glucagon Ratio and Obesity.
Topics: Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Obesity | 2023 |
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity?
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Obesity; Receptors, Glucagon | 2023 |
Glycomacropeptide Impacts Amylin-Mediated Satiety, Postprandial Markers of Glucose Homeostasis, and the Fecal Microbiome in Obese Postmenopausal Women.
Topics: Blood Glucose; Cross-Over Studies; Female; Glucagon; Glucose; Homeostasis; Humans; Insulin; Islet Amyloid Polypeptide; Metabolic Syndrome; Obesity; Postmenopause; Postprandial Period | 2023 |
Glucagon-modified Liposomes Delivering Thyroid Hormone for Anti-obesity Therapy.
Topics: Animals; Body Weight; Glucagon; Liposomes; Liver; Mice; Obesity; Thyroid Hormones | 2023 |
Sleeve gastrectomy causes weight-loss independent improvements in hepatic steatosis.
Topics: Animals; Blood Glucose; Fatty Liver; Gastrectomy; Glucagon; Mice; Obesity; Weight Loss | 2023 |
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long
Topics: Bupropion; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Humans; Liraglutide; Naltrexone; Obesity; Overweight; Peptides; Proglucagon; Weight Loss | 2023 |
Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion.
Topics: Animals; Blood Glucose; Cation Transport Proteins; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Secreting Cells; Glucose; Humans; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Macaca mulatta; Mice; Obesity | 2023 |
Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals.
Topics: Blood Glucose; Female; Glicentin; Glucagon; Humans; Male; Meals; Obesity; Peptides; Postprandial Period; Proglucagon; Thinness | 2023 |
Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors.
Topics: Diabetes Mellitus; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Obesity; Peptides; Receptors, Glucagon | 2023 |
Obesity dysregulates fasting-induced changes in glucagon secretion.
Topics: Adult; Animals; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Resistance; Male; Mice, Inbred C57BL; Middle Aged; Obesity; Pancreas | 2019 |
Sustained ER stress promotes hyperglycemia by increasing glucagon action through the deubiquitinating enzyme USP14.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Gene Knockdown Techniques; Glucagon; Gluconeogenesis; Glucose; Glucose Intolerance; Hyperglycemia; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Ubiquitin Thiolesterase | 2019 |
Computational Analysis of Insulin-Glucagon Signalling Network: Implications of Bistability to Metabolic Homeostasis and Disease states.
Topics: Algorithms; Amino Acids; Blood Glucose; Cyclic Nucleotide Phosphodiesterases, Type 3; Diabetes Mellitus; Diglycerides; Fatty Acids; Feedback, Physiological; Glucagon; Homeostasis; Humans; Insulin; Insulin Receptor Substrate Proteins; Models, Theoretical; Obesity; Protein Kinase C; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Signal Transduction | 2019 |
Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic properties.
Topics: Amino Acid Sequence; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Energy Intake; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Hypoglycemic Agents; Mice; Obesity; Oxyntomodulin; Peptides; Sequence Homology, Amino Acid; Streptozocin; Structure-Activity Relationship; Weight Loss | 2020 |
Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Blood Glucose; Fatty Liver; Glucagon; Hormones; Humans; Hyperammonemia; Insulin; Male; Middle Aged; Obesity; Pancreas; Somatostatin | 2020 |
Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes.
Topics: Amino Acids; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Humans; Hypertension; Insulin; Lipid Metabolism; Liver; Male; Metabolic Syndrome; Multifactorial Inheritance; Obesity; Pancreas; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Rats, Zucker | 2020 |
Lamin C Counteracts Glucose Intolerance in Aging, Obesity, and Diabetes Through β-Cell Adaptation.
Topics: Aging; Animals; Blood Glucose; Diabetes Mellitus; Energy Metabolism; Glucagon; Glucose Intolerance; Insulin; Insulin-Secreting Cells; Lamin Type A; Mice; Mice, Transgenic; Obesity; Pancreas | 2020 |
Design and characterization of novel oxyntomodulin derivatives with potent dual GLP-1/glucagon receptor activation and prolonged antidiabetic effects.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Dimerization; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Hypoglycemic Agents; Macaca fascicularis; Male; Mice; Mice, Knockout; Mice, Obese; Obesity; Oxyntomodulin; Polyethylene Glycols; Rats, Sprague-Dawley; Receptors, Glucagon; Solid-Phase Synthesis Techniques; Weight Loss | 2020 |
Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
Topics: Amino Acid Sequence; Animals; Anti-Obesity Agents; Apoptosis; Blood Glucose; Body Weight; Cell Proliferation; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Transporter Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Neoplasm Proteins; Obesity; Receptors, Glucagon; Structure-Activity Relationship | 2020 |
Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Glucagon; Glucose; Hepatocytes; Humans; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Signal Transduction | 2020 |
Combination of Lorcaserin and GLP-1/glucagon Coagonist Improves Metabolic Dysfunction in Diet Induced-obese Mice.
Topics: Animals; Benzazepines; Body Weight; Diet, High-Fat; Energy Metabolism; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Liver; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, Glucagon; Weight Loss | 2020 |
Rational design of a GLP-1/GIP/Gcg receptor triagonist to correct hyperglycemia, obesity and diabetic nephropathy in rodent animals.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Design; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide-1 Receptor; Hyperglycemia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity | 2020 |
Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state.
Topics: Adolescent; Adult; Aged; Blood Glucose; Fasting; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Healthy Volunteers; Humans; Insulin; Male; Middle Aged; Obesity; Pancreatic Hormones; Peptide YY; Postprandial Period; Reference Values; Young Adult | 2021 |
Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice.
Topics: Animals; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Energy Intake; Female; Glucagon; Half-Life; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Obesity; Oligopeptides; Oxytocin; Protein Stability; Triglycerides | 2021 |
Glucagon receptor signaling regulates weight loss via central KLB receptor complexes.
Topics: Animals; Body Weight; Eating; Fibroblast Growth Factors; Gene Expression; Glucagon; Glucose; Homeostasis; Klotho Proteins; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Peptides; Receptors, Glucagon; Signal Transduction; Weight Loss | 2021 |
S3-2, a novel long-lasting oxyntomodulin derivative, exerts improvement on diabesity and renal injury through activating GLP-1 and glucagon receptors.
Topics: Albumins; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Hypoglycemic Agents; Insulin; Kidney; Male; Mice; Mice, Inbred C57BL; Obesity; Oxyntomodulin; Peptides; Receptors, Glucagon | 2021 |
Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Hispanic or Latino; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Prediabetic State; United States; Veterans | 2021 |
Energy hormone response to fasting-induced dyslipidemia in obese and non-obese donkeys.
Topics: Adiponectin; Animals; Blood Glucose; Dyslipidemias; Energy Metabolism; Equidae; Fasting; Female; Ghrelin; Glucagon; Insulin; Insulin-Like Growth Factor I; Leptin; Lipids; Obesity | 2021 |
ADP Induces Blood Glucose Through Direct and Indirect Mechanisms in Promotion of Hepatic Gluconeogenesis by Elevation of NADH.
Topics: Adenosine Diphosphate; Animals; Diet; Glucagon; Gluconeogenesis; Glucose; Liver; Male; Mice; Mice, Inbred C57BL; NAD; Obesity; Signal Transduction; Thinness | 2021 |
GRK2 contributes to glucose mediated calcium responses and insulin secretion in pancreatic islet cells.
Topics: Animals; Calcium; Cell Line; Cyclic AMP; Diabetes Mellitus, Type 2; Diet, High-Fat; Down-Regulation; G-Protein-Coupled Receptor Kinase 2; Glucagon; Glucose; Glucose Intolerance; Glucose Tolerance Test; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Lipid Peroxidation; Mice; Mice, Knockout; Obesity | 2021 |
Grape-Seed Proanthocyanidin Extract Reverts Obesity-Related Metabolic Derangements in Aged Female Rats.
Topics: Adiposity; Animals; Blood Glucose; Disease Models, Animal; Fatty Liver; Female; Glucagon; Grape Seed Extract; Insulin; Obesity; Proanthocyanidins; Rats; Rats, Wistar; Weight Loss | 2021 |
O-GlcNAcylated p53 in the liver modulates hepatic glucose production.
Topics: Acetylglucosamine; Animals; Base Sequence; Caloric Restriction; Cell Line; Colforsin; Diabetes Mellitus, Type 2; Epinephrine; Glucagon; Glucocorticoids; Gluconeogenesis; Glucose; Glycosylation; Hepatocytes; Humans; Hydrocortisone; Hyperglycemia; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Liver; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phosphoenolpyruvate Carboxykinase (GTP); Promoter Regions, Genetic; Protein Binding; Protein Stability; Pyruvic Acid; RNA, Messenger; Transcription, Genetic; Tumor Suppressor Protein p53 | 2021 |
The Human and Mouse Islet Peptidome: Effects of Obesity and Type 2 Diabetes, and Assessment of Intraislet Production of Glucagon-like Peptide-1.
Topics: Animals; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Islets of Langerhans; Mice; Obesity | 2021 |
Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis.
Topics: Adaptation, Physiological; Aging; Animals; Diet, High-Fat; Diphtheria Toxin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose; Glucose Intolerance; Glucose Tolerance Test; Homeostasis; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice, Inbred C57BL; Mice, Knockout; Obesity; Proprotein Convertases; Rats; Stress, Physiological | 2017 |
Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists.
Topics: Amino Acid Sequence; Animals; Blood Glucose; Body Weight; Drug Design; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Mice, Inbred C57BL; Mice, Obese; Molecular Docking Simulation; Obesity; Peptides; Structure-Activity Relationship; Swine; Venoms | 2017 |
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice.
Topics: Adiposity; Animals; Diet, High-Fat; Dyslipidemias; Eating; Fatty Liver; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Male; Mice; Mice, Inbred C57BL; Obesity; Sex Factors | 2017 |
Glucagon-induced extracellular cAMP regulates hepatic lipid metabolism.
Topics: Animals; Cells, Cultured; Cyclic AMP; Fatty Acids; Fatty Liver; Gene Expression Regulation; Glucagon; Hepatocytes; Lipid Metabolism; Mice; Multidrug Resistance-Associated Proteins; Obesity; Oxidation-Reduction | 2017 |
Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Body Mass Index; Female; Glucagon; Glucose Clamp Technique; Hormones; Humans; Hypoglycemia; Insulin; Obesity; Polycystic Ovary Syndrome; Postmenopause | 2017 |
Single-Molecule Combinatorial Therapeutics for Treating Obesity and Diabetes.
Topics: Brain; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; Precision Medicine | 2017 |
Recycling of glucagon receptor to plasma membrane increases in adipocytes of obese rats by soy protein; implications for glucagon resistance.
Topics: Adipocytes; Adipose Tissue, White; Animals; Cell Membrane; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Gene Expression Regulation; Glucagon; Hyperglycemia; Male; Obesity; rab GTP-Binding Proteins; Rats; Rats, Zucker; Receptors, Glucagon; Soybean Proteins; Triglycerides | 2017 |
Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity.
Topics: Animals; Aorta; Carmustine; Cattle; Cyclic GMP-Dependent Protein Kinase Type I; Diet, High-Fat; Endothelial Cells; Gene Expression Regulation; Glucagon; Hypertension; Leptin; Methotrexate; Mice; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Obesity; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Resistin; Signal Transduction; Sugar Acids; Uncoupling Agents | 2017 |
Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
Topics: Blood Glucose; Cohort Studies; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Female; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Insulin; Insulin Secretion; London; Male; Middle Aged; Monitoring, Ambulatory; Obesity; Postoperative Complications; Postprandial Period; Prevalence; Risk Factors | 2017 |
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Genetic Predisposition to Disease; Glucagon; Hep G2 Cells; Humans; Lipogenesis; Liver; Liver Neoplasms; Male; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Obesity; Phenotype; Phosphoprotein Phosphatases; Phosphorylation; Proteolysis; Signal Transduction | 2017 |
Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Obesity; Pancreas; Somatostatin | 2017 |
Measurement of Gastrointestinal Hormones.
Topics: Bariatric Surgery; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Mass Spectrometry; Neuropeptides; Obesity; Oxyntomodulin; Specimen Handling | 2017 |
Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats.
Topics: 3-Hydroxybutyric Acid; Adiponectin; Animals; Cat Diseases; Cats; Diabetes Mellitus; Drinking; Electrolytes; Fatty Acids, Nonesterified; Female; Fructosamine; Glucagon; Glucose Tolerance Test; Glycosuria; Hypoglycemic Agents; Leptin; Male; Nitriles; Obesity; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men.
Topics: Adiposity; Adult; alpha-2-HS-Glycoprotein; Biomarkers; Blood Glucose; Body Composition; Body Mass Index; Body Weight; Case-Control Studies; Exercise; Exercise Test; Fibroblast Growth Factors; Follistatin; Glucagon; Humans; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Life Style; Male; Middle Aged; Obesity; Overweight; Selenoprotein P; Young Adult | 2018 |
Central administration of coagonist of GLP-1 and glucagon receptors improves dyslipidemia.
Topics: Animals; Cholesterol; Dyslipidemias; Energy Metabolism; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Homeostasis; Lipid Metabolism; Liver; Male; Mesocricetus; Obesity; Receptors, Glucagon; Signal Transduction; Triglycerides | 2018 |
Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
Topics: Adipose Tissue; Animals; Blood Glucose; Blood Pressure; Body Weight; Brain; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hypertension; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Obesity; Prolactin-Releasing Hormone; Rats, Inbred SHR | 2018 |
Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Topics: Blood Glucose; Caloric Restriction; Diabetes Mellitus, Type 2; Fasting; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Liver; Male; Middle Aged; Obesity; Peptide YY; Postprandial Period; Remission Induction | 2018 |
Agonism of receptors in the gut-pancreas axis in type 2 diabetes: are two better than one?
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; Overweight; Peptides; Receptors, Glucagon | 2018 |
Gastric Plication and Sleeve Gastrectomy in an Experimental Model of Obesity: New Insights into Weight Loss, Intake and Metabolic Results.
Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Energy Intake; Gastrectomy; Ghrelin; Glucagon; Laparoscopy; Male; Obesity; Random Allocation; Rats; Rats, Sprague-Dawley; Stomach; Weight Loss | 2018 |
[Life-threatening ketoacidosis in patients with type 2 diabetes on LCHF diet].
Topics: Adult; Critical Illness; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Diet, Ketogenic; Glucagon; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon.
Topics: Adult; Aged; Arginine Vasopressin; Biomarkers; Cross-Sectional Studies; Fasting; Glucagon; Glycopeptides; Humans; Ideal Body Weight; Male; Middle Aged; Obesity | 2019 |
Glucose intolerance in monosodium glutamate obesity is linked to hyperglucagonemia and insulin resistance in α cells.
Topics: Adipose Tissue, White; Animals; Biomarkers; Blood Glucose; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Glucagon; Glucagon-Secreting Cells; Glucose Intolerance; Insulin; Insulin Resistance; Liver; Male; Mice; Obesity; Phosphoenolpyruvate Carboxykinase (ATP); Phosphorylation; Sodium Glutamate; TOR Serine-Threonine Kinases | 2019 |
Cafeteria Diet Feeding in Young Rats Leads to Hepatic Steatosis and Increased Gluconeogenesis under Fatty Acids and Glucagon Influence.
Topics: Animals; Diet; Energy Intake; Fatty Acids; Fatty Liver; Feeding Behavior; Glucagon; Gluconeogenesis; Glucose; Lactic Acid; Male; Obesity; Oxygen Consumption; Pyruvic Acid; Rats; Rats, Wistar | 2018 |
Dynamic changes in insulin and glucagon during disease progression in rhesus monkeys with obesity-related type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Glucagon; Glucose Tolerance Test; Insulin; Macaca mulatta; Male; Monitoring, Physiologic; Obesity | 2019 |
Intranasal glucagon acutely increases energy expenditure without inducing hyperglycaemia in overweight/obese adults.
Topics: Administration, Intranasal; Blood Glucose; Cross-Over Studies; Eating; Energy Metabolism; Female; Glucagon; Humans; Hyperglycemia; Male; Middle Aged; Obesity; Overweight | 2019 |
Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Obesity | 2013 |
Glucose homeostasis, obesity and diabetes.
Topics: Aging; Body Mass Index; Diabetes Mellitus, Type 2; Glucagon; Glucose; Glucose Intolerance; Glucose Transport Proteins, Facilitative; Glycogen; Homeostasis; Humans; Inflammation Mediators; Insulin; Insulin Resistance; Metabolic Syndrome; Obesity; Obesity, Abdominal; Sodium-Glucose Transport Proteins | 2013 |
Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
Topics: Adolescent; Adult; Aged; Area Under Curve; Bariatric Surgery; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Duodenum; Eating; Endoscopy; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Jejunum; Male; Middle Aged; Netherlands; Obesity; Pilot Projects; Postprandial Period; Remission Induction; Time Factors; Treatment Outcome; Weight Loss | 2013 |
desHis¹Glu⁹-glucagon-[mPEG] and desHis¹Glu⁹(Lys³⁰PAL)-glucagon: long-acting peptide-based PEGylated and acylated glucagon receptor antagonists with potential antidiabetic activity.
Topics: Acylation; Animals; Cell Line; Cyclic AMP; Dipeptidyl Peptidase 4; Drug Stability; Glucagon; HEK293 Cells; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Obese; Obesity; Polyethylene Glycols; Receptors, Glucagon; Recombinant Proteins; Second Messenger Systems | 2013 |
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gastric Bypass; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Obesity; Obesity, Morbid; Weight Loss | 2013 |
A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice.
Topics: Amino Acid Sequence; Animals; Blood Glucose; Cyclic AMP; Diet, High-Fat; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Molecular Sequence Data; Obesity; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Recombinant Fusion Proteins | 2013 |
Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis.
Topics: Animals; Appetite Depressants; Body Weight; Dietary Fats; Dietary Sucrose; Drug Resistance; Energy Metabolism; Feeding Behavior; Female; Glucagon; Glucose; Homeostasis; Hyperglycemia; Hyperinsulinism; Hyperphagia; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Mice, Knockout; Neurons; Obesity; Pro-Opiomelanocortin; Receptor, Serotonin, 5-HT2C; Recombinant Fusion Proteins; Serotonin; Serotonin Receptor Agonists | 2013 |
GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet.
Topics: Animals; Diet, High-Fat; Eating; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Polyethylene Glycols; Receptors, Glucagon; Weight Loss | 2014 |
Effects of AMPK activation on insulin sensitivity and metabolism in leptin-deficient ob/ob mice.
Topics: Acetyl-CoA Carboxylase; Adenylate Kinase; Animals; Female; Glucagon; Insulin; Insulin Resistance; Leptin; Lipid Metabolism; Male; Mice; Mice, Obese; Muscle, Skeletal; Obesity; Phosphorylation | 2014 |
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist.
Topics: Animals; Benzamides; Blood Glucose; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Discovery; Glucagon; Mice; Mice, Inbred ICR; Obesity; Prediabetic State; Receptors, Glucagon; Spiro Compounds; Structure-Activity Relationship | 2014 |
Long-term commercial cow's milk consumption and its effects on metabolic parameters associated with obesity in young mice.
Topics: Adipose Tissue, White; Amino Acids, Branched-Chain; Animals; Blood Glucose; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Corticosterone; Ghrelin; Glucagon; Hormones; Insulin; Leptin; Liver; Male; Mice; Mice, Inbred C57BL; Milk; Obesity; Time Factors; Triglycerides | 2014 |
Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.
Topics: Animals; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Eating; Glucagon; Glucokinase; Glucose; Glucose Clamp Technique; Glucosides; Hyperglycemia; Hyperinsulinism; Immunohistochemistry; Liver; Male; Obesity; Organ Size; Oxygen Consumption; Rats; Rats, Zucker; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2014 |
Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice.
Topics: Animals; Blood Glucose; Cell Line, Tumor; Diet, High-Fat; Gene Expression; Glucagon; Hepatocytes; Hypoglycemic Agents; Insulin; Insulysin; Liver; Mice; Mice, Inbred C57BL; Obesity; Palmitic Acid; Pioglitazone; RNA, Messenger; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2014 |
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
Topics: Animals; Binding Sites; Blood Glucose; Catalytic Domain; Diabetes Mellitus, Type 2; Disease Models, Animal; Gastric Emptying; Genetic Predisposition to Disease; Glucagon; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulysin; Islet Amyloid Polypeptide; Macrocyclic Compounds; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Obesity; Signal Transduction; Thinness | 2014 |
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Male; Mice; Mice, Knockout; Obesity; Receptors, Glucagon | 2014 |
Arginine is preferred to glucagon for stimulation testing of β-cell function.
Topics: Adult; Aged; Arginine; Blood Glucose; Body Mass Index; C-Peptide; Female; Glucagon; Humans; Hyperglycemia; Infusions, Intravenous; Insulin; Insulin Secretion; Insulin-Secreting Cells; Kinetics; Male; Middle Aged; Mouth Mucosa; Nausea; Obesity; Paresthesia; Reproducibility of Results | 2014 |
Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.
Topics: Adolescent; Adult; Body Composition; Body Mass Index; Cross-Sectional Studies; Glucagon; Human Growth Hormone; Humans; Male; Middle Aged; Obesity; Overweight; Pituitary Diseases; Reference Values; Retrospective Studies; Young Adult | 2014 |
Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Diet, High-Fat; Drug Synergism; Eating; Exenatide; Glucagon; Glucagon-Like Peptide 1; Insulin Resistance; Male; Mice, Inbred C57BL; Mice, Obese; Obesity; Peptides; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Venoms | 2014 |
[The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus].
Topics: Animals; Blood Glucose; Carbohydrate Metabolism, Inborn Errors; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Eating; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Homeostasis; Humans; Hyperglycemia; Incretins; Insulin; Insulin Secretion; Insulin-Secreting Cells; Malabsorption Syndromes; Mice; Mice, Knockout; Models, Biological; Obesity; Receptors, Glucagon | 2014 |
Protein and glucose metabolic responses to hyperinsulinemia, hyperglycemia, and hyperaminoacidemia in obese men.
Topics: Adult; Amino Acids; Glucagon; Glucose; Human Growth Hormone; Humans; Hyperglycemia; Hyperinsulinism; Infusions, Intravenous; Insulin; Male; Middle Aged; Muscle Proteins; Muscle, Skeletal; Obesity; Octreotide; Pancreas; Postprandial Period; Young Adult | 2015 |
Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats.
Topics: Adaptation, Physiological; Age Factors; Animals; Body Weight; Female; Gene Expression; Glucagon; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Microscopy, Electron, Scanning; Obesity; Organ Size; Oxidative Stress; Rats; Rats, Mutant Strains; Somatostatin | 2014 |
A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Exenatide; Glucagon; Insulin; Mice; Obesity; Peptides; Satiation; Sincalide; Venoms | 2015 |
Incretin secretion in obese Korean children and adolescents with newly diagnosed type 2 diabetes.
Topics: Adolescent; Analysis of Variance; Asian People; Blood Glucose; Body Mass Index; C-Peptide; Case-Control Studies; Child; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Obesity; Republic of Korea | 2016 |
Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice.
Topics: Animals; Blood Glucose; Calcium; Dietary Supplements; Glucagon; Homeostasis; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Leptin; Male; Mice; Mice, Inbred C57BL; Obesity; Taurine | 2015 |
A Northern contaminant mixture impairs pancreas function in obese and lean JCR rats and inhibits insulin secretion in MIN6 cells.
Topics: Alcohol Drinking; Animals; Cell Death; Cell Line, Tumor; Complex Mixtures; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Environmental Pollutants; Glucagon; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Male; Mice; Mitochondria; Obesity; Oxidative Stress; Pancreatic Neoplasms; Rats; Risk Assessment; Thinness | 2015 |
Pancreatic alpha-cells from female mice undergo morphofunctional changes during compensatory adaptations of the endocrine pancreas to diet-induced obesity.
Topics: Adaptation, Physiological; Animals; Apoptosis; Blood Glucose; Cell Proliferation; Cells, Cultured; Diet, High-Fat; Enzyme-Linked Immunosorbent Assay; Exocytosis; Female; Glucagon; Glucagon-Secreting Cells; Hyperinsulinism; Immunohistochemistry; Insulin-Secreting Cells; Islets of Langerhans; Mice, Inbred C57BL; Obesity; Time Factors | 2015 |
[I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice.
Topics: Adiposity; Animals; Antimicrobial Cationic Peptides; Blood Glucose; Body Composition; Diet, High-Fat; Glucagon; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Lipids; Male; Mice; Obesity; Peptides; Triglycerides | 2016 |
Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Fibroblast Growth Factors; Glucagon; Insulin; Mice, Inbred C57BL; Obesity; Pancreas | 2015 |
The Drosophila ortholog of TMEM18 regulates insulin and glucagon-like signaling.
Topics: Animals; Animals, Genetically Modified; Drosophila melanogaster; Drosophila Proteins; Fat Body; Gene Knockdown Techniques; Genes, Insect; Glucagon; Humans; Insulin; Larva; Membrane Proteins; Models, Biological; Obesity; Polymorphism, Single Nucleotide; Signal Transduction; Species Specificity | 2016 |
Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice.
Topics: Animals; Cell Line; Cyclic AMP; Diabetes Mellitus, Type 2; Diet, High-Fat; Energy Metabolism; Gastric Inhibitory Polypeptide; Glucagon; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Mice, Obese; Motor Activity; Obesity; Rats; Receptors, Glucagon | 2016 |
Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes.
Topics: Analysis of Variance; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gene Expression; Ghrelin; Glucagon; Insulin; Male; Obesity; Peptide Hormones; Rats, Wistar; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Triglycerides | 2017 |
A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats.
Topics: Absorptiometry, Photon; Adipokines; Adiponectin; Animals; Body Composition; Cats; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Insulin; Insulin Secretion; Leptin; Male; Obesity; Peptides; Venoms | 2016 |
Disrupted Leptin Signaling in the Lateral Hypothalamus and Ventral Premammillary Nucleus Alters Insulin and Glucagon Secretion and Protects Against Diet-Induced Obesity.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Glucagon; Hypothalamic Area, Lateral; Hypothalamus; Insulin; Insulin Secretion; Leptin; Mice; Mice, Knockout; Neurons; Obesity; Receptors, Leptin; Signal Transduction; Ventromedial Hypothalamic Nucleus | 2016 |
Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Dogfish; Glucagon; Glucose Tolerance Test; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Obese; Obesity | 2016 |
Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of Hyperglycemia.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Enteroendocrine Cells; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Hyperglycemia; Insulin-Secreting Cells; Male; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Peptide Fragments; Phenotype | 2016 |
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.
Topics: Animals; Atherosclerosis; Body Weight; Bone and Bones; Chemical Engineering; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Combinations; Drug Delivery Systems; Drug Synergism; Glucagon; Hyperglycemia; Liver; Metabolic Diseases; Mice; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Obesity; Triiodothyronine | 2016 |
Plasma Irisin Modestly Increases during Moderate and High-Intensity Afternoon Exercise in Obese Females.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Exercise; Female; Fibronectins; Gene Expression; Glucagon; Humans; Insulin; Lactic Acid; Obesity; Oxygen Consumption; Random Allocation; Time Factors | 2017 |
Hybrid peptides in the landscape of drug discovery.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Discovery; Estrogens; Glucagon; Glucagon-Like Peptide 1; Humans; Ligands; Models, Animal; Obesity; Peptide Hormones; Recombinant Fusion Proteins | 2017 |
Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
Topics: Animals; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Obesity; Sus scrofa | 2017 |
The Characteristics of Hepatic Gsα-cAMP Axis in HSHF Diet-Fed Obese Insulin Resistance Rats and Genetic Diabetic Mice.
Topics: Animals; Blood Glucose; Cyclic AMP; Diabetes Mellitus; Diet, High-Fat; Dietary Sugars; Disease Models, Animal; Glucagon; GTP-Binding Protein alpha Subunits; Insulin; Insulin Resistance; Liver; Male; Mice, Inbred C57BL; Obesity; Rats, Wistar | 2017 |
Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
Topics: Adipokines; Adiposity; Age Factors; Aging; Animals; Blood Glucose; Crosses, Genetic; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Female; Fertility; Ghrelin; Glucagon; Glucose Intolerance; Insulin; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Lipids; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Triglycerides | 2008 |
Visceral fat and adiponectin: associations with insulin resistance are tissue-specific in women.
Topics: Absorptiometry, Photon; Adiponectin; Adiposity; Blood Glucose; Body Mass Index; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Liver; Middle Aged; Muscle, Skeletal; Obesity; Octreotide; Postmenopause; Time Factors; Tomography, X-Ray Computed | 2009 |
Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence.
Topics: Adoptive Transfer; Amyloid; Animals; Antioxidants; Azoles; Bone Marrow Cells; Bone Marrow Transplantation; Cytokines; Diabetes Mellitus, Type 2; Flow Cytometry; Fluorescent Antibody Technique; Glucagon; Immunohistochemistry; Insulin; Islet Amyloid Polypeptide; Isoindoles; Mice; Mice, Mutant Strains; Obesity; Organoselenium Compounds; Stem Cells; Transplantation, Isogeneic; Vasodilation | 2009 |
Chronic administration of voglibose, an alpha-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 activity in ob/ob mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Gene Expression; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Inositol; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Time Factors | 2009 |
Transgenic expression of insulin-response element binding protein-1 in beta-cells reproduces type 2 diabetes.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucagon-Secreting Cells; Glucose; Hyperinsulinism; Insulin; Insulin Resistance; Insulin-Secreting Cells; Iron Regulatory Protein 1; Mice; Mice, Transgenic; Obesity; Phenotype; Rats; Rats, Zucker; Somatostatin-Secreting Cells | 2009 |
Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes.
Topics: Aged; Blood Glucose; Body Mass Index; C-Peptide; Deuterium; Diabetes Mellitus, Type 2; Galactose; Glucagon; Gluconeogenesis; Humans; Insulin; Isotope Labeling; Middle Aged; Obesity; Reference Values; Transaldolase; Triose-Phosphate Isomerase | 2009 |
Effects of insulin on ketogenesis following fasting in lean and obese men.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Body Weight; Energy Metabolism; Epinephrine; Fasting; Fatty Acids, Nonesterified; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Resistance; Ketone Bodies; Male; Middle Aged; Obesity; Thinness; Young Adult | 2009 |
Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage.
Topics: Animals; Arginine; Benzoates; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity; Organ Culture Techniques; Pancreas; Peptide Fragments; Rats; Rats, Sprague-Dawley; Tolbutamide | 2009 |
Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Body Composition; Body Weight; Clozapine; Dibenzothiazepines; Dietary Fats; Disease Models, Animal; Eating; Exenatide; Food Preferences; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Resistance; Male; Obesity; Peptides; Pyrazines; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Triazoles; Venoms | 2009 |
Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Topics: Animals; Antibodies, Monoclonal; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Glucagon-Secreting Cells; Glucose; Hyperglycemia; Hyperplasia; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Obesity; Receptors, Glucagon; Tachyphylaxis | 2009 |
Histological, immunocytochemical, and morphometrical analyses of pancreatic islets in the BSB mouse model of obesity.
Topics: Animals; Blood Glucose; Disease Models, Animal; Female; Glucagon; Immunohistochemistry; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity | 2010 |
Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects.
Topics: Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Ghrelin; Glucagon; Glucose; Glucose Tolerance Test; Hormones; Humans; Injections, Intravenous; Insulin; Leptin; Male; Obesity; Peptide YY; Thinness; Young Adult | 2010 |
Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice.
Topics: Animals; Blood Glucose; Dietary Fats; Dietary Supplements; Eating; Glucagon; Hemoglobin A; Insulin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Phaeophyceae; Plant Extracts; RNA, Messenger; Weight Gain; Xanthophylls | 2010 |
Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Topics: Adaptation, Physiological; Animals; Blood Glucose; Body Weight; Cell Proliferation; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 2; Glucagon-Like Peptide-2 Receptor; Glucose Intolerance; Glucose Tolerance Test; Hypoglycemia; Insulin; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Receptors, Glucagon; Signal Transduction; Stress, Physiological; Time Factors | 2010 |
Basal alpha-cell up-regulation in obese insulin-resistant adolescents.
Topics: Adolescent; Analysis of Variance; Area Under Curve; Blood Glucose; C-Peptide; Glucagon; Glucagon-Secreting Cells; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Obesity; Regression Analysis; Up-Regulation; Young Adult | 2011 |
Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Cardiotonic Agents; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucagon-Like Peptide 1; Insulin; Insulin Resistance; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Obesity; Pancreas; Phosphotransferases; Prediabetic State; Rats; Rats, Wistar | 2011 |
Sustained glucagon-like peptide 1 expression from encapsulated transduced cells to treat obese diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Muscle, Smooth, Vascular; Obesity; Rats; Rats, Wistar; Receptors, Leptin; Transduction, Genetic | 2011 |
Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells.
Topics: Animals; Calcium-Binding Proteins; Cell Line; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Glucagon; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Nucleobindins; Obesity | 2011 |
Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
Topics: Analysis of Variance; Animals; Colon; Diet, Fat-Restricted; Diet, Reducing; Enzyme-Linked Immunosorbent Assay; Gastric Bypass; Gastric Mucosa; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Leptin; Male; Mice; Obesity; Peptide YY; Radioimmunoassay; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; Weight Loss | 2011 |
Evaluation of beta-cell sensitivity to glucose and first-phase insulin secretion in obese dogs.
Topics: Animals; Blood Glucose; Dog Diseases; Dogs; Glucagon; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Obesity | 2011 |
Dual modulation of GIP and glucagon action by the low molecular weight compound 4-hydroxybenzoic acid 2-bromobenzylidene hydrazide.
Topics: Adipokines; Animals; Benzene Derivatives; Gastric Inhibitory Polypeptide; Glucagon; Hydrocarbons, Brominated; Insulin Resistance; Male; Mice; Obesity; Parabens; Receptors, Gastrointestinal Hormone | 2011 |
Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach.
Topics: Animals; Blood Glucose; Body Composition; Choline; Glucagon; Insulin; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, VLDL; Magnetic Resonance Spectroscopy; Metabolomics; Methylamines; Multivariate Analysis; Obesity; Swine | 2012 |
Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Composition; Body Weight; Diet, High-Fat; Food Preferences; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Liver; Male; Obesity; Olanzapine; Rats; Schizophrenia; Weight Gain | 2011 |
Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Hypertrophy; In Vitro Techniques; Male; Mice; Mice, Knockout; Obesity; Receptors, Glucagon; Streptozocin | 2011 |
Circulating glucagon is associated with inflammatory mediators in metabolically compromised subjects.
Topics: Adult; Aged; Anthropometry; Body Mass Index; Cohort Studies; Complement Factor B; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Inflammation Mediators; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Metabolic Diseases; Middle Aged; Obesity; Triglycerides; Weight Loss | 2011 |
Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1.
Topics: Adolescent; Adult; Age of Onset; Aged; Case-Control Studies; Child; Child, Preschool; Czechoslovakia; Denmark; Diabetes Mellitus, Type 2; Europe; Female; Genetic Association Studies; Glucagon; Glucagon-Like Peptide 1; Homozygote; Humans; Infant; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Obesity; Polymorphism, Single Nucleotide | 2011 |
PKA phosphorylation couples hepatic inositol-requiring enzyme 1alpha to glucagon signaling in glucose metabolism.
Topics: Animals; Base Sequence; Cyclic AMP-Dependent Protein Kinases; Cytoplasm; Endoplasmic Reticulum; Endoribonucleases; Gene Expression Profiling; Glucagon; Glucose; Hepatocytes; Immunoblotting; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Obesity; Oligonucleotide Array Sequence Analysis; Phosphorylation; Primary Cell Culture; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Serine | 2011 |
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Obesity | 2012 |
Breakfast skipping in prepubertal obese children: hormonal, metabolic and cognitive consequences.
Topics: Area Under Curve; Attention; Blood Glucose; Carbohydrate Metabolism; Child; Cognition; Cross-Sectional Studies; Diet; Fasting; Feeding Behavior; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Memory; Obesity; Oxidation-Reduction; Peptide YY; Postprandial Period; Verbal Learning | 2012 |
The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin.
Topics: Animals; Anti-Obesity Agents; Energy Intake; Glucagon; Glucagon-Like Peptide-1 Receptor; Glycogenolysis; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; Oxyntomodulin; Receptors, Glucagon; Weight Loss | 2012 |
Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.
Topics: Animals; Blood Glucose; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Nucleus; Cyclic AMP; Fasting; Forkhead Box Protein O1; Forkhead Transcription Factors; Glucagon; Gluconeogenesis; Glucose; Glycogenolysis; Hepatocytes; Homeostasis; Inositol 1,4,5-Trisphosphate Receptors; Liver; Mice; Mice, Inbred C57BL; Obesity; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Signal Transduction | 2012 |
NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Glucagon; Glucose; Glucose Intolerance; Hyperglycemia; Liver; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; NF-kappaB-Inducing Kinase; Obesity; Phosphorylation; Protein Serine-Threonine Kinases | 2012 |
Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*.
Topics: Animals; Anti-Obesity Agents; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Gastrins; Glucagon; Hypoglycemic Agents; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred Strains; Mice, Obese; Obesity; Omeprazole; Peptides; Venoms | 2013 |
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dietary Fats; Eating; Glucagon; Glucose Tolerance Test; Insulin; Insulin Resistance; Lipids; Mice; Mice, Obese; Obesity; Pancreas; Receptors, Cholecystokinin; Sincalide | 2013 |
Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
Topics: Animals; Artificial Intelligence; Diabetes Mellitus, Type 2; Exenatide; Expert Systems; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; High-Throughput Screening Assays; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Obesity; Pattern Recognition, Automated; Peptides; Rats; Rats, Zucker; Somatostatin; Somatostatin-Secreting Cells; Venoms | 2013 |
AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; ATP Citrate (pro-S)-Lyase; Biomarkers; Calcium; Carbohydrate Metabolism; Cricetinae; Dicarboxylic Acids; Diet; Dyslipidemias; Energy Metabolism; Enzyme Activation; Enzyme Inhibitors; Fatty Acids; Female; Glucagon; Glucose; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Male; Mice; Molecular Targeted Therapy; Obesity; Protein Serine-Threonine Kinases; Rats; Signal Transduction; Sterols | 2013 |
Obstructive sleep apnoea syndrome is associated with relative hypocortisolemia and decreased hypothalamo-pituitary-adrenal axis response to 1 and 250μg ACTH and glucagon stimulation tests.
Topics: Adrenocorticotropic Hormone; Adult; Body Mass Index; Circadian Rhythm; Cushing Syndrome; Dose-Response Relationship, Drug; Female; Glucagon; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Obesity; Pituitary-Adrenal System; Polysomnography; Reference Values; Sleep Apnea, Obstructive | 2013 |
Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity.
Topics: Adrenocorticotropic Hormone; Adult; Body Constitution; Body Mass Index; Female; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Kinetics; Obesity | 2002 |
Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Synergism; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; Injections, Intravenous; Insulin; Male; Middle Aged; Obesity; Peptide Fragments; Protein Precursors; Reference Values; Time Factors | 2002 |
Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding.
Topics: Animals; Blood Glucose; Blotting, Northern; Dietary Fats; Dogs; Fasting; Fatty Acids, Nonesterified; Gene Expression; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; Hyperinsulinism; Insulin; Insulin Resistance; Islets of Langerhans; Kinetics; Magnetic Resonance Imaging; Male; Obesity; Peptide Fragments; Receptors, Glucagon; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Dietary Proteins; Energy Intake; Exercise; Fasting; Fatty Acids; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Proinsulin; Pyrazines | 2003 |
Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals.
Topics: Adult; Anthropometry; Body Composition; Case-Control Studies; Cross-Sectional Studies; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Human Growth Hormone; Humans; Hypopituitarism; Leptin; Lipids; Male; Middle Aged; Obesity; Peptide Fragments; Peptides; Thinness | 2003 |
Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.
Topics: Aged; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Injections, Intravenous; Male; Middle Aged; Obesity; Osmolar Concentration; Peptide Fragments; Protein Precursors; Reference Values | 2003 |
Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice.
Topics: Animals; Animals, Newborn; Cell Division; Glucagon; Immunohistochemistry; Insulin; Islets of Langerhans; Kinetics; Male; Mice; Mice, Inbred ICR; Obesity; Pancreas; Sodium Glutamate; Somatostatin; Tritium | 2003 |
Pharmacologic treatment of type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Exenatide; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Secretion; Monosaccharide Transport Proteins; Obesity; Peptide Fragments; Peptide Hormones; Peptides; Peroxisome Proliferators; Protein Precursors; Receptors, Cell Surface; Thiazoles; Venoms | 2003 |
Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
Topics: Animals; Cells, Cultured; Cricetinae; Cricetulus; Cyclic AMP; Diabetes Mellitus; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Mice; Obesity; Peptide Fragments; Postprandial Period; Protein Precursors; Spectrometry, Mass, Electrospray Ionization | 2003 |
Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Case-Control Studies; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Feeding Behavior; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Obesity; Peptide Fragments; Protein Precursors; Random Allocation | 2003 |
Analysis of the blood sugar response of obese-hyperglycemic mice and normal mice to hormones: insulin, glucagon, and epinephrine.
Topics: Animals; Blood Glucose; Epinephrine; Glucagon; Hormones; Hyperglycemia; Insulin; Mice; Mice, Obese; Obesity; Pancreas | 1956 |
Effects of pituitary growth hormone on the insulin and hyperglycaemic-glycogenolytic factor extractable from the pancreas of obese-hyperglycaemic mice.
Topics: Animals; Glucagon; Growth Hormone; Hyperglycemia; Insulin; Mice; Mice, Obese; Obesity; Pancreas | 1956 |
Therapy of exogenous obesity in childhood and adolescence.
Topics: Appetite Depressants; Diet; Diet, Reducing; Glucagon; Gymnastics; Humans; Obesity; Pediatric Obesity | 1963 |
THE PICKWICKIAN SYNDROME. STUDIES ON VENTILATION AND CARBOHYDRATE METABOLISM: CASE REPORT OF A CHILD WHO RECOVERED.
Topics: Carbohydrate Metabolism; Child; Glucagon; Humans; Metabolism; Obesity; Obesity Hypoventilation Syndrome; Respiratory Function Tests; Sleep Wake Disorders | 1963 |
PANCREATIC AND SERUM INSULIN IN THE NEW ZEALAND STRAIN OF OBESE MICE.
Topics: Animals; Blood Chemical Analysis; Blood Glucose; Carbohydrate Metabolism; Cysteine; Diaphragm; Epididymis; Glucagon; Glucose; Glycogen; Humans; Insulin; Male; Mice; Mice, Obese; New Zealand; Obesity; Pancreas; Pharmacology; Research | 1964 |
[MODIFICATIONS OF THE INSULO-PANCREATIC FUNCTIONAL ACTIVITY BY PARASYMPATHOLYTIC PHARMACOLOGIC EFFECT IN ESSENTIAL OBESITY].
Topics: Blood Chemical Analysis; Blood Glucose; Glucagon; Glucose Tolerance Test; Insulin; Islands; Islets of Langerhans; Obesity; Pancreas; Parasympatholytics; Pharmacology | 1964 |
[GLUCAGON. ITS ACTION ON CARBOHYDRATE METABOLISM. ITS CLINICAL APPLICATIONS IN THE DIAGNOSIS OF GLYCOREGULATION DISORDERS AND IN THE THERAPY OF HYPOGLYCEMIA AND GLYCOGENOSIS].
Topics: Carbohydrate Metabolism; Chemical Phenomena; Chemistry; Diabetes Mellitus; Diagnosis; Glucagon; Glycogen Storage Disease; Humans; Hypoglycemia; Liver Diseases; Metabolism; Obesity; Physiology; Toxicology | 1964 |
CHRONIC ACIDOSIS DUE TO AN ERROR IN LACTATE AND PYRUVATE METABOLISM. REPORT OF TWO CASES.
Topics: Acetoacetates; Acidosis; Blood; Blood Gas Analysis; Carbohydrate Metabolism; Carbohydrate Metabolism, Inborn Errors; Epinephrine; Fructose; Glucagon; Glucose Tolerance Test; Humans; Indians, North American; Infant; Insulin; Intellectual Disability; Ketoglutaric Acids; Lactates; Lactic Acid; Methylene Blue; Muscular Diseases; Obesity; Pantothenic Acid; Penicillamine; Pyruvates; Pyruvic Acid; Seizures; Thiamine; United States | 1964 |
[MECHANISM OF ACTION OF PHENETHYLBIGUANIDE].
Topics: Diabetes Mellitus; Glucagon; Glucose; Humans; Insulin; Muscles; Obesity; Pharmacology; Phenformin | 1964 |
THE GLUCAGON RESPONSE OF FASTING OBESE SUBJECTS.
Topics: Biomedical Research; Blood Glucose; Body Weight; Carbohydrate Metabolism; Fasting; Glucagon; Gluconeogenesis; Humans; Ketones; Liver Glycogen; Obesity; Pharmacology; Urine | 1965 |
[Incretory behavior of the pancreatic alpha-cell apparatus in primary obesity].
Topics: Glucagon; Glucagon-Secreting Cells; Glucose; Humans; Obesity | 1962 |
Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Infusion Systems; Male; Obesity; Predictive Value of Tests; Statistics, Nonparametric | 2003 |
Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects.
Topics: Adult; Anthropometry; Black or African American; Body Composition; Body Mass Index; Energy Intake; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Male; Obesity; Peptide Fragments; Protein Precursors | 2003 |
Drug discovery and development for metabolic diseases.
Topics: Adult; Animals; Appetite; Child; Congresses as Topic; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Obesity; Peptide Fragments; Peptide YY; Pharmacology, Clinical; Protein Precursors; Receptors, Glucocorticoid | 2003 |
The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Blood Pressure; Disease Models, Animal; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Imidazoles; Imidazoline Receptors; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Yohimbine | 2003 |
Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice.
Topics: Animals; Blood Glucose; Cell Division; Glucagon; Glucose; Growth Hormone; Homeostasis; Insulin; Islets of Langerhans; Mice; Mice, Knockout; Obesity; Receptors, Somatotropin | 2004 |
Defect in glucokinase translocation in Zucker diabetic fatty rats.
Topics: Animals; Biological Transport; Blood Glucose; Carrier Proteins; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Glucokinase; Glucose; Glucose-6-Phosphate; Glycogen; Insulin; Intracellular Membranes; Intracellular Signaling Peptides and Proteins; Liver; Male; Muscle, Skeletal; Obesity; Rats; Rats, Zucker; Thinness; Tissue Distribution | 2004 |
Expression levels of genes likely involved in glucose-sensing in the obese Zucker rat brain.
Topics: Animals; Blood Glucose; Corticosterone; Energy Metabolism; Female; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucokinase; Glucose; Glucose Transporter Type 2; Hypothalamus; Insulin; Leptin; Male; Monosaccharide Transport Proteins; Neuropeptide Y; Obesity; Rats; Rats, Zucker; Receptors, Glucagon; Rhombencephalon; RNA, Messenger; Sex Characteristics; Transcription, Genetic | 2004 |
Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients: response to Damci et al.
Topics: Anti-Obesity Agents; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Lactones; Obesity; Orlistat; Peptide Fragments; Postprandial Period; Protein Precursors | 2004 |
S 23521 decreases food intake and body weight gain in diet-induced obese rats.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Dose-Response Relationship, Drug; Eating; Energy Metabolism; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Obesity; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Time Factors; Weight Gain | 2004 |
Activity-induced GLP-1 release in lean and obese subjects.
Topics: Adult; Analysis of Variance; Area Under Curve; Basal Metabolism; Blood Glucose; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Motor Activity; Obesity; Peptide Fragments; Protein Precursors; Thinness; Weight Loss | 2004 |
Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight.
Topics: Animals; Blood Glucose; Body Weight; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Insulin; Islets of Langerhans; Male; Obesity; Peptide Fragments; Peptides; Protein Precursors; Rats; Rats, Zucker; Venoms | 2005 |
Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity.
Topics: Adolescent; Anorexia Nervosa; Child; Cholecystokinin; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Obesity; Peptide Fragments; Protein Precursors; Radioimmunoassay | 2004 |
Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Insulin; Male; Mice; Mice, Obese; Obesity; Peptide Fragments; Protein Precursors; Receptors, Glucagon; Time Factors | 2005 |
Increased glucose tolerance in N-type Ca2+ channel alpha(1B)-subunit gene-deficient mice.
Topics: Animals; Blood Glucose; Body Weight; Calcium Channels, N-Type; Crosses, Genetic; Dietary Fats; Eating; Fasting; Glucagon; Glucose; Glucose Tolerance Test; Heterozygote; Homeostasis; Homozygote; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Obesity; Polymerase Chain Reaction; Protein Subunits | 2005 |
Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Obesity; Peptide Fragments; Protein Precursors | 2004 |
Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Topics: Animals; Body Weight; Dietary Fats; Dipeptidyl Peptidase 4; Eating; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Intestinal Mucosa; Liver; Male; Obesity; Oligosaccharides; Peptide Fragments; Peptide Hormones; Peptides; Proglucagon; Protein Precursors; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triglycerides | 2005 |
Insulin inhibits glucagon-induced glycogenolysis normally in perivenous hepatocytes of Wistar fatty rats.
Topics: Animals; Glucagon; Hepatocytes; Insulin; Liver Glycogen; Obesity; Rats; Rats, Wistar | 2005 |
Gastric bypass and nesidioblastosis--too much of a good thing for islets?
Topics: Adenosine Deaminase Inhibitors; Dipeptidyl Peptidase 4; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glycoproteins; Humans; Hyperinsulinism; Hyperplasia; Hypoglycemia; Islets of Langerhans; Nesidioblastosis; Obesity; Peptide Fragments; Postoperative Complications; Protein Precursors; Signal Transduction | 2005 |
Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes.
Topics: Adrenocorticotropic Hormone; Animals; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Glucagon; Glycine max; Insulin; Isoflavones; Leptin; Male; Obesity; Peptide Hormones; Phytoestrogens; Probiotics; Rats; Rats, Inbred SHR; Triglycerides | 2005 |
VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
Topics: Adipose Tissue; Animals; Diet; Disease Models, Animal; Disease Susceptibility; Energy Intake; Glucagon; Glucose; Homeostasis; Hyperglycemia; Hyperinsulinism; Hypoglycemia; Injections, Intraperitoneal; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Growth Factors; Neuropeptides; Obesity; Proteins; Receptor, Melanocortin, Type 4 | 2005 |
[A study on the mechanism of islet cell insulin resistance in high-fat-diet obese rats].
Topics: Animals; Diet, High-Fat; Glucagon; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Obesity; Rats; Rats, Wistar; Receptor, Insulin; Signal Transduction | 2005 |
Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice.
Topics: Animals; Body Weight; Diabetes Mellitus; Eating; Feeding Behavior; Glucagon; Glucose Intolerance; Insulin; Lipids; Mice; Mice, Obese; Obesity; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Time Factors | 2006 |
Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level.
Topics: Adult; Aged; Blood Glucose; Female; Ghrelin; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin; Male; Middle Aged; Obesity; Peptide Hormones; Pituitary-Adrenal System | 2006 |
Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187.
Topics: Amyloid; Animals; Blood Glucose; Gastric Emptying; Glucagon; Homeostasis; Islet Amyloid Polypeptide; Male; Obesity; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Islet Amyloid Polypeptide; Receptors, Peptide | 2006 |
Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Appetite; Body Weight; Corticosterone; Diabetes Mellitus, Type 2; Endocrine System; Energy Intake; Glucagon; Haloperidol; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Lipid Metabolism; Male; Obesity; Rats; Rats, Sprague-Dawley; Risperidone; Species Specificity; Testosterone; Weight Gain | 2006 |
Acute effect of meal glycemic index and glycemic load on blood glucose and insulin responses in humans.
Topics: Adult; Blood Glucose; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Energy Intake; Fatty Acids, Nonesterified; Female; Food; Glucagon; Glycemic Index; Humans; Insulin; Kinetics; Obesity | 2006 |
Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
Topics: Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Diabetes Mellitus; Glucagon; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Microscopy, Electron; Obesity; Pancreas; Recombinant Proteins | 2006 |
Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Insulin; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Obesity; Peptide Fragments; Peptides; Polyethylene Glycols; Rats; Rats, Wistar; Receptors, Glucagon | 2007 |
Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones.
Topics: Amino Acids; Animals; Blood Glucose; Caseins; Cells, Cultured; Dietary Fats; Dietary Proteins; Gene Expression Regulation; Glucagon; Glucose Clamp Technique; Glucose Transporter Type 2; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Isoflavones; Leptin; Obesity; PPAR gamma; Rats; Rats, Sprague-Dawley; Soybean Proteins; Sterol Regulatory Element Binding Protein 1 | 2007 |
The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus.
Topics: Aged; ATP-Binding Cassette Transporters; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Injections, Intravenous; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Polymorphism, Single Nucleotide; Potassium Channels; Potassium Channels, Inwardly Rectifying; Prevalence; Receptors, Drug; Stroke; Sulfonylurea Receptors; Time Factors | 2007 |
Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Topics: Animal Feed; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glycogen; Glycogen Synthase; Glycogenolysis; Homeostasis; Hyperglycemia; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Obese; Obesity; Receptors, Somatostatin; Triglycerides | 2007 |
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
Topics: Adiponectin; Animals; Blood Glucose; Body Weight; Corticosterone; Dietary Fats; Eating; Gastric Inhibitory Polypeptide; Glucagon; Glucose Intolerance; Glycated Hemoglobin; Insulin; Insulin Resistance; Lipids; Locomotion; Male; Mice; Mice, Obese; Obesity; Receptors, Gastrointestinal Hormone | 2007 |
Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agent.
Topics: Crystallization; Crystallography, X-Ray; Glucagon; Obesity; Peptide Fragments | 2007 |
Susceptibility to oxidative stress, insulin resistance, and insulin secretory response in the development of diabetes from obesity.
Topics: Adult; Antioxidants; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Obesity; Oxidative Stress | 2007 |
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
Topics: Adipokines; Adipose Tissue; Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Corticosterone; Dietary Fats; Eating; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Incretins; Insulin; Insulin Resistance; Lipids; Liver; Male; Mice; Motor Activity; Muscle, Skeletal; Obesity; Pancreas; Receptors, Gastrointestinal Hormone | 2007 |
Comparison of the metabolic effects of GIP receptor antagonism and PYY(3-36) receptor activation in high fat fed mice.
Topics: Animals; Blood Glucose; Corticosterone; Dietary Fats; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Insulin; Male; Mice; Obesity; Peptide Fragments; Peptide YY; Receptors, Gastrointestinal Hormone | 2007 |
Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Eating; Female; Food; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Incretins; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Obesity, Morbid; Postoperative Complications | 2007 |
An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.
Topics: Animals; Blood Glucose; Disease Models, Animal; Dose-Response Relationship, Drug; Glucagon; Glucose; Glucose Tolerance Test; Glycogen Phosphorylase; Glycogen Synthase; Hepatocytes; Hyperglycemia; Inhibitory Concentration 50; Male; Obesity; Quinolones; Rats; Rats, Wistar; Rats, Zucker; Thiophenes | 2007 |
Upregulation of the brainstem preproglucagon system in the obese Zucker rat.
Topics: Animals; Appetite Regulation; Brain Stem; Caloric Restriction; Circadian Rhythm; Fluorescent Antibody Technique; Food Deprivation; Food, Formulated; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; In Situ Hybridization; Leptin; Male; Obesity; Proglucagon; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Glucagon; Receptors, Leptin; RNA, Messenger; Solitary Nucleus; Up-Regulation | 2008 |
Influence of BMI and gender on postprandial hormone responses.
Topics: Adult; Analysis of Variance; Blood Glucose; Body Composition; Body Mass Index; Female; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Leptin; Male; Middle Aged; Obesity; Postprandial Period; Sex Characteristics | 2007 |
Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Male; Middle Aged; Obesity; Postprandial Period; Somatostatin | 2008 |
Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Calcium-Binding Proteins; Cardiomyopathies; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Glucagon; Insulin; Intercellular Signaling Peptides and Proteins; Metabolic Syndrome; Mice; Mice, Transgenic; Obesity; Pancreas; Promoter Regions, Genetic; Receptors, Leptin; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Transgenes | 2008 |
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Weight Loss | 2008 |
Exaggerated insulin response to glucagon in simple obesity.
Topics: Adult; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Obesity | 1967 |
Tissue and serum somatostatin-like immunoreactivity in lean and obese Zucker rats.
Topics: Animals; Female; Glucagon; Insulin; Male; Obesity; Rats; Somatostatin; Tissue Distribution | 1980 |
Acute hormonal effects on carnitine metabolism in thin and obese subjects: responses to somatostatin, glucagon, and insulin.
Topics: Adult; Blood Glucose; Carnitine; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Keto Acids; Kinetics; Male; Middle Aged; Obesity; Somatostatin | 1981 |
Somatostatin, insulin, and glucagon secretion from isolated perfused pancreas of obese rats.
Topics: Animals; Arginine; Blood Glucose; Body Weight; Female; Glucagon; Hypothalamic Diseases; Insulin; Insulin Secretion; Male; Obesity; Pancreas; Perfusion; Rats; Rats, Zucker; Somatostatin | 1981 |
Effects of starvation and obesity on somatostatin, insulin, and glucagon release from an isolated perfused organ system.
Topics: Amino Acids; Animals; Fasting; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity; Rats; Rats, Zucker; Somatostatin; Starvation; Tolbutamide | 1981 |
"Accelerated starvation" and the skipped breakfast in late normal pregnancy.
Topics: 3-Hydroxybutyric Acid; Alanine; Blood Glucose; Diabetes Mellitus; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hydroxybutyrates; Hypoglycemia; Obesity; Pregnancy; Pregnancy Trimester, Third; Starvation | 1982 |
Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Obesity; Pancreatic Hormones; Radioimmunoassay; Somatostatin | 1982 |
Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats.
Topics: Animals; Blood Glucose; Fasting; Female; Glucagon; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Liver; Obesity; Rats; Rats, Inbred Strains; Somatostatin; Ventromedial Hypothalamic Nucleus | 1984 |
Somatostatin, glucagon, and insulin secretion from isolated perfused pancreas of new genetically obese hyperglycemic rats.
Topics: Animals; Arginine; Blood Glucose; Body Weight; Glucagon; Insulin; Insulin Secretion; Male; Obesity; Pancreas; Perfusion; Rats; Rats, Mutant Strains; Somatostatin; Time Factors | 1984 |
Cyclic nucleotides in diabetes mellitus and obesity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue; Animals; Cyclic AMP; Cyclic GMP; Diabetes Mellitus; Diabetes Mellitus, Experimental; Epinephrine; Glucagon; Humans; Insulin; Isoproterenol; Liver; Male; Mice; Mice, Obese; Obesity; Rats | 1980 |
Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.
Topics: Adenylyl Cyclases; Age Factors; Animals; Disease Models, Animal; Enzyme Activation; Food Deprivation; Glucagon; Isoproterenol; Myocardium; Obesity; Rats; Receptors, Cell Surface; Secretin; Vasoactive Intestinal Peptide | 1981 |
Effect of glucagon infusion on blood glucose, plasma immunoreactive insulin, growth hormone and adenosine 3'5'-monophosphate in obese children.
Topics: Child; Cyclic AMP; Glucagon; Growth Hormone; Humans; Hyperinsulinism; Insulin; Obesity | 1981 |
Age-related decrease in sensitivity to glucagon and dibutyryl cyclic AMP inhibition of fatty acid synthesis in hepatocytes isolated from obese female Zucker rats.
Topics: Aging; Animals; Bucladesine; Fatty Acids; Female; Furans; Glucagon; In Vitro Techniques; Liver; Obesity; Rats; Rats, Zucker | 1984 |
Vasoactive intestinal polypeptide in obesity.
Topics: Adult; Cholesterol; Female; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon; Humans; Insulin; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Obesity; Secretin; Triglycerides; Vasoactive Intestinal Peptide | 1983 |
Fasting and postprandial plasma glucagon and glucagon-like immunoreactivity are normal in obese Pima Indians.
Topics: Adult; Blood Glucose; Fasting; Food; Glucagon; Glucagon-Like Peptides; Humans; Indians, North American; Insulin; Middle Aged; Obesity; Peptides | 1983 |
[Metabolic effect of glucagon in obese individuals. I. Effect on blood glucose and blood insulin].
Topics: Adult; Blood Glucose; Female; Glucagon; Humans; Insulin; Obesity | 1983 |
Partial purification of an insulin-releasing activity in human serum.
Topics: Animals; Biological Assay; Child; Chromatography, High Pressure Liquid; Fasting; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Islets of Langerhans; Obesity; Peptide Fragments; Peptides; Rats; Rats, Inbred Strains | 1983 |
Influence of obesity on basal glucagon levels in non-diabetic and diabetic Nauruans.
Topics: Adult; Aged; Body Weight; Diabetes Mellitus; Ethnicity; Female; Glucagon; Humans; Insulin; Male; Micronesia; Middle Aged; Obesity | 1983 |
Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.
Topics: Adult; Animals; Circadian Rhythm; Female; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Male; Mice; Obesity; Pancreatic Polypeptide | 1983 |
Elevated pancreatic glucagon in obesity.
Topics: Adult; Animals; Chromatography, Gel; Dogs; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Kidney; Male; Middle Aged; Obesity; Pancreas | 1984 |
Measurement of glucagon in human plasma by enzyme immunoassay.
Topics: Colonic Neoplasms; Diabetes Mellitus; Fatty Liver; Glucagon; Hepatitis; Humans; Immunoenzyme Techniques; Intestinal Polyps; Obesity; Radioimmunoassay | 1983 |
Normal insulin sensitivity of the islets of Langerhans in obese subjects with resistance to its glucoregulatory actions.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Humans; Insulin; Insulin Infusion Systems; Insulin Resistance; Islets of Langerhans; Male; Obesity | 1984 |
Insulin resistance in a young man with cystic fibrosis.
Topics: Adolescent; Cystic Fibrosis; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Obesity; Receptor, Insulin | 1984 |
The effects of exercise and food restriction on obesity and diabetes in young ob/ob mice.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Energy Intake; Glucagon; Insulin; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Physical Exertion | 1984 |
A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping.
Topics: Adult; Blood Glucose; C-Peptide; Drug Administration Schedule; Female; Glucagon; Humans; Hydrocortisone; Infusions, Parenteral; Insulin; Insulin Infusion Systems; Male; Obesity | 1984 |
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
Topics: Adult; Aging; Arginine; Blood Glucose; Catecholamines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Obesity | 1984 |
Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance.
Topics: Administration, Oral; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Obesity; Radioimmunoassay | 1984 |
Effects of weight reduction after gastroplasty on glucose and lipid metabolism.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Weight; Female; Glucagon; Glucose; Humans; Insulin; Lipase; Lipid Metabolism; Lipids; Lipoprotein Lipase; Lipoproteins; Liver; Male; Obesity; Stomach | 1984 |
Whole body protein breakdown rates and hormonal adaptation in fasted obese subjects.
Topics: Adult; Amino Acids, Branched-Chain; Fasting; Glucagon; Hormones; Humans; Hydrocortisone; Insulin; Lysine; Nitrogen; Obesity; Proteins; Thyroid Hormones | 1983 |
Oversecretion of glucagon by pancreases of ventromedial hypothalamic-lesioned rats: a re-evaluation of a controversial topic.
Topics: Amino Acids; Animals; Female; Glucagon; Glucose; Obesity; Pancreas; Perfusion; Rats; Rats, Inbred Strains; Ventromedial Hypothalamic Nucleus | 1984 |
Role of counterregulatory hormones in the catabolic response to stress.
Topics: Adult; Amino Acids; Ammonia; Blood Glucose; Blood Urea Nitrogen; Energy Metabolism; Epinephrine; Female; Glucagon; Hormones; Humans; Hydrocortisone; Male; Methylhistidines; Norepinephrine; Obesity; Stress, Physiological; Time Factors; Triiodothyronine | 1984 |
Decreased food intakes and body weights in rats immunized against pancreatic glucagon.
Topics: Animals; Body Weight; Feeding Behavior; Female; Glucagon; Glucagon-Like Peptides; Immunization; Obesity; Rats; Rats, Zucker | 1984 |
[Endocrine changes in obesity and emaciation].
Topics: Adrenal Cortex Hormones; Anorexia Nervosa; Catecholamines; Emaciation; Female; Gastric Inhibitory Polypeptide; Glucagon; Humans; Male; Obesity; Pancreatic Polypeptide | 1983 |
[Metabolic effect of glucagon in obese individuals. II. Effect on the levels of nonesterified fatty acids and beta-hydroxybutyric acid in the blood].
Topics: 3-Hydroxybutyric Acid; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Humans; Hydroxybutyrates; Obesity | 1983 |
Possible glucagon-mediated hypocholesterolemic activity of a nicotinic acid derivative (sorbinicate).
Topics: Adult; Cholesterol; Glucagon; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Nicotinic Acids; Obesity; Sorbitol; Triglycerides | 1983 |
Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application.
Topics: Acromegaly; Adolescent; Adult; Arginine; Cushing Syndrome; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Humans; Male; Middle Aged; Obesity; Radioimmunoassay | 1984 |
Suppression of weight gain by glucagon in obese Zucker rats.
Topics: Adipose Tissue; Animals; Aspartate Aminotransferases; Blood Glucose; Body Weight; Glucagon; Glycogen; Lipid Metabolism; Liver; Obesity; Organ Size; Rats; Rats, Zucker | 1984 |
Epinephrine-stimulated glucose production is not diminished by starvation: evidence for an effect on gluconeogenesis.
Topics: Adult; Energy Metabolism; Epinephrine; Fasting; Female; Glucagon; Gluconeogenesis; Humans; Male; Obesity; Starvation | 1984 |
Glucoregulation in obese man: effects of fasting, glucagon infusion, exercise and diabetes.
Topics: Diabetes Mellitus; Fasting; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Obesity; Physical Exertion | 1982 |
The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Male; Obesity; Peptides; Radioimmunoassay; Stimulation, Chemical; Time Factors | 1982 |
Effect of glucagon infusion on some plasma metabolites and hormones in obese children.
Topics: Amino Acids; Blood Glucose; Child; Cholesterol; Fatty Acids, Nonesterified; Glucagon; Glycerol; Growth Hormone; Humans; Insulin; Insulin Secretion; Lactates; Lactic Acid; Obesity; Pyruvates; Pyruvic Acid; Stimulation, Chemical; Triglycerides | 1982 |
Obesity, diabetes mellitus and physical activity--metabolic responses to physical training in adipose and muscle tissues.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus; Energy Metabolism; Glucagon; Humans; Insulin; Muscles; Obesity; Physical Education and Training; Physical Exertion; Rats | 1982 |
Insulin and glucagon release from cultured neonatal pancreatic islets of lean and preobese Zucker rats.
Topics: Animals; Animals, Newborn; Body Weight; Cells, Cultured; Glucagon; Glucose; Insulin; Islets of Langerhans; Obesity; Rats; Rats, Zucker | 1982 |
Starvation and age effects on glycoregulation and hormone levels of C57BL/6Job/ob mice.
Topics: Age Factors; Animals; Blood Glucose; Corticosterone; Female; Glucagon; Glycolysis; Hormones; Insulin; Male; Mice; Mice, Inbred C57BL; Obesity; Starvation | 1982 |
Effects of fasting and refeeding on glucose, insulin and glucagon concentrations in obese teenagers.
Topics: Adolescent; Blood Glucose; Child; Fasting; Food, Formulated; Glucagon; Humans; Insulin; Male; Obesity | 1982 |
Hormonal and metabolic characteristics of genetically obese Zucker and dietary obese Sprague-Dawley rats.
Topics: Animals; Diet; Fatty Acids, Nonesterified; Glucagon; In Vitro Techniques; Insulin; Ketone Bodies; Liver; Male; Obesity; Rats; Rats, Inbred Strains; Rats, Zucker; Triglycerides | 1980 |
Regulation of lipid synthesis in hepatocytes from lean and obese Zucker rats.
Topics: Animals; Carbon Dioxide; Carbon Radioisotopes; Fatty Acids; Female; Glucagon; Glucose; In Vitro Techniques; Insulin; Lactates; Liver; Obesity; Pyruvates; Rats; Rats, Zucker | 1981 |
Effects of weight reduction on plasma lipoproteins and adipose tissue metabolism in obese subjects.
Topics: Adipose Tissue; Blood Glucose; Body Weight; Cholesterol; Diet, Reducing; Female; Glucagon; Humans; Insulin; Lipolysis; Lipoprotein Lipase; Lipoproteins; Lipoproteins, HDL; Liver; Male; Obesity; Triglycerides | 1981 |
Oxidation and ketogenesis in hepatocytes of lean and obese Zucker rats.
Topics: Animals; Carbon Dioxide; Carnitine; Fasting; Female; Food; Glucagon; Glucose; Ketone Bodies; Liver; Obesity; Oxidation-Reduction; Palmitates; Palmitoylcarnitine; Rats; Rats, Zucker | 1982 |
Effect of genetic obesity on the regulation of hepatic fatty acid metabolism.
Topics: Animals; Genotype; Glucagon; In Vitro Techniques; Kinetics; Lipids; Liver; Obesity; Palmitic Acid; Palmitic Acids; Rats; Rats, Zucker; Tritium | 1983 |
Oleate metabolism in isolated hepatocytes from lean and obese Zucker rats. Influence of a high fat diet and in vitro response to glucagon.
Topics: Animals; Dietary Fats; Glucagon; In Vitro Techniques; Ketones; Liver; Male; Obesity; Oleic Acid; Oleic Acids; Rats; Rats, Zucker | 1983 |
Adaptations of alpha2- and beta-cells of rat and mouse pancreatic islets to starvation, to refeeding after starvation, and to obesity.
Topics: Adaptation, Physiological; Animals; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Obese; Obesity; Perfusion; Rats; Starvation; Tolbutamide | 1980 |
Short-term influences of dichloroacetate on genetically hyperlipemic rats.
Topics: Acetates; Animals; Dichloroacetic Acid; Disease Models, Animal; Fatty Acids, Nonesterified; Glucagon; Hyperlipidemias; Hypoglycemia; Insulin; Ketone Bodies; Obesity; Rats; Triglycerides | 1980 |
Effects of acute exercise on insulin binding to monocytes in obesity.
Topics: Adult; Blood Glucose; Female; Glucagon; Humans; Insulin; Ketones; Lactates; Male; Monocytes; Obesity; Physical Exertion; Receptor, Insulin | 1980 |
Glucagon and diabetes: evidence for marked insensitivity to local regulation of A-cell function by endogenous insulin in obese-hyperglycaemic (ob/ob) mice [proceedings].
Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Glucagon; Homozygote; Hyperglycemia; Insulin; Mice; Mice, Obese; Obesity; Pancreas; Starvation | 1980 |
Alterations in glucagon secretion in obese rats with hypothalamic lesions.
Topics: Animals; Arginine; Blood Glucose; Body Weight; Glucagon; Glucose; Hypothalamus; Insulin; Male; Obesity; Rats | 1980 |
Indomethacin and aspirin prevent the starvation-induced fall in plasma insulin.
Topics: Adult; Aspirin; Female; Glucagon; Humans; Indomethacin; Insulin; Kinetics; Male; Middle Aged; Obesity; Starvation | 1980 |
Metabolic consequences of fasting in old lean and obese Zucker rats.
Topics: Animals; Carbohydrate Metabolism; Cholesterol; Disease Models, Animal; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glycogen; Insulin; Lipid Metabolism; Liver; Male; Obesity; Phospholipids; Rats; Sex Factors; Triglycerides | 1980 |
Therapy of insulin-independent diabetes mellitus: general considerations.
Topics: Blood Glucose; Diabetes Mellitus; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Obesity; Reference Values; Tolbutamide | 1980 |
Insulin resistance in obesity as analyzed by the response of glucose kinetics to glucagon infusion.
Topics: Adult; Body Height; Body Weight; Drug Resistance; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Infusions, Parenteral; Insulin; Kinetics; Male; Methods; Middle Aged; Obesity | 1980 |
Pancreatic glucagon response to glucose in hyperlipoproteinaemia with and without abnormalities in carbohydrate metabolism.
Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperlipoproteinemias; Insulin; Insulin Secretion; Male; Obesity | 1980 |
Capacity for moderate exercise in obese subjects after adaptation to a hypocaloric, ketogenic diet.
Topics: Adult; Exercise Test; Fatty Acids, Nonesterified; Female; Glucagon; Glycogen; Humans; Insulin; Male; Muscles; Obesity; Oxygen Consumption; Physical Exertion; Pyruvates; Thyroid Hormones | 1980 |
Portal and peripheral vein concentrations of insulin and glucagon after arginine infusion in morbidly obese subjects.
Topics: Adult; Arginine; Elbow; Female; Glucagon; Humans; Insulin; Obesity; Portal Vein; Veins | 1980 |
Hormonal and metabolic rhythms in Cushing's syndrome.
Topics: Adolescent; Adult; Alanine; Blood Glucose; Circadian Rhythm; Cushing Syndrome; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Humans; Hydrocortisone; Insulin; Ketone Bodies; Lactates; Male; Middle Aged; Obesity; Pyruvates; Triglycerides | 1980 |
[Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
Topics: Adolescent; Adult; C-Peptide; Child; Diabetes Mellitus; Female; Glucagon; Glucose; Humans; Injections, Intravenous; Insulin; Male; Middle Aged; Obesity; Peptides; Stimulation, Chemical | 1980 |
Increased ketonaemia in hyperthyroidism. Evidence for a beta-adrenergic mechanism.
Topics: Adult; Aged; Alanine; Blood Glucose; Diet, Reducing; Energy Intake; Female; Glucagon; Glycerol; Humans; Hyperthyroidism; Insulin; Ketone Bodies; Middle Aged; Obesity; Reference Values; Triiodothyronine | 1980 |
[Studies on glucagon secretion in obese rats with hypothalamic lesions (author's transl)].
Topics: Animals; Arginine; Epinephrine; Glucagon; Glucose; Hypothalamus; Insulin; Male; Obesity; Rats | 1980 |
The metabolic response to yellow fever immunization: protein-sparing modified fast.
Topics: Adult; Blood Glucose; Dietary Proteins; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Immunization; Insulin; Ketone Bodies; Male; Obesity; Proteins; Yellow Fever | 1981 |
Effect of diet on the metabolic response to infection: protein-sparing modified fast plus 100 grams glucose and yellow fever immunization.
Topics: Adolescent; Adult; Blood Glucose; Dietary Proteins; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Immunization; Insulin; Ketone Bodies; Male; Obesity; Proteins; Yellow Fever | 1981 |
Pancreatic glucagon response to glucose in obesity with normal and impaired carbohydrate tolerance.
Topics: Adult; Blood Glucose; Body Weight; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Obesity; Pancreas | 1981 |
Glucoregulatory and metabolic response to exercise in obese noninsulin-dependent diabetes.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucose; Heart Rate; Humans; Insulin; Male; Middle Aged; Obesity; Physical Exertion; Respiration | 1981 |
Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
Topics: Adult; Blood Glucose; Epinephrine; Glucagon; Humans; Insulin; Insulin Secretion; Obesity; Phentolamine; Propranolol; Sympathetic Nervous System | 1981 |
[Evaluation of the metabolic action of glucagon in subjects undergoing anti-insulin therapy].
Topics: Adult; Blood Glucose; Diazoxide; Glucagon; Growth Hormone; Humans; Hyperinsulinism; Insulin; Lipids; Male; Middle Aged; Obesity; Phenytoin; Prolactin | 1981 |
Non-essential role of dietary factors in the development of diabetes in ob/ob mice.
Topics: Animals; Biometry; Blood Glucose; Body Weight; Corticosterone; Diabetes Mellitus; Diet; Glucagon; Insulin; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Weaning | 1981 |
The gastro-entero-pancreatic hormone response to fasting in obesity.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Fasting; Female; Gastrointestinal Hormones; Glucagon; Glycerol; Humans; Hydroxybutyrates; Insulin; Lipolysis; Male; Middle Aged; Obesity; Secretin; Vasoactive Intestinal Peptide | 1981 |
Metabolic adaptations to starvation, semistarvation, and carbohydrate restriction.
Topics: Adult; Dietary Carbohydrates; Fasting; Glucagon; Glucose; Glutamine; Humans; Hydrocortisone; Insulin; Ketone Bodies; Male; Muscles; Obesity; Proteins; Starvation; Triiodothyronine | 1981 |
Preservation of glucose tolerance and insulin secretory response to repeated glucose levels by the feeding of minimal glucose during prolonged fasting.
Topics: Adult; Blood Glucose; Body Weight; Fasting; Fatty Acids, Nonesterified; Food; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Lactates; Lactic Acid; Male; Middle Aged; Obesity | 1981 |
Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans.
Topics: Adult; Blood Glucose; Female; Glucagon; Humans; Insulin; Male; Obesity; Periodicity | 1982 |
Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
Topics: C-Peptide; Diabetes Mellitus; Glucagon; Glucose; Humans; Insulin; Obesity; Peptides | 1982 |
Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity.
Topics: Adult; Blood Glucose; C-Peptide; Feedback; Female; Glucagon; Humans; Indians, North American; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity | 1982 |
Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Obesity | 1982 |
Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in man.
Topics: Adult; Age Factors; Aged; Blood Glucose; Fasting; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged; Obesity | 1982 |
[Low-energy diet and hormonal regulation in obese individuals. Secretion of glucagon (author's transl)].
Topics: Body Weight; Diet, Reducing; Glucagon; Humans; Insulin; Obesity | 1982 |
Effect of protein-supplemented fasting on metabolic and hormonal responses to epinephrine infusion in obese subjects.
Topics: Adult; Blood Glucose; Dietary Proteins; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Lactates; Lactic Acid; Male; Middle Aged; Obesity; Time Factors | 1982 |
[Decreased secretion of epinephrine during protein-supplemented fasting in obese subjects (author's transl)].
Topics: Adrenal Medulla; Adult; Dietary Proteins; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Male; Obesity | 1981 |
Age-related changes in insulin receptor regulation in liver membranes from Zucker fatty rats.
Topics: Aging; Animals; Blood Glucose; Cell Membrane; Female; Glucagon; Insulin; Liver; Male; Obesity; Rats; Rats, Zucker; Receptor, Insulin; Triglycerides | 1982 |
[Incretory function of the pancreas in obesity].
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Obesity | 1982 |
[Raised plasma glucagon levels in obesity (author's transl)].
Topics: Adult; Blood Glucose; Body Weight; Female; Glucagon; Humans; Hyperinsulinism; Male; Middle Aged; Obesity; Triglycerides | 1982 |
[Glucagon secretion in hyperlipoproteinemia and adiposity].
Topics: Animals; Glucagon; Glucose Tolerance Test; Humans; Hyperlipoproteinemias; Obesity; Rats | 1982 |
Abnormal glucagon secretion in Zucker fatty rats.
Topics: Animals; Arginine; Blood Glucose; Body Temperature; Cold Temperature; Epinephrine; Female; Glucagon; Hypothalamus, Middle; Obesity; Rats; Rats, Zucker | 1981 |
[Gastrointestinal hormones in pathogenesis of obesity].
Topics: Animals; Appetite Regulation; Cholecystokinin; Endorphins; Enkephalins; Gastrointestinal Hormones; Glucagon; Humans; Mice; Obesity; Secretin; Vasoactive Intestinal Peptide | 1980 |
Nitrogen handling in adult hypothalamic obese rats.
Topics: Amino Acids; Animals; Female; Glucagon; Hyperinsulinism; Hypothalamus; Hypothalamus, Middle; Lipid Metabolism; Liver; Nitrogen; Obesity; Pancreas; Protein Biosynthesis; Rats; Urea | 1980 |
Glucagon kinetics in fasting: physiological elevations in serum 3,5,3'-triiodothyronine increase the metabolic clearance rate of glucagon.
Topics: Adult; Diet, Reducing; Energy Intake; Fasting; Female; Glucagon; Humans; Kinetics; Male; Metabolic Clearance Rate; Obesity; Triiodothyronine | 1980 |
Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia.
Topics: 3-Hydroxybutyric Acid; Analysis of Variance; Blood Glucose; Body Mass Index; C-Peptide; Child; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glycerol; Humans; Hydroxybutyrates; Infusions, Intravenous; Insulin; Kinetics; Liver; Male; Obesity; Reference Values; Triglycerides | 1995 |
Significance of obesity on nutritional, immunologic, hormonal, and clinical outcome parameters in burns.
Topics: Acute-Phase Proteins; Adolescent; Adult; Bacteremia; Bacterial Infections; Body Composition; Burns; Burns, Inhalation; Child; Cholesterol; Creatinine; Energy Metabolism; Glucagon; Humans; Incidence; Length of Stay; Middle Aged; Obesity; Respiration, Artificial; Retrospective Studies | 1993 |
Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.
Topics: Animals; Diabetes Mellitus, Experimental; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity; Peptide Fragments; Perfusion; Rats; Rats, Zucker | 1995 |
Diabetic ketoacidosis in obese African-Americans.
Topics: Adult; Black People; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Georgia; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Reference Values; Thinness | 1995 |
Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Obesity | 1995 |
Inhibition of hepatic very-low-density lipoprotein secretion in obese Zucker rats adapted to a high-protein diet.
Topics: Adaptation, Physiological; Animals; Body Weight; Dietary Proteins; Fatty Acids; Glucagon; Insulin; Lipid Metabolism; Lipoproteins, LDL; Lipoproteins, VLDL; Liver; Male; Obesity; Oleic Acid; Oleic Acids; Rats; Rats, Zucker; Triglycerides | 1995 |
The differential effects of body fat distribution on insulin and glucose metabolism during pregnancy.
Topics: Adipose Tissue; Adult; Analysis of Variance; Body Constitution; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Longitudinal Studies; Obesity; Pregnancy; Pregnancy Complications; Regression Analysis | 1994 |
Glucose and fat metabolism in adults with growth hormone deficiency.
Topics: Adipose Tissue; Adult; Body Composition; Cross-Sectional Studies; Female; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Lipid Metabolism; Male; Obesity | 1994 |
Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Food; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hydroxybutyrates; Insulin; Lactates; Lactic Acid; Liver; Male; Middle Aged; Obesity | 1994 |
Moderate diet restriction alters the substrate and hormone response to exercise.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Body Composition; Carbohydrate Metabolism; Carbohydrates; Diet, Reducing; Energy Intake; Energy Metabolism; Exercise Therapy; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Heart Rate; Humans; Hydroxybutyrates; Insulin; Lipid Metabolism; Lipids; Obesity; Oxygen Consumption; Weight Loss | 1994 |
Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Reducing; Energy Intake; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Receptor, Insulin; Weight Loss | 1994 |
Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance.
Topics: Adult; Blood Glucose; C-Peptide; Feedback; Female; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Humans; Insulin; Insulin Secretion; Male; Obesity; Reference Values | 1993 |
[Effects of insular hormones on the secretion of atrial natriuretic factor].
Topics: Adolescent; Adult; Atrial Natriuretic Factor; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hyperinsulinism; Insulin; Male; Middle Aged; Obesity; Potassium; Secretory Rate; Sodium | 1993 |
Alpha- and beta-cell function in obese Zucker (fa/fa) rats: a study with the isolated perfused pancreas.
Topics: Animals; Arginine; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Male; Norepinephrine; Obesity; Perfusion; Rats; Rats, Zucker; Stimulation, Chemical; Tyramine | 1994 |
Pancreatic islet cells in preobese yellow Avy/- mice: relation to adult hyperinsulinemia and obesity.
Topics: Age Factors; Animals; Body Weight; Female; Glucagon; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Obesity; Organ Size; Pancreas | 1994 |
Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.
Topics: Adult; Alanine; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Ethanol; Fasting; Fatty Acids, Nonesterified; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Humans; Lactates; Liver; Liver Glycogen; Obesity; Reference Values | 1994 |
Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
Topics: Blood Glucose; Body Composition; Body Mass Index; C-Peptide; Calorimetry, Indirect; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glyburide; Glycogen Synthase; Humans; Insulin; Male; Middle Aged; Muscles; Obesity; Oxidation-Reduction; Pyruvate Dehydrogenase Complex | 1993 |
Very low calorie diet-induced weight loss reverses exaggerated insulin secretion in response to glucose, arginine and glucagon in obesity.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Body Mass Index; C-Peptide; Energy Intake; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Kinetics; Male; Obesity; Weight Loss | 1993 |
Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Hypertension; Insulin; Insulin Resistance; Male; Norepinephrine; Obesity; Polycystic Ovary Syndrome; Reference Values; Sex Factors | 1993 |
The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Islets of Langerhans; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Effects of exercise and weight loss on leucine turnover in different types of obesity.
Topics: Adult; Body Composition; Body Mass Index; Epinephrine; Exercise; Female; Glucagon; Growth Hormone; Hormones; Humans; Hydrocortisone; Insulin; Leucine; Norepinephrine; Obesity; Weight Loss | 1993 |
Diagnosis of naturally acquired type-I and type-II diabetes mellitus in cats.
Topics: Animals; Blood Glucose; Cat Diseases; Cats; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Insulin; Obesity | 1993 |
Werner syndrome and genetic obesity: speculation.
Topics: Glucagon; Humans; Insulin; Insulin Secretion; Models, Genetic; Obesity; Syndrome; Werner Syndrome | 1995 |
The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Kinetics; Male; Obesity; Opioid Peptides | 1996 |
Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity | 1996 |
Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Progression; Female; Food; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Linear Models; Male; Middle Aged; Obesity; Stimulation, Chemical; Treatment Outcome | 1996 |
The possible role of insulin release in cardiovascular morbidity and mortality in NIDDM patients.
Topics: Age Factors; Aged; Analysis of Variance; Blood Pressure; Body Mass Index; C-Peptide; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Glucagon; Humans; Insulin; Insulin Secretion; Male; Morbidity; Myocardial Ischemia; Obesity; Risk Factors; Sex Factors | 1995 |
Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects.
Topics: Administration, Oral; Adult; Analysis of Variance; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Fructose; Glucagon; Gluconeogenesis; Glucose; Glycogen; Humans; Infusions, Intravenous; Kinetics; Male; Middle Aged; Models, Theoretical; Obesity; Reference Values | 1996 |
Insulin and glucagon responses to adrenaline infusion in abdominal obese men.
Topics: Abdomen; Adipose Tissue; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Glycerol; Heart Rate; Homeostasis; Humans; Insulin; Male; Obesity | 1996 |
Metabolic and endocrine effects of interleukin-1 in obese, diabetic Zucker fa/fa rats.
Topics: Animals; Blood Glucose; Cholesterol; Corticosterone; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Fatty Acids, Nonesterified; Glucagon; Humans; Injections, Intraperitoneal; Insulin; Interleukin-1; Lactic Acid; Lipid Metabolism; Lipids; Male; Obesity; Rats; Rats, Zucker; Recombinant Proteins; Time Factors; Triglycerides | 1996 |
Attenuated GLP-1 secretion in obesity: cause or consequence?
Topics: Adult; Case-Control Studies; Dietary Carbohydrates; Dietary Fats; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Heparin; Humans; Obesity; Peptide Fragments; Radioimmunoassay | 1996 |
Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
Topics: Adult; Age of Onset; Body Mass Index; Body Weight; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Male; Obesity | 1996 |
Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
Topics: Adult; Aged; Biopsy; Blood Glucose; Body Mass Index; Carbon Isotopes; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Liver; Liver Glycogen; Male; Middle Aged; Models, Biological; Obesity; Reference Values; Thinness | 1997 |
Theoretical analysis of the mechanisms of chronic hyperinsulinemia.
Topics: Adult; Blood Glucose; Computer Simulation; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Obesity; Software | 1997 |
Metabolic characteristics of induced ketosis in normal and obese dairy cows.
Topics: Animals; Biopsy; Blood Glucose; Body Weight; Butylene Glycols; Cattle; Cattle Diseases; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Food Deprivation; Glucagon; Insulin; Ketosis; Lactation; Liver; Obesity; Pregnancy | 1997 |
Differential effects of GH stimulation on fasting and prandial metabolism and plasma IGFs and IGF-binding proteins in lean and obese sheep.
Topics: Analysis of Variance; Animals; Area Under Curve; Blood Glucose; Blotting, Western; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Human Growth Hormone; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Models, Biological; Obesity; Radioimmunoassay; Sheep; Somatomedins | 1997 |
Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.
Topics: Analysis of Variance; Animals; Body Weight; Cerebral Ventricles; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Infusion Pumps, Implantable; Male; Obesity; Peptide Fragments; Protein Precursors; Rats; Rats, Zucker; Time Factors | 1998 |
Alterations of insulin and glucagon secretion from the perfused pancreas before, at the onset and after the development of diabetes in male Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Topics: Animals; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucose; Immunohistochemistry; Insulin; Insulin Secretion; Male; Obesity; Pancreas; Perfusion; Rats; Rats, Inbred Strains; Time Factors | 1997 |
Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
Topics: Animals; Body Weight; Eating; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Injections, Intraventricular; Insulinoma; Male; Neurotransmitter Agents; Obesity; Pancreatic Neoplasms; Peptide Fragments; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Glucagon; Tumor Cells, Cultured | 1998 |
Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
Topics: Adult; Blood Pressure; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypertension; Insulin; Lactic Acid; Male; Middle Aged; Obesity | 1998 |
Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation.
Topics: Analysis of Variance; Animals; Drinking Behavior; Energy Metabolism; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Injections, Intraventricular; Male; Obesity; Peptide Fragments; Protein Precursors; Rats; Rats, Zucker | 1998 |
Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity.
Topics: Age Factors; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Reference Values; Sex Characteristics; Tumor Necrosis Factor-alpha | 1998 |
Lack of defect in insulin action on hepatic glycogen synthase and phosphorylase in insulin-resistant monkeys.
Topics: Adipose Tissue; Animals; Glucagon; Glucose Clamp Technique; Glycogen Synthase; Insulin; Insulin Resistance; Liver; Macaca mulatta; Male; Muscle, Skeletal; Obesity; Omentum; Phosphorylases | 1998 |
Physiological importance of first-phase insulin release in elderly patients with diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Liver; Obesity; Time Factors | 1998 |
The effect of glucose and glucagon-like peptide-1 stimulation on insulin release in the perfused pancreas in a non-insulin-dependent diabetes mellitus animal model.
Topics: Animals; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Secretion; Male; Obesity; Pancreas; Peptide Fragments; Perfusion; Protein Precursors; Rats; Sex Factors | 1998 |
Oral triacylglycerols regulate plasma glucagon-like peptide-1(7-36) and insulin levels in normal and especially in obese rats.
Topics: Administration, Oral; Animals; Blood Glucose; Corn Oil; Fatty Acids; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Glycerol; Insulin; Intubation, Gastrointestinal; Obesity; Peptide Fragments; Rats; Rats, Wistar; Reference Values; Triglycerides; Veins | 1999 |
Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity.
Topics: Adipose Tissue; Aged; Biomarkers; Body Mass Index; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Male; Middle Aged; Obesity; Reference Values; Tumor Necrosis Factor-alpha | 1998 |
Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus.
Topics: Calcium; Carrier Proteins; Cells, Cultured; Diabetes Mellitus; Gene Expression; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Leptin; Obesity; Peptide Fragments; Potassium Channels; Proinsulin; Protein Precursors; Proteins; Receptors, Cell Surface; Receptors, Leptin; RNA, Messenger | 1999 |
Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36)amide secretion by circulating non-esterified fatty acids.
Topics: Adult; Analysis of Variance; Area Under Curve; Case-Control Studies; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Heparin; Humans; Insulin; Models, Biological; Neurotransmitter Agents; Obesity; Peptide Fragments; Postprandial Period; Pyrazines; Triglycerides | 1999 |
The effect of circulating non-esterified fatty acids on the entero-insular axis.
Topics: Adult; Blood Glucose; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Heparin; Humans; Insulin; Intestines; Islets of Langerhans; Obesity; Peptide Fragments; Protein Precursors; Pyrazines | 1999 |
Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
Topics: Body Mass Index; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Fasting; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Obesity; Proinsulin; Radioimmunoassay | 1999 |
Linkage analysis of candidate obesity genes among the Mexican-American population of Starr County, Texas.
Topics: Adult; Anthropometry; Carrier Proteins; Case-Control Studies; Chromosome Mapping; Female; Gene Frequency; Genetic Variation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Ion Channels; Leptin; Male; Membrane Proteins; Mexican Americans; Microsatellite Repeats; Middle Aged; Mitochondrial Proteins; Neuropeptide Y; Obesity; Pedigree; Peptide Fragments; Protein Precursors; Proteins; Receptors, Cell Surface; Receptors, Glucagon; Receptors, Leptin; Receptors, Neuropeptide Y; Texas; Uncoupling Protein 1 | 1999 |
Peptides as drugs.
Topics: Anti-Bacterial Agents; Glucagon; Glucagon-Like Peptide 1; Growth Substances; Humans; Insulin; Interferons; Leptin; Obesity; Peptide Fragments; Peptides; Protein Precursors; Proteins | 1999 |
Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
Topics: Animals; Blood Glucose; Diabetes Mellitus; Dose-Response Relationship, Drug; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Kinetics; Macaca mulatta; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Peptide Fragments; Peptides; Protein Precursors; Rats; Rats, Zucker; Sequence Homology; Venoms | 1999 |
Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
Topics: Animals; Electrocardiography; Female; Glucagon; Gluconeogenesis; Glucose; Growth Hormone; Heart Rate; Infusions, Intravenous; Insulin; Insulin-Like Growth Factor I; Leptin; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle, Skeletal; Obesity; Proteins | 1999 |
The European Association for the Study of Diabetes Annual Meeting, 1998. Treatment of type 2 diabetes and the pathogenesis of complications.
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Peptide Fragments; Protein Precursors | 1999 |
Leptin increases circulating glucose, insulin and glucagon via sympathetic neural activation in fasted mice.
Topics: Animals; Blood Glucose; Body Weight; Eating; Fasting; Glucagon; Injections, Intraperitoneal; Insulin; Leptin; Mice; Mice, Inbred Strains; Obesity; Proteins | 1999 |
A new mouse model of spontaneous diabetes derived from ddY strain.
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Glucagon; Glycosuria; Hyperinsulinism; Hypertrophy; Immunohistochemistry; Inbreeding; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred Strains; Obesity; Pedigree; Pregnancy; Triglycerides | 1999 |
Serum glucagon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity.
Topics: Adult; Analysis of Variance; Cardiovascular Diseases; Case-Control Studies; Fatty Acids, Nonesterified; Female; Glomerular Filtration Rate; Glucagon; Glucose Tolerance Test; Glycoproteins; Hemodynamics; Humans; Hyperinsulinism; Immunoglobulin G; Insulin; Insulin Resistance; Kidney; Male; Membrane Glycoproteins; Middle Aged; Obesity; Proteinuria; Risk Factors; Trypsin Inhibitor, Kunitz Soybean | 1999 |
Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.
Topics: Animals; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; Male; Nitriles; Obesity; Osmolar Concentration; Peptide Fragments; Pyrrolidines; Rats; Rats, Zucker; Reference Values | 1999 |
Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity.
Topics: Animals; Cardiovascular Diseases; China; Diet, Vegetarian; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Liver; Male; Neoplasms; Obesity; Plant Proteins, Dietary; Puberty; Risk Factors; Weight Loss | 1999 |
Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Fats; Fatty Liver; Gene Expression; Glucagon; Glucose; Glucose Tolerance Test; Hyperinsulinism; Hyperplasia; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; RNA, Messenger | 2000 |
Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Topics: Amines; Animals; Appetite; Body Weight; Brain; Diabetes Mellitus; Drinking; Eating; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; In Situ Hybridization; Injections, Intraventricular; Injections, Subcutaneous; Male; Obesity; Peptide Fragments; Peptides; Rats; Rats, Wistar; Rats, Zucker; Receptors, Glucagon; RNA, Messenger; Venoms | 2000 |
Effects of early protein restriction and adult obesity on rat pancreatic hormone content and glucose tolerance.
Topics: Amyloid; Animals; Blood Glucose; Body Weight; Dietary Proteins; Female; Glucagon; Insulin; Islet Amyloid Polypeptide; Obesity; Organ Size; Pancreas; Pancreatic Hormones; Rats; Rats, Sprague-Dawley | 2000 |
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Constitution; Body Mass Index; Deuterium; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Male; Middle Aged; Obesity; Reference Values; Regression Analysis | 2000 |
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.
Topics: Animals; Base Sequence; CCAAT-Enhancer-Binding Proteins; DNA Primers; DNA-Binding Proteins; Gene Expression; Glucagon; Humans; In Vitro Techniques; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Lipodystrophy; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Mice, Transgenic; Models, Biological; Nuclear Proteins; Obesity; Phosphoproteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Transcription Factors | 2000 |
Hyperinsulinemia and glucagon serum concentrations influence renal hemodynamics and urinary protein loss in normotensive patients with central obesity.
Topics: Adult; Fatty Acids, Nonesterified; Glomerular Filtration Rate; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Immunoglobulin G; Kidney; Middle Aged; Obesity; Proteinuria | 2000 |
Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperinsulinism; Insulin; Leptin; Male; Middle Aged; Obesity; Peptide Fragments; Protein Precursors | 2000 |
Impaired neural regulation of insulin secretion related to the leptin receptor gene mutation in Wistar fatty rats.
Topics: Animals; Atropine Derivatives; Blood Glucose; Carrier Proteins; Crosses, Genetic; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Injections, Intraventricular; Insulin; Insulin Resistance; Insulin Secretion; Mutation; Obesity; Peptide Fragments; Protein Precursors; Rats; Rats, Inbred WKY; Rats, Zucker; Receptors, Cell Surface; Receptors, Leptin; Vagotomy; Vagus Nerve | 2000 |
Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
Topics: Animals; Calcium; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Peptide Fragments; Protein Precursors; Rats; Rats, Zucker | 2000 |
Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes.
Topics: Animals; Blood Glucose; Chromosome Mapping; Diabetes Mellitus, Type 2; Dietary Fats; Genetic Predisposition to Disease; Glucagon; Glucokinase; Insulin; Liver; Mice; Mice, Transgenic; Obesity; Reference Values; RNA, Messenger; Transgenes | 2001 |
Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects.
Topics: Adult; Anticoagulants; Blood Glucose; Dietary Carbohydrates; Dietary Fats; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Heparin; Humans; Insulin; Lipoprotein Lipase; Obesity; Peptide Fragments; Protein Precursors; Triglycerides | 2001 |
Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats.
Topics: Animals; Behavior, Animal; Body Composition; Body Temperature; Cholesterol; Drinking; Eating; Glucagon; Hypothalamus; Injections, Intraventricular; Insulin; Leptin; Male; Melanocyte-Stimulating Hormones; Motor Activity; Neurotransmitter Agents; Obesity; Pro-Opiomelanocortin; Rats; Rats, Wistar; Receptors, Corticotropin; Receptors, Melanocortin; RNA, Messenger; Signal Transduction | 2001 |
Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Endosomes; Gene Expression Regulation, Enzymologic; Glucagon; Golgi Apparatus; Growth Hormone; Hormones; Insulin; Isoenzymes; Liver; Male; Obesity; Phosphodiesterase Inhibitors; Pyridazines; Quinolones; Rats; Rats, Zucker; Subcellular Fractions | 2001 |
Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice.
Topics: Animals; Carboxypeptidase H; Carboxypeptidases; Chromatography, Gel; Diabetes Mellitus, Experimental; Furin; Glucagon; Glucagon-Like Peptide 1; Intestinal Mucosa; Mice; Mice, Mutant Strains; Obesity; Pancreas; Peptide Fragments; Proglucagon; Protein Precursors; Subtilisins; Tissue Extracts | 2001 |
Assessment of hepatic insulin action in obese type 2 diabetic patients.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver; Middle Aged; Obesity | 2001 |
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
Topics: Absorptiometry, Photon; Adult; Appetite; Area Under Curve; Energy Intake; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Obesity; Peptide Fragments; Postprandial Period; Satiation; Weight Loss | 2001 |
Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats.
Topics: Aging; Amyloid; Animals; Collagen; Diabetes Mellitus; Female; Glucagon; Insulin; Islet Amyloid Polypeptide; Islets of Langerhans; Male; Obesity; Pancreatic Polypeptide; Rats; Rats, Zucker; Somatostatin | 2001 |
Hepatothermic therapy of obesity: rationale and an inventory of resources.
Topics: Carnitine O-Palmitoyltransferase; Glucagon; Glucose; Humans; Hyperthermia, Induced; Insulin; Liver; Obesity; RNA, Messenger; Thermogenesis | 2001 |
Pancreatic beta-cells from obese-hyperglycemic mice are characterized by excessive firing of cytoplasmic Ca2+ transients.
Topics: Animals; Caffeine; Calcium; Cytoplasm; Glucagon; Hyperglycemia; Islets of Langerhans; Leptin; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Ryanodine; Signal Transduction; Type C Phospholipases | 2001 |
Nitric oxide induces synchronous Ca2+ transients in pancreatic beta cells lacking contact.
Topics: Animals; Calcium; Cytoplasm; Glucagon; Hydroxylamine; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Obesity; Periodicity; Signal Transduction | 2001 |
Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
Topics: Animals; Blood Glucose; Body Weight; Defecation; Diuresis; Dose-Response Relationship, Drug; Drinking; Drug Administration Schedule; Eating; Energy Metabolism; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Lipids; Liraglutide; Male; Obesity; Peptide Fragments; Protein Precursors; Rats; Rats, Wistar; Reference Values; Time Factors | 2001 |
Plasma glucagon and free fatty acid responses to a glucose load in the obese spontaneous hypertensive rat (SHROB) model of metabolic syndrome X.
Topics: Animals; Fatty Acids; Glucagon; Glucose; Glucose Tolerance Test; Metabolic Syndrome; Obesity; Rats; Rats, Inbred SHR | 2002 |
Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet.
Topics: Adaptation, Physiological; Adipose Tissue, Brown; Animals; Blood Glucose; Diabetes Mellitus; Dietary Fats; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Myocardium; Obesity; RNA, Messenger; Weight Gain | 2002 |
Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Insulin Resistance; Liver; Male; Middle Aged; Obesity; Somatostatin | 2002 |
GLP-1 as a satiety factor in children with eating disorders.
Topics: Adolescent; Anorexia Nervosa; Blood Glucose; Fasting; Feeding and Eating Disorders; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Obesity; Peptide Fragments; Protein Precursors; Satiation | 2002 |
Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Drinking; Eating; Fatty Acids, Nonesterified; Gene Expression; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Humans; Insulin; Male; Nitriles; Obesity; Pancreas; Peptide Fragments; Protease Inhibitors; Protein Precursors; Pyrrolidines; Rats; Rats, Zucker; Receptors, Glucagon; Triglycerides; Weight Gain | 2002 |
[Glucagon producing adenomatosis of Islands of Langerhans with polyendocrine symptoms].
Topics: Adipose Tissue; Adrenal Cortex; Adrenal Glands; Adult; Calcinosis; Cholecystectomy; Cushing Syndrome; Diabetes Complications; Gastrins; Glucagon; Humans; Hyperplasia; Islets of Langerhans; Male; Multiple Endocrine Neoplasia; Necrosis; Obesity; Pancreas; Zollinger-Ellison Syndrome | 1976 |
Organismic states and their effect on recovery from neurosurgery: a new perspective with implications for a general theory.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Castration; Female; Fenclonine; Glucagon; Hippocampus; Hypothalamus; Insulin; Lighting; Male; Maternal-Fetal Exchange; Models, Biological; Neurosurgery; Nutrition Disorders; Obesity; Pregnancy; Rats | 1978 |
Effects of insulin, tolbutamide, and glucagon on activities of jejunal carbohydrate-metabolizing enzymes in humans.
Topics: Adolescent; Adult; Carbohydrate Metabolism; Fructose-Bisphosphatase; Fructose-Bisphosphate Aldolase; Glucagon; Glycolysis; Hexokinase; Humans; Insulin; Jejunum; Male; Middle Aged; Obesity; Phosphofructokinase-1; Pyruvate Kinase; Species Specificity; Tolbutamide | 1975 |
The effect of fasting on tissue cyclic cAMP and plasma glucagon in the obese hyperglycemic mouse.
Topics: Animals; Body Weight; Cyclic AMP; Fasting; Female; Glucagon; Hyperglycemia; Liver Glycogen; Mice; Obesity | 1975 |
Insulin and glucagon-receptor interactions in the genetically obese Zucker rat: studies of hormone binding and glucagon-stimulated cyclic AMP levels in isolated hepatocytes.
Topics: Animals; Cyclic AMP; Dose-Response Relationship, Drug; Fasting; Female; Glucagon; Insulin; Liver; Obesity; Rats; Receptor, Insulin; Receptors, Cell Surface; Time Factors | 1977 |
Serum hormone levels and tissue metabolism in pair-fed lean and obese Zucker rats.
Topics: Adipose Tissue; Alanine; Animals; Cyclic AMP; Fatty Acids; Female; Glucagon; Gluconeogenesis; Glycolysis; Growth Hormone; Insulin; Kidney; Liver; Male; Obesity; Organ Size; Prolactin; Rats; Sex Factors | 1977 |
Urinary and plasma cyclic AMP levels during short term starvation in obese man: response to glucagon stimulation.
Topics: Adult; Cyclic AMP; Fasting; Glucagon; Humans; Insulin; Obesity | 1978 |
The effect of induced hyperglucagonaemia on the Zucker fatty rat.
Topics: Adenosine Triphosphatases; Adenylyl Cyclases; Animals; Blood Glucose; Cell Membrane; Glucagon; Insulin; Lipids; Liver; Male; Nucleotidases; Obesity; Rats; Receptors, Cell Surface | 1978 |
Influence of genetic obesity in mice on the lipolytic response of isolated adipocytes to isoproterenol and ACTH-(1-24).
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Animals; Cell Count; Glucagon; Glycerol; Isoproterenol; Lipid Metabolism; Male; Mice; Mice, Obese; Obesity; Triglycerides | 1978 |
The influence of obesity and diabetes in the monkey on insulin and glucagon binding to liver membranes.
Topics: Animals; Cell Membrane; Diabetes Mellitus; Diabetes Mellitus, Experimental; Glucagon; Haplorhini; Hypothalamus; Insulin; Kinetics; Liver; Macaca mulatta; Male; Obesity; Receptor, Insulin; Receptors, Cell Surface | 1979 |
The influence of glucagon on sodium retention after fasting.
Topics: Adolescent; Adult; Alanine; Diet; Fasting; Female; Glucagon; Glucose; Humans; Middle Aged; Obesity; Sodium | 1977 |
Factors influencing insulin and glucagon secretion in lean and genetically obese mice.
Topics: Animals; Arginine; Epinephrine; Glucagon; Glucose; Immune Sera; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Obesity | 1977 |
Involvement of a humoral factor in regulation of body weight in parabiotic rats.
Topics: Animals; Blood Glucose; Body Composition; Body Weight; Electric Stimulation; Feeding Behavior; Female; Glucagon; Hormones; Hypothalamus; Insulin; Islets of Langerhans; Obesity; Parabiosis; Rats | 1977 |
Glucose suppression of glucagon: relationship to pancreatic beta cell function?
Topics: Adult; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Male; Obesity | 1977 |
[A new beta cell efficiency test in the islands of Langerhans].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Obesity; Tolbutamide | 1977 |
Comparison of metabolic alterations in hypothalamic and high fat diet-induced obesity.
Topics: Animals; Blood Glucose; Denervation; Dietary Fats; Female; Glucagon; Hypothalamus; Insulin; Islets of Langerhans; Mathematics; Models, Biological; Obesity; Rats | 1977 |
Insulin and glucagon: plasma levels and pancreatic release in the genetically obese Zucker rat.
Topics: Animals; Blood Glucose; Body Weight; Dietary Carbohydrates; Dietary Fats; Female; Glucagon; Insulin; Islets of Langerhans; Male; Obesity; Rats | 1977 |
Alteration of islet cell populations in spontaneously diabetic mice.
Topics: Animals; Diabetes Mellitus; Disease Models, Animal; Fluorescent Antibody Technique; Glucagon; Insulin; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Peptides; Somatostatin | 1978 |
Correlation between morphology and function in isolated islets of the Zucker rat.
Topics: Aminophylline; Animals; Arginine; Glucagon; Glucose; Homozygote; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Rats | 1979 |
[Glucagon secretion in obesity].
Topics: Blood Glucose; Glucagon; Humans; Insulin; Islets of Langerhans; Obesity; Somatostatin | 1979 |
Metabolic and behavioral differences between dieting and intestinal bypass.
Topics: Blood Glucose; Body Weight; Diet, Reducing; Feeding Behavior; Female; Glucagon; Glycerol; Humans; Insulin; Intestine, Small; Male; Obesity; Pancreatic Polypeptide; Self-Assessment | 1979 |
Perfused liver carnitine palmitoyl-transferase activity and ketogenesis in streptozotocin treated and genetic hyperinsulinemic rats. Effect of glucagon.
Topics: Acyltransferases; Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Experimental; Glucagon; Hyperinsulinism; In Vitro Techniques; Insulin; Ketone Bodies; Mitochondria, Liver; Obesity; Perfusion; Rats | 1979 |
[Changes of the lipid pattern and the insulin/glucagon ratio after a high-protein meal in normal and diabetic subjects].
Topics: Adult; Aged; Diabetes Mellitus; Dietary Proteins; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Lipids; Middle Aged; Obesity | 1979 |
Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
Topics: Adult; Arginine; Blood Glucose; Diabetes Mellitus; Diet, Diabetic; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Obesity; Receptor, Insulin | 1979 |
[Some aspects of the dynamic behavior of IRI in obesity and in diabetes mellitus].
Topics: Adult; Aged; Aminophylline; Antigens; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Obesity; Propranolol | 1979 |
[Behavior of glucagonemia in hyperglycemia and hypoglycemia conditions provoked in obese children by means of oral load of normal and pathological doses of glucose].
Topics: Age Factors; Child; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemia; Injections, Intravenous; Insulin; Male; Obesity | 1979 |
Influence of glucose, insulin, and glucagon on sodium balance in fasting obese subjects.
Topics: Blood Glucose; Fasting; Glucagon; Humans; Insulin; Kidney; Natriuresis; Obesity | 1979 |
Suppression of insulin secretion by protein deprivation in obesity.
Topics: 17-Hydroxycorticosteroids; Adult; Blood Glucose; Dietary Carbohydrates; Dietary Proteins; Female; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Secretion; Male; Obesity; Time Factors | 1979 |
[Preliminary considerations on the behavior of single plasmatic free fatty acids in obese subjects exposed to lipolytic stimulus before and after a period of caloric restriction].
Topics: Adult; Diet, Reducing; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Obesity | 1979 |
[Effect of ergot alkaloids on lipolysis and on glucagon-induced insulin secretion in normal and obese subjects].
Topics: Adult; Dihydroergotoxine; Female; Glucagon; Humans; Insulin; Insulin Secretion; Lipid Metabolism; Male; Middle Aged; Obesity | 1977 |
[Diazoxide in the treatment of obesity].
Topics: Diazoxide; Dietary Proteins; Fenfluramine; Furosemide; Glucagon; Humans; Obesity; Triiodothyronine | 1977 |
The Staub-Traugott phenomenon. III. Effects of starvation.
Topics: Adult; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Lactates; Male; Middle Aged; Obesity; Starvation | 1978 |
Oxidation of an exogenous glucose load using naturally labelled 13C-glucose. Effect of butylbiguanide therapy in obese mildly diabetic subjects.
Topics: Adult; Biguanides; Blood Glucose; Buformin; Carbon Dioxide; Carbon Isotopes; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Male; Middle Aged; Obesity | 1978 |
Reduced triglyceride secretion: a metabolic consequence of chronic exercise.
Topics: Animals; Body Weight; Disease Models, Animal; Female; Glucagon; Hyperlipidemias; Insulin; Lipid Metabolism; Liver; Obesity; Physical Exertion; Rats; Rats, Inbred Strains; Thinness; Triglycerides | 1978 |
[Diet and insulin resistance].
Topics: Adult; Cell Membrane; Diabetes Mellitus; Diet, Reducing; Fatty Acids, Unsaturated; Glucagon; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Receptor, Insulin | 1978 |
Somatostatin in maturity-onset diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Insulin; Middle Aged; Obesity; Somatostatin | 1978 |
[Insulin resistance not due to antibodies].
Topics: Blood Glucose; Glucagon; Humans; Hyperlipidemias; Insulin; Insulin Resistance; Obesity; Triglycerides | 1978 |
[Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients].
Topics: Adult; Arginine; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Male; Obesity; Stimulation, Chemical | 1978 |
[Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese diabetics].
Topics: Arginine; Blood Glucose; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Obesity; Stimulation, Chemical | 1978 |
[Physiolopathologic aspects of diabetic ketosis and the ketosis of fasting].
Topics: Acetoacetates; Acidosis; Blood Glucose; Diabetic Ketoacidosis; Fasting; Fatty Acids, Nonesterified; Glucagon; Humans; Hydroxybutyrates; Insulin; Ketone Bodies; Ketosis; Liver; Obesity | 1976 |
Intestinal adaptation after jejunoileal bypass in man.
Topics: Bile Acids and Salts; Cholesterol; Duodenum; Energy Intake; Gastric Juice; Gastrins; Glucagon; Glucose; Humans; Ileum; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Jejunum; Obesity; Oxalates; Phospholipids; Vitamin B 12 | 1977 |
Glucagon response to arginine stimulation in obese and diabetic children.
Topics: Adolescent; Arginine; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucagon; Growth Hormone; Humans; Male; Obesity | 1977 |
Elevated serum enteroglucagon after jejunoileal bypass.
Topics: Animals; Glucagon; Glucose; Humans; Ileum; Intestine, Small; Jejunum; Obesity | 1977 |
Lack of a simple relationship between endogenous growth hormone and NSILA-s related peptides.
Topics: Adult; Animals; Binding, Competitive; Biological Assay; Cell Membrane; Dihydroxyphenylalanine; Estrogens; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Kinetics; Liver; Male; Nonsuppressible Insulin-Like Activity; Obesity; Pregnancy; Radioligand Assay; Rats; Starvation | 1977 |
Short-term hormonal control of hepatic carbohydrate and lipid catabolism.
Topics: Angiotensin II; Animals; Diabetes Mellitus; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerides; Hormones; Insulin; Liver; Liver Glycogen; Nucleotides, Cyclic; Obesity; Oxytocin; Parathyroid Hormone; Protein Kinases; Starvation; Stress, Physiological; Vasopressins | 1977 |
Immunoreactive glucagon levels in obese-hyperglycemic (ob/ob) mice.
Topics: Animals; Arginine; Blood Glucose; Drug Synergism; Fasting; Glucagon; Glucose; Hyperglycemia; Insulin; Male; Mice; Mice, Obese; Obesity; Phenotype | 1977 |
Turnover and recycling of glucose in man during prolonged fasting.
Topics: Adult; Blood Glucose; Carbon; Carbon Radioisotopes; Fasting; Female; Glucagon; Glucose; Humans; Insulin; Male; Middle Aged; Obesity; Radioimmunoassay; Tritium | 1977 |
Glucagon, insulin and glucose response to physiologic testing in normal and massively obese adults.
Topics: Adult; Amino Acids; Arginine; Circadian Rhythm; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Obesity; Time Factors | 1977 |
[Levels of glucagon and insulin in the blood of obese children].
Topics: Adolescent; Child; Glucagon; Humans; Insulin; Obesity | 1977 |
Clofibrate-induced changes in glucagon and insulin secretion in patients with angiographically documented coronary artery disease.
Topics: Adult; Arginine; Clofibrate; Coronary Disease; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity | 1977 |
[Metabolic differences between males and females and between normal and obese subjects during total fast].
Topics: Adult; Blood Glucose; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Insulin; Ketone Bodies; Male; Obesity; Sex Factors | 1976 |
[Value of the method of Cerasi and Luft in checking the progression of metabolic disorders in childhood].
Topics: Blood Glucose; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diet, Diabetic; Glucagon; Humans; Insulin; Insulin Secretion; Obesity | 1976 |
Acute effect of ascorbic acid infusion on carbohydrate tolerance.
Topics: Ascorbic Acid; Blood Glucose; Carbohydrate Metabolism; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Obesity | 1976 |
Effect of 24 hour fast in obese children.
Topics: Adolescent; Alanine; Blood Glucose; Child; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Insulin; Isoleucine; Ketone Bodies; Leucine; Male; Obesity; Valine | 1976 |
The comparison of glucose- and glucagon-induced insulin release in obese and nonobese subjects.
Topics: Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Obesity | 1976 |
[Somatotropic response to a propranolol-glucagon test].
Topics: Child; Glucagon; Growth Disorders; Growth Hormone; Humans; Hypothyroidism; Obesity; Pituitary Gland; Propranolol | 1976 |
Kinetics of glucagon in man: effects of starvation.
Topics: Adult; Blood Glucose; Fasting; Female; Glucagon; Humans; Insulin; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Obesity | 1976 |
[The role of islets of Langerhans in the utilization of energy-providing and structural substrates of food].
Topics: Adult; Age Factors; Diabetes Mellitus; Glucagon; Humans; Infant; Infant, Newborn; Insulin; Insulin Secretion; Islets of Langerhans; Obesity | 1975 |
Hormone-substrate responses to total fasting in lean and obese mice.
Topics: Adaptation, Physiological; Animals; Blood Glucose; Fasting; Genotype; Glucagon; Gluconeogenesis; Insulin; Islets of Langerhans; Ketone Bodies; Lipid Mobilization; Liver Glycogen; Mice; Mice, Inbred C57BL; Obesity; Proteins; Radioimmunoassay; Seasons | 1975 |
What's new for diabetes?
Topics: Adolescent; Adult; Aged; Diabetes Mellitus; Female; Glucagon; Glycosuria; Humans; Insulin; Male; Middle Aged; Obesity; Tolbutamide | 1975 |
Effect of alanine and glycine on glucagon secretion in postabsorptive and fasting obese man.
Topics: Adolescent; Adult; Alanine; Blood Glucose; Fasting; Female; Glucagon; Glycine; Humans; Insulin; Male; Obesity; Stimulation, Chemical; Time Factors | 1975 |
[Insulin secretion in obese and diabetic children evaluated with venous perfusion of glucose and stimulation with glucagon. preliminary data].
Topics: Child; Child, Preschool; Diabetes Mellitus, Type 1; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Obesity; Prediabetic State | 1975 |
Altered tissue response to glucagon in obesity.
Topics: Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hydroxybutyrates; Insulin; Obesity; Time Factors | 1975 |
Effect of ketone infusions on amino acid and nitrogen metabolism in man.
Topics: Adult; Alanine; Amino Acids; Blood Glucose; Fasting; Female; Glucagon; Humans; Hydroxybutyrates; Infusions, Parenteral; Insulin; Ketones; Male; Nitrogen; Obesity | 1975 |
[Dynamics of GH secretion in essential obesity when is stimulated by glucagon].
Topics: Adolescent; Adrenal Gland Diseases; Adrenal Glands; Adult; Child; Female; Glucagon; Growth Hormone; Humans; Injections, Subcutaneous; Male; Middle Aged; Obesity; Pituitary Gland; Pituitary Gland, Anterior; Stimulation, Chemical | 1975 |
Effect of physical exercise on secretion of growth hormone, glucagon, and cortisol in obese and diabetic children.
Topics: Adolescent; Blood Glucose; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Male; Obesity; Physical Exertion | 1975 |
Development of brown and white adipose tissue.
Topics: Adaptation, Physiological; Adipose Tissue; Adipose Tissue, Brown; Animals; Animals, Newborn; Catecholamines; Cold Temperature; Fatty Acids; Female; Glucagon; Glycerol; Glycolysis; Humans; Infant, Newborn; Lactation; Lipid Metabolism; Male; Obesity; Oxidation-Reduction; Pregnancy | 1975 |
Nitrogen loss in normal and obese subjects during total fast.
Topics: Amino Acids; Blood Glucose; Body Height; Body Weight; Energy Metabolism; Fasting; Female; Glucagon; Gluconeogenesis; Humans; Male; Nitrogen; Obesity; Proteins; Sex Factors; Time Factors | 1975 |
Glucagon and insulin from lean rats and genetically obese fatty rats: studies by radioimmunoassay, radioreceptorassay and bioassay.
Topics: Adenylyl Cyclases; Adipose Tissue; Animals; Biological Assay; Cell Membrane; Glucagon; Glucose; Insulin; Liver; Mice; Mice, Obese; Obesity; Proinsulin; Radioimmunoassay; Radioligand Assay; Rats | 1975 |
The contribution of endogenous insulin secretion to the ketogenic response to glucagon in man.
Topics: Adipose Tissue; Adult; Body Weight; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hydroxybutyrates; Insulin; Insulin Secretion; Ketone Bodies; Liver; Male; Obesity | 1975 |
[Behavior of blood somatotropin after intramuscular administration of glucagon in prepuberal obese subjects].
Topics: Adolescent; Age Factors; Child; Glucagon; Growth Hormone; Humans; Injections, Intramuscular; Male; Obesity | 1975 |
[Clucagon].
Topics: Blood Glucose; Diabetes Mellitus; Glucagon; Growth Hormone; Humans; Hypoglycemia; Hypopituitarism; Insulin; Obesity; Radioimmunoassay | 1975 |
Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glucagon; Homeostasis; Humans; Infusions, Parenteral; Insulin; Male; Middle Aged; Obesity | 1976 |
Endogenous glucagon regulation in genetically hyperlipemic obese rats.
Topics: Animals; Arginine; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Glucose; Hyperlipidemias; Insulin; Male; Nitrogen; Obesity; Rats; Triglycerides | 1976 |
Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon.
Topics: Blood Glucose; Diabetes Mellitus; Female; Gastrectomy; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Male; Obesity | 1976 |
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Eating; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Infusion Systems; Insulin Secretion; Male; Middle Aged; Obesity; Peptide Fragments; Peptides; Somatostatin | 1992 |
Alterations in G-protein expression, Gi function and stimulatory receptor-mediated regulation of adipocyte adenylyl cyclase in a model of insulin-resistant diabetes with obesity.
Topics: Adenylyl Cyclases; Adipose Tissue; Animals; Cell Membrane; Cells, Cultured; Colforsin; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; GTP-Binding Proteins; Isoproterenol; Magnesium; Mice; Mice, Inbred CBA; Obesity; Secretin | 1992 |
Resistance to ketosis in moderately obese patients: influence of fatty liver.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Glycerol; Humans; Hydroxybutyrates; Immunity, Innate; Insulin; Ketone Bodies; Ketosis; Male; Obesity; Time Factors | 1992 |
Increase of beta-endorphin serum levels by human corticotropin-releasing factor does not affect beta-cell function in overweight women.
Topics: Adult; beta-Endorphin; Blood Glucose; Corticotropin-Releasing Hormone; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Middle Aged; Obesity | 1992 |
Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
Topics: Adult; Amyloid; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Islet Amyloid Polypeptide; Male; Middle Aged; Obesity; Radioimmunoassay; Reference Values | 1992 |
Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels.
Topics: Abdomen; Adipose Tissue; Adult; Analysis of Variance; Anthropometry; Blood Glucose; Body Mass Index; Cholesterol; Cholesterol, HDL; Glucagon; Glucose Tolerance Test; Humans; Insulin; Lipoproteins; Male; Obesity; Reference Values; Regression Analysis; Triglycerides | 1992 |
A morphological and immunohistochemical investigation of endocrine pancreata from obese ob+/ob+ mice.
Topics: Animals; Blood Glucose; Gastric Inhibitory Polypeptide; Glucagon; Immunoenzyme Techniques; Insulin; Islets of Langerhans; Mice; Mice, Obese; Obesity; Reference Values; Somatostatin | 1991 |
Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects.
Topics: Adult; beta-Endorphin; Blood Glucose; Body Weight; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Kinetics; Male; Obesity; Reference Values | 1992 |
Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Liver Glycogen; Male; Obesity; Reference Values | 1992 |
Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
Topics: Adult; Arginine; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Obesity; Reference Values | 1991 |
Basal energy expenditure in obese and normal weight schoolchildren.
Topics: Age Factors; Basal Metabolism; Body Composition; Calorimetry, Indirect; Child; Energy Metabolism; Female; Glucagon; Humans; Insulin; Italy; Male; Obesity; Oxidation-Reduction; Predictive Value of Tests; Regression Analysis | 1991 |
Importance of glucagon as a determinant of resting metabolic rate and glucose-induced thermogenesis in obese women.
Topics: Adult; Body Temperature Regulation; Female; Glucagon; Humans; Obesity; Regression Analysis; Rest | 1991 |
Alterations in G-protein expression and the hormonal regulation of adenylate cyclase in the adipocytes of obese (fa/fa) Zucker rats.
Topics: Adenylyl Cyclases; Adipose Tissue; Animals; Cell Membrane; Cells, Cultured; Glucagon; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Isoproterenol; Kinetics; Macromolecular Substances; Male; Obesity; Rats; Rats, Zucker; Secretin; Thyrotropin | 1991 |
The effect of high-fibre diet on plasma lipoproteins and hormones in genetically obese Zucker rats.
Topics: Animals; Blood Glucose; Cholesterol; Dietary Fiber; Glucagon; Insulin; Lipoproteins; Obesity; Rats; Rats, Zucker | 1990 |
Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity.
Topics: Adipose Tissue; Adult; Fatty Acids, Nonesterified; Female; Forearm; Glucagon; Humans; Insulin; Lipids; Lipolysis; Obesity; Palmitic Acid; Palmitic Acids | 1991 |
Persistence of altered metabolic responses to beta-endorphin after normalization of body weight in human obesity.
Topics: Adult; beta-Endorphin; Blood Glucose; Body Weight; C-Peptide; Female; Glucagon; Humans; Insulin; Kinetics; Male; Obesity | 1991 |
[Plasma levels of beta-endorphin in obese subjects with normal glucose tolerance test and in diabetics].
Topics: Adult; beta-Endorphin; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Obesity | 1991 |
Hyperinsulinemia in Macaca nigra: precession to obesity and/or diabetes?
Topics: Animals; Blood Glucose; Body Mass Index; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Hyperinsulinism; Insulin; Macaca; Male; Monkey Diseases; Obesity | 1990 |
Glucagon in women with polycystic ovary syndrome (PCO): relationship to abnormalities of insulin and androgens.
Topics: Adult; Androgens; Androstenedione; Blood Glucose; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans.
Topics: Adult; Blood Glucose; Body Temperature Regulation; C-Peptide; Energy Metabolism; Epinephrine; Female; Glucagon; Glucose; Humans; Insulin; Male; Middle Aged; Norepinephrine; Obesity; Sympathetic Nervous System; Weight Loss | 1990 |
Impaired plasma catecholamine response to submaximal treadmill exercise in obese women.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Blood Pressure; Body Temperature; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glycated Hemoglobin; Growth Hormone; Heart Rate; Hematocrit; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Lactates; Norepinephrine; Obesity; Oxygen; Physical Exertion; Reference Values | 1990 |
Glucose tolerance and insulin response in normal-weight and obese cats.
Topics: Animals; Blood Glucose; Cat Diseases; Cats; Female; Glucagon; Glucose Tolerance Test; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Obesity; Radioimmunoassay; Time Factors | 1990 |
No change of beta-endorphin plasma levels during hyperglycemic glucose clamping in obese patients and lean controls.
Topics: Adult; beta-Endorphin; Body Mass Index; Female; Glucagon; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Obesity | 1990 |
Endogenous insulin secretion in newly diagnosed diabetic patients in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus; Fasting; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Saudi Arabia | 1990 |
Amylase/creatinine clearance ratio response to hyperglucagonemia in diabetes and obesity.
Topics: Adult; Amylases; Creatinine; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Male; Metabolic Clearance Rate; Obesity | 1986 |
Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
Topics: Blood Glucose; C-Peptide; Carbon Dioxide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Eating; Female; Glucagon; Glucose; Humans; Insulin; Insulin, Long-Acting; Lipid Metabolism; Liver; Male; Middle Aged; Obesity | 1989 |
Effect of dietary carbohydrates on insulin and glucagon receptors in a new model of noninsulin-dependent diabetes-SHR/N-corpulent rat.
Topics: Animals; Blood Glucose; Cell Membrane; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Glucagon; Insulin; Obesity; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptor, Insulin; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Starch; Sucrose; Triglycerides | 1989 |
Multiple defects occur in the guanine nucleotide regulatory protein system in liver plasma membranes of obese (fa/fa) but not lean (Fa/Fa) Zucker rats: loss of functional Gi and abnormal Gs function.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Blotting, Western; Cell Membrane; Cholera Toxin; Colforsin; Diabetes Mellitus, Experimental; Glucagon; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Insulin Resistance; Liver; Male; NAD; Obesity; Pertussis Toxin; Phosphorus Radioisotopes; Rats; Rats, Inbred Strains; Rats, Zucker; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Virulence Factors, Bordetella | 1989 |
Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Infusion Systems; Insulin Resistance; Male; Norepinephrine; Obesity | 1989 |
Circulating amino acids and pancreatic endocrine function after ingestion of a protein-rich meal in obese subjects.
Topics: Adult; Amino Acids; Blood Glucose; Dietary Proteins; Female; Glucagon; Humans; Insulin; Male; Obesity; Pancreas; Pancreatic Polypeptide | 1989 |
Metformin treatment of lean and obese Zucker rats modulates the ability of glucagon and insulin to regulate hepatocyte adenylate cyclase activity.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cell Membrane; Enzyme Activation; Glucagon; Insulin; Liver; Male; Metformin; Obesity; Rats; Rats, Zucker | 1989 |
Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Kuwait; Lipids; Obesity; Reference Values; Sex Hormone-Binding Globulin; Triglycerides | 1989 |
Plasma glucagon response to intravenous alanine in obese and non-obese subjects.
Topics: Alanine; Fatty Acids; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Obesity; Weight Loss | 1989 |
Peptide and steroid hormones in subjects at different risk for diet-related diseases.
Topics: beta-Endorphin; Cholecystokinin; Cholesterol; Coronary Disease; Diet; Diet, Vegetarian; Dietary Fiber; Female; Gastrins; Glucagon; Humans; Insulin; Lipids; Middle Aged; Neoplasms; Obesity; Risk Factors | 1988 |
Pancreatic islet hormone response to oral glucose in morbidly obese patients.
Topics: Adult; Blood Glucose; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Obesity; Pancreatic Polypeptide; Somatostatin | 1985 |
Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
Topics: Adult; Blood Glucose; Female; Food; Glucagon; Humans; Insulin; Male; Middle Aged; Obesity; Pancreas; Peptides; Somatostatin; Stomach; Time Factors | 1985 |
Relationship between lipogenesis, ketogenesis, and malonyl-CoA content in isolated hepatocytes from the obese Zucker rat adapted to a high-fat diet.
Topics: Acetyl-CoA Carboxylase; Acyl Coenzyme A; Animals; Dietary Fats; Glucagon; In Vitro Techniques; Ketone Bodies; Lactates; Lipids; Liver; Male; Malonyl Coenzyme A; Obesity; Oleic Acid; Oleic Acids; Pyruvates; Rats; Rats, Zucker | 1985 |
[Pancreatic incretory function in the hypothalamic puberty syndrome].
Topics: Adolescent; Adult; Female; Glucagon; Humans; Hyperinsulinism; Hypothalamic Diseases; Insulin Antibodies; Islets of Langerhans; Male; Obesity; Puberty; Somatostatin; Syndrome | 1986 |
Comparative hormonal profile of two newly developed obese congenic rat strains.
Topics: Animals; Corticosterone; Dietary Carbohydrates; Glucagon; Growth Hormone; Hormones; Insulin; Male; Obesity; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Reference Values; Species Specificity | 1988 |
Somatostatin response to glucose before and after prolonged fasting in lean and obese non-diabetic subjects.
Topics: Adult; Blood Glucose; Body Weight; Chromatography, Gel; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Male; Obesity; Somatostatin | 1988 |
Two compartment pharmacodynamics of somatostatin in non-obese non-insulin-dependent diabetes.
Topics: Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Half-Life; Humans; Insulin; Male; Middle Aged; Obesity; Somatostatin | 1987 |
Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
Topics: Adult; beta-Endorphin; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endorphins; Glucagon; Humans; Hyperglycemia; Infusions, Intravenous; Middle Aged; Obesity | 1987 |
Glucagon and insulin response to meals in non-obese and obese Dutch women.
Topics: Adult; beta-Endorphin; Dietary Carbohydrates; Dietary Fats; Female; Food; Glucagon; Humans; Insulin; Netherlands; Obesity | 1987 |
Sensitivity to beta-endorphin as a cause of human obesity.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Naloxone; Obesity | 1987 |
Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Humans; Infusions, Intravenous; Insulin; Male; Obesity | 1988 |
Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
Topics: Adenylyl Cyclases; Adult; Aged; Animals; Enzyme Activation; Female; Glucagon; Humans; In Vitro Techniques; Kinetics; Liver; Male; Membranes; Middle Aged; Molecular Weight; Obesity; Rats; Receptors, Cell Surface; Receptors, Glucagon; Species Specificity | 1985 |
Hypothalamic control of lipid metabolism.
Topics: Animals; beta-Endorphin; Cholecystokinin; Eating; Endorphins; Glucagon; Humans; Hypothalamic Diseases; Insulin; Intestinal Absorption; Lipid Mobilization; Lipids; Lipolysis; Obesity; Pro-Opiomelanocortin; Receptors, Opioid; Satiety Response; Vagus Nerve | 1985 |
Impaired pancreatic polypeptide response to insulin hypoglycemia in obese subjects.
Topics: Adrenocorticotropic Hormone; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Male; Obesity; Pancreatic Polypeptide | 1985 |
Genetic obesity and dietary sucrose decrease hepatic glucagon and insulin receptors in LA/N-corpulent rats.
Topics: Animals; Body Weight; Dietary Carbohydrates; Glucagon; Glucosephosphate Dehydrogenase; Insulin; Liver; Obesity; Organ Size; Rats; Rats, Inbred Strains; Receptor, Insulin; Receptors, Cell Surface; Receptors, Glucagon; Sucrose | 1986 |
Abnormal regulation of insulin secretion in the genetically obese (ob/ob) mouse.
Topics: Animals; Calcium; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Species Specificity | 1986 |
Effect of dietary carbohydrates on glucagon and insulin receptors in genetically obese female Zucker rats.
Topics: Animals; Cell Membrane; Dietary Carbohydrates; Female; Glucagon; Insulin; Liver; Obesity; Rats; Rats, Inbred Strains; Receptor, Insulin; Receptors, Gastrointestinal Hormone; Receptors, Glucagon | 1987 |
First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity | 1988 |
Glucagon response to insulin-induced hypoglycemia in obese men.
Topics: Glucagon; Humans; Hypoglycemia; Insulin; Male; Obesity | 1988 |
Sparteine sulfate prevalently stimulates B rather than A cell secretion in obese subjects.
Topics: Adult; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Middle Aged; Obesity; Sparteine | 1988 |
Blood levels of insulin, glucagon and gastrin following intravenous and oral glucose administration in children with simple obesity.
Topics: Administration, Oral; Adolescent; Child; Female; Gastrins; Glucagon; Glucose; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Male; Obesity | 1988 |
Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.
Topics: Blood Glucose; Blood Urea Nitrogen; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Energy Metabolism; Epinephrine; Female; Glucagon; Glyburide; Glycosuria; Humans; Insulin; Male; Middle Aged; Norepinephrine; Obesity | 1988 |
[Insulin therapy of obese diabetic patients? Consequences for the evaluation of insulin secretion and metabolic behavior].
Topics: Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Energy Metabolism; Female; Glucagon; Glucose Tolerance Test; Glyburide; Humans; Insulin; Male; Middle Aged; Obesity | 1987 |
[The effect of physical activity in obese subjects on the levels of cortisol, glucagon and beta-endorphins in the blood].
Topics: Adult; beta-Endorphin; Endorphins; Female; Glucagon; Humans; Hydrocortisone; Obesity; Physical Exertion | 1985 |
The regulation of adenylate cyclase in liver membranes of lean and obese mice.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Cell Membrane; Cholera Toxin; Enzyme Activation; Glucagon; Guanosine Triphosphate; Isoproterenol; Liver; Magnesium; Magnesium Chloride; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Obesity; Pertussis Toxin; Propranolol; Virulence Factors, Bordetella; Yohimbine | 1988 |
Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
Topics: Basal Metabolism; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Reducing; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Liver; Male; Middle Aged; Obesity; Pancreas | 1988 |
Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Infusions, Intravenous; Insulin; Liver; Male; Middle Aged; Obesity | 1988 |
Interrelationships between dietary carbohydrates, B cell function and rate of ketogenesis during underfeeding in obese patients.
Topics: Adult; Blood Glucose; C-Peptide; Diet, Reducing; Dietary Carbohydrates; Energy Intake; Fasting; Female; Glucagon; Humans; Insulin; Ketone Bodies; Male; Obesity | 1987 |
Gastric inhibitory polypeptide, dietary-induced thermogenesis, and obesity.
Topics: Blood Glucose; Body Temperature; Body Temperature Regulation; Diet; Female; Gastric Inhibitory Polypeptide; Glucagon; Humans; Hydrocortisone; Insulin; Male; Obesity; Oxygen Consumption; Skin Temperature; Thyroid Hormones | 1987 |
Association of serum lipids and lipoproteins with plasma C-peptide concentration in non-insulin-dependent diabetic and non-diabetic subjects.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Secretion; Lipids; Lipoproteins; Male; Middle Aged; Obesity | 1987 |
[Secretion of growth hormone, insulin and glucagon in obese persons before and after using low-calorie diet].
Topics: Adult; Diet, Reducing; Female; Glucagon; Growth Hormone; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity | 1987 |
Failure of carbohydrate to spare leucine oxidation in obese subjects.
Topics: Administration, Oral; Adult; Blood Glucose; Female; Glucagon; Glucose; Humans; Insulin; Leucine; Male; Middle Aged; Obesity | 1987 |
Age-related qualitative and quantitative changes in the endocrine pancreas of the LA/N-corpulent rat.
Topics: Aging; Animals; Glucagon; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity; Rats; Rats, Mutant Strains | 1987 |
Anomeric specificity of the insulin and glucagon secretory responses to D-glucose in lean and obese Zucker rats.
Topics: Animals; Female; Glucagon; Glucose; Insulin; Insulin Secretion; Isomerism; Obesity; Perfusion; Rats; Rats, Zucker | 1987 |
Abnormal regulation of pancreatic glucagon secretion in obese fa/fa rats.
Topics: Animals; Arginine; Female; Glucagon; Male; Obesity; Pancreas; Rats; Rats, Mutant Strains | 1988 |
Nitrogen conservation in starvation revisited: protein sparing with intravenous fructose.
Topics: Acid-Base Equilibrium; Adult; Amino Acids; Blood Glucose; Fasting; Female; Fructose; Glucagon; Humans; Insulin; Lipid Metabolism; Middle Aged; Natriuresis; Nitrogen; Obesity; Proteins; Thyroxine; Triiodothyronine; Uric Acid | 1986 |
Metabolic response to a specific lipid-depleting factor in parabiotic rats.
Topics: Adipose Tissue; Animals; Fatty Acids; Female; Glucagon; Glycerol; Growth Hormone; Insulin; Lipid Metabolism; Liver; Obesity; Oxidation-Reduction; Parabiosis; Proteins; Rats; Rats, Inbred Strains; Tongue | 1986 |
Possible role of pancreatic insulin and glucagon in the hyperlipidemia and obesity of obese strain of chicken.
Topics: Animals; Chickens; Glucagon; Hyperlipidemias; Hypothyroidism; Insulin; Male; Obesity; Propylthiouracil; Thyroid Hormones | 1986 |
Adipocyte heat production before and after weight reduction by gastroplasty.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Temperature Regulation; Body Weight; Calorimetry; Fasting; Female; Follow-Up Studies; Glucagon; Glucose; Humans; Insulin; Lipoprotein Lipase; Male; Obesity; Postoperative Period; Stomach; Time Factors | 1986 |
Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
Topics: Adult; Aged; Blood Glucose; Fasting; Fatty Acids, Nonesterified; Female; Food; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged; Obesity | 1986 |
In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.
Topics: Adult; Blood Glucose; Glucagon; Glucose; Glucose Tolerance Test; Humans; Infusions, Parenteral; Insulin; Kinetics; Liver; Middle Aged; Obesity; Time Factors | 1986 |
Insulinotropic activity in the serum of obese and nonobese infants and children.
Topics: Adolescent; Child; Child, Preschool; Glucagon; Humans; Infant; Infant, Newborn; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity | 1986 |
Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity.
Topics: Adult; Blood Glucose; Fasting; Female; Gastrins; Glucagon; Humans; Insulin; Male; Middle Aged; Obesity; Pancreatic Hormones; Pancreatic Polypeptide; Stomach | 1986 |
Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus.
Topics: Activity Cycles; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged; Obesity | 1987 |
Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Glucagon; Gluconeogenesis; Glucose; Glycogen; Growth Hormone; Insulin; Insulin-Like Growth Factor I; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Muscles; Obesity | 1987 |
Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Kinetics; Middle Aged; Obesity | 1987 |
Gastrointestinal peptides and insulin secretion.
Topics: Animals; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Secretion; Liver; Neuropeptides; Obesity; Peptide Fragments | 1987 |
Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
Topics: Adult; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Food; Glucagon; Humans; Islets of Langerhans; Male; Obesity | 1987 |
Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Kinetics; Liver; Male; Obesity | 1987 |
[Secretion of gastrin, pancreatic polypeptide and glucagon in persons with simple obesity].
Topics: Adult; Diet, Reducing; Female; Gastrins; Glucagon; Humans; Male; Middle Aged; Obesity; Pancreatic Polypeptide | 1987 |
Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.
Topics: Adult; Female; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Jejunoileal Bypass; Male; Obesity; Pancreatic Polypeptide | 1986 |
Role of glucagon in the control of food intake in Zucker obese and lean rats.
Topics: Animals; Feeding Behavior; Female; Glucagon; Immune Sera; Injections, Intraperitoneal; Male; Obesity; Rats; Rats, Inbred Strains; Rats, Zucker; Satiation | 1986 |
Starvation enhances the ability of insulin to inhibit its own secretion.
Topics: Adult; Blood Glucose; C-Peptide; Feedback; Glucagon; Humans; Insulin; Insulin Secretion; Middle Aged; Obesity; Starvation | 1985 |
Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity.
Topics: Age Factors; Animals; Arginine; Atropine; Disease Susceptibility; Glucagon; Insulin; Obesity; Pancreas; Parasympathetic Nervous System; Rats; Rats, Zucker; Vagus Nerve | 1985 |
Maximal pancreatic beta-cell stimulation and the counter-regulatory hormonal responses in South African black and white obese subjects.
Topics: Adult; Black or African American; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Obesity; Time Factors; Tolbutamide; White People | 1985 |
Changes in lipid metabolism in diet-induced obesity.
Topics: Adipose Tissue; Animals; Blood Glucose; Diet; Energy Intake; Energy Metabolism; Glucagon; Glycerol; Insulin; Lipid Metabolism; Lipids; Liver; Male; Obesity; Oxidation-Reduction; Rats; Rats, Inbred Strains; Stress, Physiological | 1985 |
Fluctuations in basal plasma levels of pancreatic polypeptide in monkeys and humans.
Topics: Adult; Animals; Blood Glucose; Fasting; Female; Glucagon; Humans; Insulin; Macaca mulatta; Male; Obesity; Pancreatic Polypeptide; Periodicity; Species Specificity | 1985 |
Morphology of the endocrine pancreas in diabetic sand rat (Psammomys obesus).
Topics: Animals; Arvicolinae; Blood Glucose; Diabetes Mellitus, Experimental; Female; Glucagon; Insulin; Islets of Langerhans; Male; Microscopy, Electron; Obesity; Reference Values | 1985 |
[Effect of mazindol on insulin and glucagon secretion in ventromedial hypothalamic obese rats].
Topics: Animals; Body Weight; Female; Glucagon; Hypothalamic Diseases; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Mazindol; Obesity; Rats; Rats, Inbred Strains | 1985 |
Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus.
Topics: Adult; Arginine; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Epinephrine; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Norepinephrine; Obesity; Pregnancy; Pregnancy in Diabetics | 1985 |
Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Obesity; Receptor, Insulin | 1985 |
A role for the vagus nerve in the etiology and maintenance of the hyperinsulinemia of genetically obese fa/fa rats.
Topics: Animals; Arginine; Atropine; Electric Stimulation; Glucagon; Glucose; Hyperinsulinism; Insulin; Insulin Secretion; Obesity; Pancreas; Perfusion; Rats; Rats, Zucker; Vagus Nerve | 1985 |
Carbohydrate intolerance in gonadal dysgenesis: evidence for insulin resistance and hyperglucagonemia.
Topics: Adolescent; Adult; Aging; Arginine; Blood Glucose; Body Weight; Child; Glucagon; Glucose Tolerance Test; Gonadal Dysgenesis; Growth Hormone; Humans; Insulin; Insulin Resistance; Malabsorption Syndromes; Male; Obesity; Tolbutamide | 1985 |
Decreased prolactin secretion in childhood obesity.
Topics: Adolescent; Blood Glucose; Child; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin; Obesity; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1985 |
Fetal hormone and metabolite levels in lean and obese pigs.
Topics: Adipose Tissue; Animals; Blood Glucose; Female; Fetus; Glucagon; Growth Hormone; Hormones; Hydrocortisone; Lipid Metabolism; Maternal-Fetal Exchange; Obesity; Pregnancy; Swine; Triglycerides; Triiodothyronine | 1985 |
Glucagon secretion in obesity.
Topics: Adult; Alanine; Child; Diabetes Mellitus; Fasting; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Insulin Secretion; Obesity; Pancreas; Radioimmunoassay; Time Factors | 1973 |
Glucagon secretion in obesity.
Topics: Glucagon; Humans; Obesity | 1973 |
Insulin degradation by fat cell ghosts.
Topics: Adipose Tissue; Animals; Binding, Competitive; Biodegradation, Environmental; gamma-Globulins; Glucagon; Humans; Insulin; Iodine Radioisotopes; Lipid Metabolism; Male; Obesity; Rats | 1974 |
Decreased glucagon activity: A mechanism for genetic and acquired endogenous hyperlipaemia.
Topics: Animals; Chlorides; Cobalt; Contraceptives, Oral; Diet; Dietary Carbohydrates; Disease Models, Animal; Fatty Acids; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hyperlipidemias; Lipid Metabolism, Inborn Errors; Lipoproteins; Liver; Obesity; Rats | 1974 |
Comparative investigations on lipolysis and re-esterification in adipose tissue of man and various species of mice.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Adult; Animals; Cyclic AMP; Epididymis; Fasting; Fatty Acids; Fatty Acids, Nonesterified; Genetic Code; Glucagon; Glycerol; Humans; Lipid Metabolism; Lipid Mobilization; Male; Mice; Mice, Inbred Strains; Norepinephrine; Obesity; Skin; Species Specificity; Theophylline | 1974 |
Hyperglucagonaemia in obese children.
Topics: Child; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Obesity | 1968 |
Insulin response to glucagon in obese children.
Topics: Blood Glucose; Child; Child, Preschool; Glucagon; Humans; Insulin; Obesity | 1968 |
A combined biochemical and histological study on the islets of Langerhans in the genetically obese hyperglycaemic mouse and the lean mouse, including observations on the effects of streptozotocin treatment.
Topics: Animals; Blood Glucose; Body Weight; Cell Count; Glucagon; Histocytochemistry; Hyperglycemia; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred Strains; Obesity; Organ Size; Pancreas; Streptozocin | 1973 |
[Study of disorders of glycoregulation in the course of chronic hepatopathies of alcoholic origin].
Topics: Adrenal Cortex Hormones; Adult; Alcoholism; Chronic Disease; Diabetes Complications; Diuretics; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver Diseases; Male; Middle Aged; Obesity | 1967 |
[Control of ATP levels in stimulated pancreatic B-cells].
Topics: Adenosine Triphosphate; Animals; Butyrates; Carbutamide; Cyclic AMP; Diazoxide; Epinephrine; Glucagon; Glucose; Glycogen; Histocytochemistry; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Ischemia; Islets of Langerhans; Mice; Obesity; Pancreatic Diseases; Sulfonamides; Theophylline | 1969 |
[2 cases of Langerhans adenoma].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma, Islet Cell; Adult; Aged; Angiography; Celiac Artery; Female; Gastrointestinal Hemorrhage; Glucagon; Humans; Hypoglycemia; Insulin; Intracranial Arteriosclerosis; Leucine; Mesenteric Arteries; Obesity; Pancreatectomy; Pancreatic Neoplasms; Pregnancy; Pregnancy Complications; Prognosis; Tolbutamide | 1969 |
Regulation of pancreatic beta-cell glycogen through cyclic-3,5-AMP.
Topics: Adenine Nucleotides; Animals; Cyclic AMP; Epinephrine; Female; Glucagon; Glucose; Glycogen; Hyperglycemia; In Vitro Techniques; Islets of Langerhans; Mice; Obesity; Theophylline | 1971 |
Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumors.
Topics: Acromegaly; Adenoma, Islet Cell; Adolescent; Adult; Animals; Child; Chromatography, Gel; Cricetinae; Cushing Syndrome; Diazoxide; Disease Models, Animal; Female; Glucagon; Glucose Tolerance Test; Half-Life; Humans; Hypoglycemia; Hypokalemia; Insulin; Iodine Isotopes; Leucine; Male; Middle Aged; Myotonic Dystrophy; Neoplasms, Experimental; Obesity; Proinsulin; Radioimmunoassay; Stimulation, Chemical; Tolbutamide | 1971 |
Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.
Topics: Animals; Cell Fractionation; Cell Membrane; Electrophoresis, Disc; Genetics; Glucagon; Growth Hormone; Hypoglycemia; Insulin; Insulin Antibodies; Insulin Resistance; Iodine Isotopes; Isoproterenol; Liver; Mice; Mice, Inbred C57BL; Microscopy, Phase-Contrast; Obesity; Protein Binding; Proteins; Receptors, Cell Surface | 1973 |
A preview of growth hormone stimulation tests in children.
Topics: Adrenocorticotropic Hormone; Arginine; Diethylstilbestrol; Dihydroxyphenylalanine; Endotoxins; Female; Glucagon; Glucocorticoids; Glucose; Gonadal Steroid Hormones; Growth Hormone; Humans; Hypoglycemia; Hypothyroidism; Insulin; Male; Obesity; Physical Exertion; Pituitary Function Tests; Pseudomonas; Puberty; Sleep; Vasopressins | 1974 |
[Metabolic and hormonal peculiarities of obesity].
Topics: Adipose Tissue; Adrenal Cortex Hormones; Blood Glucose; Catecholamines; Cyclic AMP; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Hormones; Humans; Insulin; Lipid Mobilization; Obesity; Prostaglandins | 1973 |
The preparation of, and studies on, free cell suspensions from mouse pancreatic islets.
Topics: Animals; Cell Count; Cell Separation; Cell Survival; Culture Media; Cytological Techniques; Cytoplasmic Granules; DNA; Female; Glucagon; Glucose; Hyaluronoglucosaminidase; Hyperglycemia; Insulin; Insulin Secretion; Iodine Radioisotopes; Islets of Langerhans; Mice; Mice, Inbred Strains; Microbial Collagenase; Microscopy, Electron; Obesity; Pronase; Theophylline | 1974 |
Presence and mobilization of glycogen in mammalian pancreatic beta cells.
Topics: Animals; Cyclic AMP; Fluorometry; Glucagon; Glucosephosphate Dehydrogenase; Glucosyltransferases; Glycogen; Hexokinase; Hyperglycemia; Ischemia; Islets of Langerhans; Mice; NADP; Obesity; Phosphoglucomutase | 1969 |
[Obesity and the somatotropic hormone. I. Somatotropin secretion in obesity].
Topics: Adolescent; Adult; Aged; Arginine; Dihydroxyphenylalanine; Female; Glucagon; Glucose; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin; Male; Middle Aged; Obesity; Pituitary Gland | 1974 |
Paradoxical glucagon release in obese hyperglycemic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Glucagon; Hyperglycemia; Mice; Mice, Inbred Strains; Mutation; Obesity; Pancreas; Perfusion; Time | 1974 |
The role of glucagon as a catabolic hormone.
Topics: Alanine; Amino Acids; Ammonia; Carbon Radioisotopes; Fasting; Glucagon; Half-Life; Humans; Obesity; Urea | 1974 |
Metabolism of genetically obese rates on normal or high-fat diet.
Topics: Adipose Tissue; Animals; Blood Glucose; Dietary Fats; Disease Models, Animal; Epididymis; Fatty Acids; Glucagon; Glucose; Glycogen; In Vitro Techniques; Insulin; Lipids; Liver; Male; Muscles; Obesity; Pancreas; Phospholipids; Rats; Rats, Inbred Strains; Triglycerides | 1974 |
[Metabolic and hormonal effects of complete short-term fasting in the obese person].
Topics: Blood Glucose; Body Weight; Chlorides; Creatinine; Fasting; Female; Glucagon; Glucose; Humans; Insulin; Male; Obesity; Sodium | 1974 |
[Secretion of insulin and growth hormone during glucagon loading in obesity].
Topics: Adolescent; Adult; Arginine; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Secretion; Middle Aged; Obesity | 1974 |
[Indirect stimulation of the adrenal cortex].
Topics: 11-Hydroxycorticosteroids; Adolescent; Adrenal Glands; Adult; Androgen-Insensitivity Syndrome; Blood Glucose; Child; Child, Preschool; Cushing Syndrome; Dermatomyositis; Gigantism; Glucagon; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Insulin; Kidney Failure, Chronic; Middle Aged; Nephrosis; Obesity; Pituitary-Adrenal Function Tests; Tonsillitis | 1972 |
B-pancreatic function in obese and diabetic children.
Topics: Arginine; Blood Glucose; Child; Diabetes Mellitus, Type 1; Ethylenediamines; Female; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Islets of Langerhans; Male; Obesity; Theophylline; Tolbutamide | 1972 |
Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects.
Topics: Adolescent; Adult; Alanine; Blood Glucose; Diabetes Mellitus; Glucagon; Humans; Injections, Intravenous; Insulin; Islets of Langerhans; Middle Aged; Obesity; Starvation | 1973 |
Plasma glucagon in obesity. Response to arginine, glucose and protein administration.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Diet, Reducing; Dietary Proteins; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Immunoassay; Injections, Intravenous; Insulin; Islets of Langerhans; Obesity; Stimulation, Chemical; Time Factors | 1973 |
Studies of immunoreactive insulin secretion in NZO mice in vivo.
Topics: Aminophylline; Animals; Antigens; Arginine; Diabetes Mellitus; Disease Models, Animal; Fasting; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Isoproterenol; Mice; Mice, Inbred Strains; Obesity; Phenytoin; Radioimmunoassay; Secretory Rate | 1974 |
Diabetes in the sand-rat: diabetogenesis, responses to mannoheptulose and atriplex ash.
Topics: Animals; Basal Metabolism; Blood Glucose; Cataract; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diet; Disaccharides; Glucagon; Glucose Tolerance Test; Glycosuria; Heptoses; Hyperglycemia; Mannose; Obesity; Plants, Medicinal; Rats; Respiration; Species Specificity | 1972 |
[The effect of glucagon on metabolism].
Topics: Acute Disease; Adolescent; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucagon; Hepatitis; Humans; Male; Obesity | 1972 |
Obesity: evidence of decreased secretion of glucagon.
Topics: Adult; Alanine; Animals; Blood Glucose; Fasting; Glucagon; Humans; Injections, Intravenous; Insulin; Obesity; Time Factors | 1972 |
Glucagon and obesity.
Topics: Child; Glucagon; Humans; Obesity | 1973 |
The natriuretic effect of glucagon and its role in starvation.
Topics: Adolescent; Adult; Diet Therapy; Fasting; Female; Glucagon; Humans; Male; Natriuresis; Obesity | 1973 |
Relationship between diabetes mellitus and obesity in the child.
Topics: Adolescent; Arginine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Obesity | 1973 |
Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man.
Topics: Adult; Alanine; Amino Acids; Blood Glucose; Cushing Syndrome; Dexamethasone; Dietary Proteins; Fasting; Female; Glucagon; Glucocorticoids; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Male; Middle Aged; Obesity; Pancreas | 1973 |
Plasma insulin and glucose profiles in normal, obese, and diabetic persons.
Topics: Adolescent; Adult; Aged; Blood Glucose; Carbohydrate Metabolism, Inborn Errors; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Eating; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity | 1973 |
Chronophysiologic effects of a restricted diet (220 cal-24 H as casein) in young healthy but obese women.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adult; Body Temperature; Circadian Rhythm; Diet, Reducing; Dietary Proteins; Eating; Female; Food Deprivation; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Motor Skills; Nitrogen; Obesity; Oxygen Consumption; Potassium; Sodium | 1973 |
[Influence of the liver on serum insulin level].
Topics: Arm; Cholelithiasis; Chronic Disease; Glucagon; Hepatitis; Humans; Hyperinsulinism; Insulin; Liver; Obesity; Pancreas; Portal Vein; Stimulation, Chemical | 1973 |
Relative influence of obesity and diabetes on plasma alpha-cell glucagon.
Topics: Adult; Arginine; Blood Glucose; Diabetes Mellitus; Dietary Proteins; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Nitrogen; Obesity | 1974 |
[Lipolytic action of glucagon in obese children].
Topics: Adolescent; Child; Fatty Acids, Nonesterified; Glucagon; Humans; Lipid Metabolism; Obesity | 1974 |
Effect of glucagon on amino acid and nitrogen metabolism in fasting man.
Topics: Acetoacetates; Adult; Alanine; Amino Acids; Ammonia; Blood Glucose; Blood Urea Nitrogen; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Hydroxybutyrates; Infusions, Parenteral; Injections, Intravenous; Insulin; Kidney; Liver; Nitrogen; Obesity; Radioisotopes | 1974 |
Growth hormone and cortisol secretion after propranolol--glucagon testing in the adult.
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Glucose; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Injections, Intramuscular; Insulin; Male; Middle Aged; Myxedema; Obesity; Pituitary Gland; Pituitary-Adrenal Function Tests; Propranolol | 1974 |
Role of insulin and glucagon in obesity.
Topics: Arginine; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Nitrogen; Obesity | 1974 |
Pathogenetic aspects of the obese-hyperglycemic syndrome in mice (genotype obob). I. Function of the pancreatic B-cells.
Topics: Age Factors; Animals; Blood Glucose; Body Weight; Disease Models, Animal; Glucagon; Glucose Tolerance Test; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Obesity | 1970 |
Some aspects of the problem of regulating food intake and obesity.
Topics: Adolescent; Adult; Animals; Appetite; Appetite Regulation; Blood Glucose; Child; Child, Preschool; Dogs; Female; Glucagon; Glucose; Gold; Haplorhini; Humans; Hunger; Hypothalamus; Infant; Lactation; Male; Mice; Obesity; Pregnancy; Pregnancy Complications; Psychology; Sulfur | 1970 |
I.R.I. after glucagon administration in groups of obese subjects, with no family history of diabetes, with normal glucose tolerance test, with chemical diabetes, or with mild not ketotic diabetes mellitus.
Topics: Diabetes Mellitus; Diabetic Ketoacidosis; Glucagon; Glucose Tolerance Test; Humans; Insulin; Obesity | 1970 |
Metabolic and hormonal patterns after three days of total fasting in 27 obese and nonobese subjects.
Topics: Arginine; Blood Glucose; Depression, Chemical; Diabetes Complications; Diabetes Mellitus; Fasting; Glucagon; Growth Hormone; Humans; Insulin; Insulin Secretion; Obesity; Radioimmunoassay; Stimulation, Chemical; Time Factors | 1972 |
Nutrient regulation of insulin secretion in human subjects.
Topics: Administration, Oral; Adolescent; Animals; Blood Glucose; Dactinomycin; Diabetes Mellitus; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Glucagon; Glucose; Humans; Hypoglycemia; Infusions, Parenteral; Injections, Intravenous; Insulin; Insulin Secretion; Male; Norepinephrine; Obesity; Phenformin; Rats | 1972 |
Glucagon and obesity.
Topics: Glucagon; Humans; Obesity | 1972 |
[Hypocalcemia during L-arginine infusion in a group of obese adolescents].
Topics: Adolescent; Arginine; Blood Glucose; Calcitonin; Calcium; Child; Chlorides; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Male; Obesity; Potassium; Sodium | 1971 |
Changes in plasma insulin related to the type of dietary carbohydrate in overweight hyperlipidemic male patients.
Topics: Adult; Angina Pectoris; Body Weight; Diabetes Mellitus; Diet, Diabetic; Dietary Carbohydrates; Glucagon; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Pancreas; Polysaccharides; Sex Factors | 1971 |
[Role of glucagon in sodium retention observed in case of glucose administration to obese persons subjected to total fasting].
Topics: Fasting; Glucagon; Glucose; Humans; Insulin; Obesity; Sodium | 1971 |
[Missing stimulation of STH secretion by glucagon i.v. in normal, adipose, and diabetic adults].
Topics: Adult; Diabetes Mellitus; Female; Glucagon; Growth Hormone; Humans; Injections, Intravenous; Male; Obesity; Sex Factors | 1971 |
Enhanced postglucose hypophosphatemia during starvation therapy of obesity.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Body Weight; Depression, Chemical; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hyperglycemia; Insulin; Liver; Middle Aged; Muscles; Obesity; Phosphorus; Stimulation, Chemical; Time Factors; Tolbutamide | 1969 |
Studies in spiny mice (Acomys cahirinus): metabolic state and pancreatic insulin release in vitro.
Topics: Age Factors; Animals; Antigens; Arginine; Blood Glucose; Caffeine; Calcium; Diabetes Mellitus; Glucagon; Glycosuria; Hyperglycemia; In Vitro Techniques; Insulin; Insulin Secretion; Leucine; Mice; Mice, Inbred Strains; Obesity; Pancreas; Tolbutamide | 1969 |
Glucose and insulin response to intravenous glucagon during starvation.
Topics: Adult; Glucagon; Glucose; Humans; Injections, Intravenous; Insulin; Middle Aged; Obesity; Starvation; Time Factors | 1970 |
Hormones and substrates in the regulation of gluconeogenesis in fasting man.
Topics: Adult; Amino Acids; Fasting; Female; Glucagon; Gluconeogenesis; Growth Hormone; Humans; Male; Middle Aged; Obesity | 1970 |
Studies on the radioimmunological determination of blood insulin by means of 125-I-insulin of high specific activity.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Animals; Blood Glucose; Diabetes Mellitus, Type 1; Fasting; Female; Glucagon; Glucose; Humans; Infant; Insulin; Iodine Isotopes; Leucine; Methods; Obesity; Radioimmunoassay; Swine; Tolbutamide | 1970 |
Glucagon-induced growth hormone release in children.
Topics: Adolescent; Child; Diabetes Mellitus, Type 1; Female; Glucagon; Growth Hormone; Humans; Male; Obesity | 1970 |
[Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
Topics: Diabetes Mellitus; Glucagon; Humans; Injections, Intravenous; Insulin; Iodine Radioisotopes; Obesity; Radioimmunoassay; Tolbutamide | 1967 |
Preservation of insulin and liver glycogen stores during very long fasts.
Topics: Adult; Blood Glucose; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Glycogen; Obesity | 1968 |
The insulin response to glucagon: effects of diabetes and obesity on nonglucose-dependent insulin secretion.
Topics: Blood Glucose; Diabetes Mellitus; Glucagon; Humans; Immunoassay; Infusions, Parenteral; Insulin; Insulin Antibodies; Insulin Secretion; Obesity | 1968 |
[Metabolic effect of glucagon in relation to obesity and fasting].
Topics: Blood Glucose; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Ketone Bodies; Obesity | 1968 |
Early phase of insulin release.
Topics: Adult; Aged; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Prediabetic State; Time Factors | 1968 |
Blood flow through human adipose tissue during lipolysis.
Topics: Adipose Tissue; Adult; Aged; Arteries; Blood Glucose; Blood Pressure; Body Weight; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Infusions, Parenteral; Injections, Intravenous; Lipids; Male; Middle Aged; Norepinephrine; Obesity; Radioisotopes; Regional Blood Flow; Stimulation, Chemical; Time Factors; Xenon | 1968 |
Alcohol hypoglycemia. VII. Further studies on the refractoriness of obese subjects.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diet; Dietary Fats; Ethanol; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hypoglycemia; Insulin; Lactates; Liver Glycogen; Male; Middle Aged; Obesity; Physical Exertion; Starvation; Thyroxine | 1968 |
[On the cause and treatment of the senile diabetes].
Topics: Aged; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Diet Therapy; Exercise Therapy; Fatty Liver; Glucagon; Humans; Hypoglycemic Agents; Injections, Intramuscular; Insulin; Liver Glycogen; Obesity; Rabbits | 1968 |
[The outcome of the glucagon test in obesity].
Topics: Adolescent; Adult; Aged; Blood Glucose; Fatty Liver; Glucagon; Humans; Injections, Intravenous; Liver Function Tests; Liver Glycogen; Middle Aged; Obesity | 1968 |
[Insulinemic response to various stimuli in normal, obese, diabetic and acromegalic subjects].
Topics: Acromegaly; Adult; Diabetes Mellitus; Female; Glucagon; Glucose; Humans; Insulin; Male; Mannose; Middle Aged; Obesity; Secretin | 1968 |
Insulin response to glucagon. The opposing effects of diabetes and obesity.
Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Obesity; Stimulation, Chemical | 1969 |
[Insulin-like activity determined as an antilipolytic effect of the serum in relation to obesity and fasting].
Topics: Adipose Tissue; Adult; Animals; Blood; Diabetes Mellitus; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Middle Aged; Obesity | 1969 |
[The effect of glucagon on the serum levels of free fatty acids and glycerol in children].
Topics: Blood Glucose; Child; Child, Preschool; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Male; Methods; Obesity; Time Factors | 1969 |
Heterogeneity of glucagon-like immunoreactive peptides (GLi) in the intestine of obese hyperglycaemic (ob/ob) mice.
Topics: Animals; Chromatography, Gel; Glucagon-Like Peptides; Hyperglycemia; Intestines; Mice; Mice, Obese; Obesity; Peptides | 1983 |